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Abstract
Thyroid associated ophthalmopathy (TAO) and chronic allergic eye disease (CAED) 
both can be classified as immune deviated eye diseases. Both diseases affect the eye, 
are associated with a localised CD4+ T cell infiltration, chronic inflammation and a high 
risk of visual impairment Localised T cell lines had previously been characterised as 
Thl-like in TAO and Th2-like in VKC using ELISA and RT-PCR However, using 
these techniques peripheral blood-derived T cell lines did not show any bias. This study 
has sought to establish whether using intracellular cytokine staining, a more sensitive 
method of single cell cytokine analysis, of TAO and CAED peripheral blood T cell 
lines revealed any skewing of cytokine profiles. At the same time this technique allows 
die analysis of cytokine expression from both CD4+ and CD8+ T cells to be investigated.
Using peripheral blood T cell lines, stained intracellularly for Thl and Th2 cytokines, a 
skewing of cytokine profiles towards Thl in TAO and Th2 in CAED was observed, 
suggesting that the blood-derived T cells might reflect die localised immune cell 
processes occurring during disease. Because of the cytokine profiles observed in vivo 
cytokine immunotherapy for patients suffering from ocular inflammatory conditions 
(TAO, CAED) might be of benefit. Hence the latter part of these Ph.D. studies has 
focussed on strategies to modulate cytokine expression in vitro.
Current therapy for chronic inflammatory disease relies predominantly on 
corticosteroids and cyclosporin A (CsA). The effect of dexamethasone on cytokine 
profiles has been investigated in this study as well as CsA, both having suppressive 
actions on T cells. Other approaches that may have potential in inflammatory 
conditions have also been investigated. Firstly the effects of the application of 
exogenous cytokines along with blocking cytokines have been studied. An alternative 
approach that may be adopted to alter cytokine profiles in inflammatory conditions 
could be by targeting molecules involved in the signalling pathways for pro- 
inflammatory cytokines. NFkB is known to be involved in the signalling pathway for 
the generation of several pro-inflammatory cytokines. In this study the consequences of 
blockading NFkB in T cells has been investigated.
Work towards this thesis has involved the study of T cell cytokine profiles in CD4+ T 
cell mediated inflammatory diseases affecting the eye in vitro. Hopefully, this data will 
be helpful in understanding the basic mechanisms involved and contribute to the future 
design of immunotherapeutic interventions.
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1.1 Overview of the immune system
The immune system is made up of a vast array of cells that have developed to recognize 
and eradicate a wide spectrum of microorganisms and to maintain an unresponsive state 
to coexist with a large variety of self-antigens. The immune system can be divided into 
two functional categories, the innate immune system and adaptive immune responses, 
the latter involving humoral and cell mediated responses.
1.1.1 Innate and Specific immunity
The innate immune system is die first fine of defence that acts immediately to resist 
against infection. The innate response is characterized by a limited capacity to 
distinguish between infectious agents and die efficacy to respond is not improved with 
repeated exposure, due to the absence of memory.
The cells of the innate immune system specifically recognize pathogen-derived antigens 
by means of pattem-recognition receptors (PRRs), the specificity of these are highly 
conserved and genetically dictated (Kyewski et al, 2002). This group of receptors 
belong to the family of Toll-like receptors (TLRs), which recognize pathogen- 
associated molecular patterns (PAMPs) uniquely expressed on cells of microorganisms 
and absent from host cells (Aderem and Ulevitch, 2000). The TLRs are type I 
transmembrane proteins with an intracellular domain very similar to that of the 
cytoplasmic domain of the interleukin (IL) -1 receptor (IL-1R) and possibly use an 
analogous molecular signalling pathway. EL-1 activation involves the triggering of 
several transcription factors, including nuclear factor kappa B (NF-kB) and c-jun/AP-1 
that are crucial for the transcription of several pro-inflammatory cytokines, co­
stimulators and chemokines.
The specific immune response displays specificity, diversity and memory that improves 
with repeated exposure and seltfnon-self recognition. The specific immune system is 
capable of recognizing billions of uniquely different structures on foreign antigens via 
specific receptors on the surface of T and B lymphocytes. The capacity of these cells to 
distinguish foreign molecules from self is learned during ontogeny. The components 
involved in the specific immune response include T and B lymphocytes, antigen 
presenting cells (APCs) and plasma cells.
21
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1.1.2 Lymphocytes
Each B and T cell is genetically programmed to encode for a surface receptor and is 
responsible for the recognition of a particular antigen. Antigen receptor diversity is 
generated in immunoglobulin (Ig) and T cell receptor (TCR) variable regions by the 
process o f VDJ recombination from a spectrum of germline gene segments to produce a 
randomly selected lymphocyte receptor with a unique specificity. In T cells subsequent 
thymic selection governs the composition of the peripheral TCR repertoire. Individual 
TCR’s exhibit a certain degree of cross-reactivity therefore a single TCR can recognize 
multiple peptide-major histocompatibility complex (MHC) antigens and, vice versa, a 
single peptide-MHC can be recognized by multiple TCR’s. Thus a T cell response to a 
given individual antigen can involve more than one TCR clonotype (as reviewed by 
Goronzy et al, 1998).
The adaptive immune response to an antigen can be divided into three phases: firstly the 
recognition stage, secondly a phase of activation, and finally the effector phase. The 
first stage involves the binding of antigens to specific B or T cell receptors. This is 
followed by a sequence of events occurring within the immune cell resulting in the 
proliferation and expansion of the activated cell and consequently the differentiation of 
the activated cell and its progeny into effector cells. Effector lymphocytes either 
directly kill infected body cells or they secrete cytokines. The cytokines act either by 
directly destroying pathogens or induce other cell types, such as cytotoxic T 
lymphocytes (CTL) and macrophages to enhance their capacity to eliminate the 
invading organism (Koevary, 1999).
The B cells have specific surface antibodies and once antigen is bound to the antibody 
the B cell begins to multiply and differentiate into plasma cells which in turn secrete 
large amounts of antibodies. There are five antibody isotypes each with a unique heavy 
chain immunoglobulin (Ig): IgM IgG, IgD, IgA and IgE. The T cells can be divided 
into two main classes that can be characterised by their cell surface markers. Subsets of 
CD4+ T cells, originally cloned CD4+ T cells, can be further subdivided into ThO, Thl 
Th2 (Mosmann, 1995) and more recently CD4+ CD25+ T regulatory cells subsets 
(reviewed by Maloy and Powrie, 2001). It must also be mentioned that a small 
proportion of CD4+ T cells actually function as cytotoxic cells. The CD8+ T cells may 
also be subdivided into Tel and Tc2 subsets. CD4+ T cell subsets will be discussed in a 
later section (1.2).
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1.13 Antigen presentation and recognition by T cells
Antigens, whether self of foreign, are presented to CD4+ T cells by antigen presenting 
cells (APCs) in the context of MHC class II molecules. APCs are a heterogeneous 
population of leucocytes that function as immunostimulatory cells. The main role of 
APCs is to present antigen to CD4+ T cells. APCs are found primarily in die skin, 
lymph nodes, spleen, within or below most mucosal epithelia and in the thymus. 
Professional APCs include B cells, macrophages and dendritic cells with surface MHC 
class II molecules that enable the presentation of antigenic peptides to T cells. Other 
non-professional APCs such as orbital fibroblasts (Muhlberg et al, 1997) are also 
involved in presenting processed antigen to CD4+ T cells. The main function of CD4+ 
T cells is to activate other cells of the immune system
It is the a{3 chains of the TCR that recognise processed antigen as peptide fragments 
bound to MHC class I or class II molecules. Within 30-60 minutes of contact between a 
T cell and an APC, an immunologocial synapse is formed. This is characterised by 
several centrally-located signalling molecules, for example the TCR-MHC, and 
important costimulatory molecules (CD28-B7) surrounded by a peripheral ‘glue’ of 
adhesion molecules including intercellular adhesion molecule 1 (ICAM-1) and 
leukocyte function-associated antigen 1 (LFA-1), (as reviewed by Lanzavecchia and 
Sallusto, 2000). T cell activation is only induced when the binding of a TCR with MHC 
peptide complex is accompanied by the binding of costimulatory molecules.
Dendritic cells (DCs) are the most potent of the APCs. In order for DCs to become 
potent T cell stimulators they undergo a maturation process accompanied by functional 
and phenotypic changes (Banchereau and Steinman, 1998). During this maturation 
process CD83, a 45-kDa glycoprotein, is strongly upregulated along with costimulatory 
molecules CD80 and CD86 (Zhou and Tedder, 1996). During maturation, the DCs 
migrate into the lymphoid organs to stimulate naive T cells. Depending on the stimulus 
DCs acquire a DC1 or a DC2 phenotype that subsequently facilitates die development 
of Thl and Th2 CD4+ cells (Schneider et al, 2002).
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1J2 Human T cell subsets
T cells are important in the recognition and eradication of a wide variety of 
microorgansims. Once they have been stimulated by peptide antigen presented on HLA 
class II DR molecules the T cells begin to produce IL-2 and clonally expand and 
subsequently differentiate to express new patterns of genes essential for immune 
effector function. The Th cells express CD4+ antigen and can differentiate into different 
subsets including ThO, Thl and Th2 subsets which are distinguished by the array of 
cytokine genes they express (reviewed by O’Garra and Arai, 2000). It should be noted 
here that with the identification of novel molecules, further reclassifications of T cell 
subsets are possible, and the descriptions provided below are based on the current 
understanding of the field from several different laboratories. Additionally, for the 
purpose of this thesis only the CD4+ subsets will be discussed.
0 .1  CD4+ ThO cells
The cytokine profiles secreted from activated CD4+ T cells can serve to identify a 
particular subset that has been activated (Willheim et al, 1997). The ThO cells are 
denoted when there is an absence of clear polarising signals indicating either Thl or 
Th2 subsets and contain a mixture of Thl and Th2 cytokines (reviewed by Sallusto et 
al, 1998). ThO CD4+ T cells have the potential to differentiate into Thl or Th2 
depending on the nature of die stimulating Ag, the APC or die cytokine environment. 
IL-12, IFN-y and transforming growth factor-0 (TGF-0) influence the ThO to 
differentiate into Thl cells whereas IL-4 is responsible for driving ThO cells to become 
Th2 cells.
1.2.2 CD4 + Thl cells
Typical human Thl cytokines include IFN-y, TNF-0, and IL-2. This subset of CD4+ T 
cells is involved in cell-mediated inflammatory reactions. The mode of action of some 
of the Thl cytokines is to activate cytotoxic, inflammatory and delayed type 
hypersensitivity reactions. Several autoimmune conditions such as rheumatoid arthritis 
(RA) and Graves' Disease (GD), a condition strongly associated with thyroid associated 
ophthalmopathy (TAO), have been associated with Thl cytokines (Yang et al, 1999). 
Many investigators, studying a wide range of clinical diseases, have implicated a strong 
link between IFN-y and increased HLA-DR expression as a mechanism for causing 
autoimmune pathogenesis (Bottazzo, eta l 1986).
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The generation of a strong Thl response is essential with intracellular organisms, such 
as leishmania parasites which are obligate intra-macrophage organisms (Alexander and 
Russel, 1992). The survival of these parasites is dependent on whether the infected 
macrophages receive and act upon appropriate signals from the hosts’ immune response 
(Proudfoot et al, 1996). In cutaneous leishmaniasis it has been observed that a Thl cell 
response is protective and that a Th2 response is ineffective at controlling the spread of 
infection. Mice strains resistant to disease produce high levels of IFN-y with virtually 
no IL-4 during infection, in contrast to strains that are susceptible to infection who 
produce high levels of IL-4 (Akiba et al, 2000). It has been proposed that IFN-y is one 
of the most potent cytokines, secreted by activated Thl cells in the activation and 
stimulation of macrophages. Activated macrophages secrete an array of cytokines, have 
increased microbicidal and phagocytic activity and an increased ability to activate T 
cells. Cytotoxic and antimicrobial mediators produced by activated macrophages 
include oxygen-dependent killing mechanisms such as reactive oxygen intermediates: 
superoxide anion, hydroxyl radicals, hydrogen peroxide; and reactive nitrogen 
intermediates including nitric oxide and nitrogen dioxide. Oxygen independent killing 
mechanisms include defens ins, TNF, lysozyme and hydrolytic enzymes as described in 
a review by Spitznagel (1977).
1J13 CD4+ Th2 cells
It is widely accepted that Th2 cells can be identified by the secretion of the following 
cytokines: IL-4, IL-5, IL-13. The CD4+ Th2 cells promote humoral immune responses 
and allergic reactions associated with the production of IgE (Akiba et al, 2000). 
Humoral responses involve antibodies effective in the fluid components of blood and 
tissues. Antibodies are bi-functional molecules involved in the binding of native 
protein or polysaccharide antigens via specific immunoglobulin receptors (Fab portion), 
while the Fc portion is capable of interacting with different cells of the immune system 
or the complement system. Antibodies mainly mediate their protective effects by cross- 
linking antigens with Fc receptors on phagocytic cells such as neutrophils and 
macrophages thereby enabling phagocytosis of antigen-anti body immune complexes. 
Antibodies also function in ADCC to sensitize cells or large parasites for attack by 
cytotoxic cells (Marieb, 1992).
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Mast cells and basophils have on their surface high affinity Fc receptors for IgE which, 
when bound to specific allergens (second or subsequent exposure), cause degranulation 
of the cells and the release of several pharmacologically-active mediators influencing 
vascular permeability and vasodilation including histamine, leukotrienes, proteases and 
prostaglandins. In several disease states such as asthma and vernal keratoconjunctivitis 
(VKC), the chronic inflammation associated with these diseases is a consequence of an 
inappropriate immune response to a non-noxious substance such as an allergen.
It is widely accepted that IL-6 secreted from APCs influence naive CD4 + T cells to 
generate IL-4 which is necessary for the differentiation into Th2 effector cells (Rincon 
et al, 1997). DL-4 is necessary to drive the development of Th2 cells via signalling 
mediated by signal transducer and activator of transcription 6 (STAT6) along with 
specific downstream transcription factors such as Maf, GATA3, NFATc and NFAT- 
interacting protein 45 (NIP45) (O’Garra et al, 1997). Once generated effector Th2 cells 
produce IL-4, IL-5 and EL-13 when they encounter APCs with processed antigen in 
context with MHC class n  molecules and induce the production of allergen-specific IgE 
by B cells, recruitment of eosinophils, production of mucus and in asthma the 
contraction of airway smooth muscle (Romagnani. 1994).
1.2.4 T regulatory cells
Since the research towards this thesis commenced in 1999 there have been significant 
developments and advances in the area of T cell immunology. In particular with 
increased focus on the subsets of regulatory T cells (T reg cells) as being strong 
candidates in modulating and modifying inflammatory diseases. A vast amount of 
emphasis has been placed on identifying specific markers for the T reg cells and 
mechanisms to exploit the regulatory capacity of these cells. Being mindful of the 
current advances a large part of the introduction for this thesis has been re-written to 
incorporate and discuss these developments. This increased attention to modulate 
immune deviated diseases utilizing the regulatory capacity of T reg cells further 
highlights the importance of altering the cytokines in immune-mediated diseases 
towards a more balanced environment and it could be argued that, thanks to T reg cells, 
an even greater appreciation of the “balance” that needs to be achieved. The underlying 
issues of skewed Thl and Th2 localised cytokine profiles, in autoimmunity and allergy 
respectively, remain to be major challenges posing problems in the clinic hence 
exploring potential avenues for treatment are unequivocally important.
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The immune system has evolved mechanisms to recognize and eliminate 
microorganisms, as well as to protect against self-destruction, known as tolerance. 
Tolerance to self-antigens is generated through two fundamental mechanisms (a) 
elimination of self-reactive cells in thymus during maturation and (b) generation of a 
variety of peripheral regulatory cells to control self-reactive cells that escape the 
thymus.
The potential for autoimmunity or “horror autotoxicus”, as described by Paul Ehrlich, 
was realised approximately 100 years ago. Ehrlich recognised that a “well adapted 
regulatory contrivance” must exist to combat this problem and proposed die existence 
of immunological ‘tolerance5 encompassing die idea that autoreactive lymphocyte 
clones are eliminated during development (Ehrlich, 1910). In 1953 the first 
experiments were conducted to explore die cellular basis of this immunological 
tolerance (Billingham et al, 1953). The mechanism for this acquired tolerance process 
proposed by Burnet (1957) was a selective clonal deletion of lymphocytes specific for 
alloantigens injected during development. The following half a century has witnessed a 
huge amount of experimentation revealing both cellular and molecular mechanisms 
responsible for the deletion or functional inactivation of autoreactive T and B cells in 
the primary lymphoid organs, thymus and bone marrow or the periphery leading to the 
elimination of an individual lymphocyte clone, with no effect on other self-reactive 
clones (reviewed by Fontenot and Rudensky, 2005).
Despite the well-recognised concept of T cells negatively controlling the immune 
system, there has been great controversy as to whether they actually constitute a 
functionally distinct cellular entity within the immune system and if so whether they are 
involved in controlling immunological disorders such as autoimmune (Sakaguchi, 2005) 
and allergic disease. Several studies reported that regulatory CD4+ T cells were found to 
express the DL-2 receptor a  chain (CD25), also characterised as CD45RB10 which 
constituted 5-10% of peripheral CD4+ T cells in normal mice (Powrie et al, 1996; 
Papiemik, 2001; Sakaguchi, 2004). The elimination of this population of cells results in 
the spontaneous development of a variety of autoimmune diseases such as thyroiditis or 
gastritis in susceptible hosts (Sakaguchi, 2004).
It is becoming increasingly recognised and acknowledged that the reduced activity of T 
regulatory (T reg) cells is associated with several disease states. Hence the concept of
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an alteration in the balance between the suppression and activation of harmful Thl or 
Th2 immunity has important potential implications for strategies to prevent and control 
disease (Ahem and Robinson, 2005). Over the past couple of years many important 
advances have been made in investigating the determinants of this balance for inducing 
tolerance through T reg cells, including the existence of several different subtypes. In 
addition to die T reg cells, experimental protocols for the induction of their major 
products IL-10 and TGF-J3, have been described for the resolution of autoimmune and 
allergic inflammatory diseases. Both Th2-like and Thl-like regulatory T cells have 
been described which are induced by CD8 a'DC and CD8 a + DC, respectively (Akbari et 
al, 2002; Stock et al, 2004). In the forthcoming sections the main subtypes of T reg 
cells will be discussed.
I.2.4.I. Naturally occurring T regs
Naturally occurring CD4+ CD25+ regulatory T cells are actively involved in the 
maintenance of immunological self-tolerance (Shevach, 2000) and in die down- 
regulation of immune responses (Yagi et al, 2004). The idea that T cells negatively 
control immune responses is not novel for immunologists and over die years much 
speculation and controversy has been evoked as to whether they actually constitute a 
functionally distinct entity within die immune system. Also whether, if a specific 
subset existed, they exerted control in immunological disorders such as autoimmune 
disease. In recent years there has been a resurgence of interest in “suppressor” or 
regulatory T cells (T reg cells) due to a better understanding of the immune system 
within which a CD4+ T cell subpopulation with highly specialized suppressive functions 
exists. However, when abnormal in numbers or function, the T reg cells can be a main 
cause of inflammatory diseases in humans and animals (Sakaguchi, 2005).
The unique mechanism of self-tolerance is attributed to the thymus with the generation 
of antigen-specific natural T reg cells. It has been reported that the natural T reg cells 
may be found in newborn thymus at day 2  with all the markers and functional attributes 
associated with them (Itoh et al 1999). Initial experiments to suggest the existence of 
such cells were conducted by Nishizuka and Sakakura (1969) who showed that mice 
thymectomized between 2 - 4  days of age develop organ specific autoimmune disease, 
which could be rectified by adding back syngeneic T cells obtained from adult thymus 
or spleen
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Experiments conducted by Le Douarin and colleagues showed that grafts of the thymic 
epithelial lineage are necessary for the induction of acceptance of allogeneic and 
xenogeneic limb bud grafts (Ohki, et al, 1987). This process was later classified as 
being a dominant form of tolerance involving CD25+ natural T reg cells (Modigliani, et 
al, 1995). By this mechanism, potentially destructive effector T cells could be 
converted to negative regulators, natural T reg cells, which would have low avidity 
receptors for self antigens hence not clonally deleted by the negative selection process, 
but are on the high end of the avidity spectrum of those receptors that are positively 
selected (Jordan, et al, 2001; Hsieh, et al, 2004; Modigliani, et al, 1996). These cells 
would be potentially autoreactive in strongly activating conditions or possibly slightly 
autoreactive in all conditions if they escaped clonal deletion (Kawahata, et al, 2002; 
Hsieh, 2004).
The naturally occurring T reg cells were characterised as CD4+CD25+ (Sakaguchi et a l , 
1995) expressed constitutively in addition to other cell surface markers such as die T 
cell inhibitory receptor CTLA-4 and the glucocorticoid-inducible tumour necrosis factor 
receptor (GITR). The most specific marker that has been identified with the naturally 
occurring T reg cells is the transcription factor Foxp3 (Hori, et al, 2003) that is essential 
for the generation of these cells. The CD4+CD25+ natural T reg cells that express 
Foxp3 make up to 5 -  10% of peripheral CD4+T cells in both mice and humans (Asano, 
etal, 1996).
The key molecules whose deficiency or functional alteration affects the generation or 
function of natural T reg cells contributing to autoimmune diseases are illustrated below 
in Figure 1 .i. The naturally occurring T reg cells are able to respond to a large variety 
of self-antigens and may also respond to antigens expressed by microbes. The natural T 
reg cells have the ability to proliferate, in vivo, in the presence of IL-2 (Papiemik et al, 
1998) and participate in chronic microbial infections which may influence the outcome 
in either a favourable or a detrimental manna*. Other factors influencing the outcome 
of the response might include the stage of the infection, the dose of the pathogen and 
genotype and immunological status of the host as well as the presence of concomitant 
disease or other infections (Belkaid and Rouse, 2005).
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Figure l.i. Control o f  T reg cell associated molecules in natural T reg cells
IL-2
TCR
lL-2raoxp3
Natural T reg cells
Figure 1.i. Foxp3 appears to control some genes encoding T reg cell-associated molecules such as 
CD25, CTLA-4, and GITR TCR signals and also the binding of IL-2 to IL-2R enhances CD25 expression. 
Despite Foxp3 being stably expressed in mature natural T reg cells, it remains to be determined whether 
TCR signals control Foxp3 expression in thymic development of T reg cells (adapted from Sakaguchi, 
2005).
The generation o f T reg cells has been shown to require MHC expression on cortical 
epithelial cells (Bensinger, et al, 2001) and it is probable that the receptors are MHC 
restricted based on the few examples o f  natural T reg cells for w hich antigen specificity 
is known (Jordan, et al, 2001). There is also a requirement for nominal antigen 
specificity (Jordon et al, 2001) and CD28 ligation for the induction o f Foxp3 in the 
thymus (Tai, et al, 2005). Additionally their repertoire is intended for the recognition 
o f  a very discrete set o f  antigens that are expressed in the thymic medullary epithelial 
cells so a peripheral problem could be resolved centrally (Kyewski, et al, 2002). This 
was initially highlighted in experiments conducted by Boyse and collegues (1973) who 
showed that weak immune responses against tissue-specific antigens do exist. The 
possibility’ that antigenic stimulation results in the generation o f  natural T reg cells is 
exemplified by the embryo transplantation experiments conducted by LeDourain (Ohki 
et a l 1987). Another key role o f  the natural T reg cells is in peripheral self-tolerance by 
suppressing the expansion and activation o f  self-reactive T cells which have escaped 
thymic negative selection (Sakaguchi et al, 1995).
In vivo studies o f labelled adoptively transferred cells revealed that T reg cells 
proliferate and survive over long periods o f time, highlighting the capability o f  self­
renewal in the presence o f IL-2 (Annacker, et al, 2001). IL-2 also has a vital role in the 
thymic generation and peripheral maintenance o f natural CD25+ CD4+ T reg cells. This 
high IL-2 dependency along with the expression o f  Foxp3 are important features o f  
natural T  reg cells which differentiate them from other types o f T reg cells such as IL-10
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10 or TGF-p dependent T reg cells (Chen, et al, 1994). The expansion of the T reg cells 
maintains and enhances their suppressive capacity following proliferatioa These 
naturally occurring T reg cells have been proven, in vivo, to play a role in suppressing 
autoimmunity, tumour immunity, allergy and immunity to chronic infections 
(Kronenberg and Rudensky, 2005).
The main function of the naturally occurring T reg cells is thought to be activation in 
response to signals associated with tissue destruction, to minimize subsequent collateral 
damage (Powrie et al, 2003). This phenomenon is well documented in gastrointestinal 
homeostasis. Extensive studies, utilizing the mouse model of colitis, have demonstrated 
natural CD4+ CD25+ T reg cells act as chief regulators in inflammatory lesions and that 
the adoptive transfer of CD4+ CD25+ CD4 5 RB10 T cells along with naive T cells act to 
suppress disease development The suppressive effect is mediated by IL-10, TGF-p and 
CTLA-4 (Powrie et al, 2003). Likewise the depletion of murine CD4+ CD25+ T reg 
cells or disruption of their function results in various organ-specific autoimmune 
diseases including autoimmune gastritis, thyroiditis and type 1 diabetes (Sakaguchi et 
al, 1995). Natural CD4+ CD25+ regulatory T cells limit the magnitude of effector 
responses during infectious processes. The natural T reg cells have a polyclonal T cell 
receptor repertoire which is normally thought to allow recognition of a wide array of 
self-antigens. A recent study showed that CD4+ CD25+ suppressor T cells are most 
effectively induced when the agonist peptide is applied in ‘subimmunogenic’ conditions 
(Kretschmer, et al, 2005).
In humans thymic and peripheral CD4+ CD25+ T reg cells share several immunological 
characteristics with their murine counterpart (Levings, et al, 2001). Human CD4+ 
CD25+ T reg cells are hyporesponsive to TCR stimulation and suppress the 
activation/proliferation of other T cells in a cell-cell contact-dependent manner as 
opposed to via inhibitory humoral factors such as DL-10 or TGF-p, in vitro. Foxp3 in 
both mice and humans was originally reported to be the causative gene for an X-linked 
multi-organ autoimmune/inflammatory disease. In humans this resulted in immune 
dysregulation, polyend ocrinopathy, enteropathy, X-linked syndrome (BPEX), 
characterised by an increased likelihood of autoimmune diseases and allergic disease 
and food allergy (Chatila, et al, 2000). A similar X-linked multi-organ pathology 
known as scurfy is observed in Foxp3-mutant mice (Zahorsky-Reeves and Wilkinson, 
2001). Conventional CD4+CD25‘ T cells can be infected with a retrovirus expressing
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Foxp3 converting the cells to a regulatory phenotype (CD4+ CD25+), capable of 
suppressing the proliferation of uninfected CD4+CD25' T cells and function as T regs in 
vivo. Human CD4+ naive T cells from PBMC can be converted to regulatory T cell 
phenotype similar to naturally occurring CD4+ CD25+ T cells following ex vivo 
retroviral gene transfer of Foxp3. T cells infected with the Foxp3 retrovirus protect the 
host mice from autoimmune gastritis (Hori. et ah 2003) and colitis (Brunkow. et al. 
2001).
A decrease in numbers of natural T reg cells has been associated with decreased 
immunity in older humans with an increased risk and severity of infection, impaired 
response to vaccination and poorer control of cancer. In older mice an increased 
accumulation of cells with regulatory functions has been shown compared to younger 
mice. In older humans with reduced immunity, it remains to be determined whether any 
changes in natural T reg cell function occur and whether there is a link with impaired 
immune responses (Belkaid and Rouse, 2005). A dysfunction or deficiency of T reg 
cells can be associated with immunological disorders such as autoimmune disease 
whereas a reduction in numbers can elicit tumour immunity.
Host homeostasis by T reg cells occurs in response to many microbial infections at sites 
including the lung, skin, liver and in the eye. In most instances where natural T regs are 
involved it is in response to chronic infection. For example, lethal pneumonitis in mice 
deficient in recombination-activating gene 2 (RAG 2) can be prevented by the transfer 
of natural T reg cells (Hori et al, 2002). An improvement of infection is observed in 
mice, infected with Candida ablicans, with a reduction of natural T reg cells. However, 
an undesirable consequence of this is the enhancement of inflammatory gastrointestinal 
pathology (Montagnoli et al, 2002). In a non-healing model of Leishmcmia major 
progressive cutaneous lesions develop as a consequence of a Th2 type response though 
the amplitude and pathology is kept in check by natural T reg cells (Aseffa et al, 2002; 
Xu et al, 2003). The (Belkaid and Rouse, 2005).
The table la  below highlights a possible role for natural T reg cells in response to 
various microbial infections
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Table l.a  Microbial infections with potential T reg cell activity
Microbe Species Antigen
specificity
Helicobacter hepaticus mouse ND
human
Helicobacter pylori mouse ND
human
Listeria monocytogenes mouse ND
Pneumoncistis carinii mouse ND
Leishmania major mouse Yes
Schistosoma masoni mouse Yes
Herpes simplex virus mouse ND
Friend virus mouse ND
Human immunodeficiency virus human yes
Hepatitis C virus human yes
Cytomegalovirus human yes
Murine AIDS mouse ND
Feline immunodeficiency virus cat ND
Table 1 a Microbial infections in which natural T reg cells have been suggested. ND: not determined. 
Adapted from Belkaid and Rouse, 2005.
It has been reported that natural T reg cells may themselves become infected by 
pathogens such as HTV (Oswald-Richter, et al,2004) and virion production may be 
sustained when cultured with IL-2 (Joshi, et al, 2004). Pathogens may compromise 
natural T reg cell function by creating an environment that favours pathogen retention 
and survival. In patients infected with HTV or HCV a decrease in the number of 
functional natural T reg cells has been observed in peripheral blood of symptomatic 
patients. This decrease is likely to reflect the redistribution of natural T reg cells rather 
than an overall decrease. In several experimental models infected with leishmania, 
HSV and schistosoma, regulatory cells preferentially accumulate at the sites of disease 
(Hesse et al, 2004, Suvas et al 2004, and Belkaid, et al, 2002). The local conditions 
occurring as a consequence of an infectious process favours the recruitment and 
survival of natural T reg cells. High levels of TGF-p are often produced during chronic 
infection and serve as an important factor for the local survival and function of natural 
T reg cells (Green et al, 2003). Several pathogens can directly trigger the production of 
TGF-p from the cells they infect. As a consequence of high levels of TGF-p 
conventional CD4+ T cells can become suppressive, Foxp3+ T reg cells (Chen et al,
2003).
The segregation between natural T reg cells and inducible T reg cells could prove to be 
arbitrary, though the relationship between the two populations requires further
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clarification (Belkaid and Rouse, 2005). In the next section existing literature and 
understanding of inducible T reg cells will be discussed.
1.2.4.2. Inducible T regulatory cells
In addition to naturally-occurring T reg cells other types of regulatory T cells may be 
induced in response to infectious challenge, or through exposure to specific stimulatory 
conditions such as the blockade of costimulatoiy signals, de-activating cytokines or 
drugs. These inducible T reg cells such as TR1 or T helper 3 (Th3) cells develop from 
conventional CD4+ cells (Bluestone and Abbas, 2003; Mills and McGuirk, 2004; and 
O’Garra et al, 2004). The table below provides an overview of the regulatory T cell 
populations that exist
The differentiation of thymus-derived T reg cells, is not dependent on the interaction 
with specialized DCs (Jordon et a l 2000). whereas a role for DCs in the induction of 
TrI cells has been reported by several groups. Immature DCs control peripheral 
tolerance by inducing the differentiation of TrI-like cells (Jonuleit et al, 2000). These 
TrI cells have been reported to play a role in the prevention and development of 
asthma Airway DCs control the pulmonary immune response and determine tolerance 
and immunity to newly encountered antigens. The immature DCs are distributed 
throughout the lungs, capture allergens then migrate to the T-cell area of mediastinal 
lymph nodes. They express an intermediate array of costimulatory molecules and act to 
induce T-cell tolerance (Lambrecht. et a l 2000). Antigen presentation by partially 
mature airway DCs that express IL-10 induce the formation of TrI-like cells and inhibit 
subsequent inflammatory responses (Akbari, et al, 2001).
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Table 1 .b. A brief overview of Regulatory T cell populations.
Subset Phenotype Origin Mode of action
Naturally 
occurring 
T reg cells
CD4+CD25+
FOXP3+
Thymus &
perhaps
periphery
Cell-cell contact &/or secretion of 
short range memrane-bound or soluble 
TGF-p; secretion of IL-10 in vivo
T regi 
cells
CD4 secrete IL-10 
and Thl (IFN-y) & 
Th2(IL-5) 
cytokines
Periphery Secretion of IL-10 and possibly other 
mechanisms.
IL-10 
secreting T 
reg cells
CD4+ secrete IL- 
1 0  but not Thl or 
Th2 cytokines
Periphery Secretion of IL-10 and possibly cell­
cell contact
Th3 cells CD4+ secrete TGF-
P
Periphery Secretion of TGF-P
Thl cells CD4+ secrete IFN-
r
Periphery Secretion of EFN-y which inhibits Th2  
responses and in some instances the 
secretion of EL-10 which regulates Thl 
responses via the inhibition of DC IL- 
1 2  production and of die macrophage.
Th2 cells CD4+ secrete IL-4, 
EL-5 and EL-13
Periphery Secretion of IL-4 to inhibit Thl 
responses and the secretion of IL-10 
which acts to inhibit Thl responses via 
the inhibition of macrophage and DC 
production of EL-12.
Table 1.b. T celIs with the potential in a regulatory capacity. These IL-10 producing cels may be the
same ceils but with different cytokine profiles. The expression of CD25 is observed in vitro culturing and 
on the surface of all activated T cells. (Adapted from Hawryiowicz and O’Garra, 2005).
Although molecular mechanisms of inducible T reg cell generation remain to be 
elucidated, existing therapies for inflammatory diseases such as glucocorticoids and {32- 
agonists might function to promote die numbers and enhanced activity of IL-10- 
secreting cells (Karagiannidis, et al 2004 and Peek et al., 2005) which play a role in the 
inhibition of T effector cell function in various disease states. The function of IL-10 
will be discussed in a later section (1.3.6).
1.2.4.3. Mechanisms of T reg cell suppression
Many mechanisms have been proposed for T reg cell-mediated suppression in vivo. 
One potential mechanism of suppression is via the expression of high affinity trimeric 
IL-2R which may result in growth-factor competition and act to soak up IL-2 (Barthlott, 
et al, 2003). In vitro studies have concluded that CD25+ suppressor cells are anergic 
and do not proliferate in culture when stimulated with anti-CD3 antibodies or antigens
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unless supplemented with high doses of IL-2 (Shevach, 2002). It has also been 
observed that even in the presence of exogenous IL-2, T reg cells inhibit the 
upregulation of IL-2 mRNA in responder T cells (Thornton, et al, 2004). Unlike 
passive deprivation of EL-2 in suppression of T effector cells two immunosuppressive 
cytokines IL-10 and TGF-p have been implicated as active effector cytokines for T reg 
cell-mediated suppression in vivo (Sakaguchi, 2004, and Powrie, etal, 1996). However, 
other cell types, including non-regulatory T cells, are able to produce these cytokines. 
Hence, the relative contribution of IL-10 and TGF-p derived from T reg cells or from 
other cellular sources in relation to the overall control of autoimmune inflammation in a 
particular organ and genetic background is not known (Kronenberg and Rudensky, 
2005).
In vitro studies of T reg cells have shown their ability to suppress CD4+ and CD8 + T 
cell responses, independent of IL-10 and TGF-p, but which is contact-dependent 
(Shevach, 2002). One example using the contact-dependent method may involve 
‘reverse5 signaling by B7 molecules upon crosslinking on the surface of DCs or 
activated T cells by CTLA4, die high affinity receptor for B7 of which high levels are 
expressed on T reg cells (Paust, et al, 2004). It has recently been reported that murine 
pre-activated T reg cells induce granzyme-B-dependent, but perforin independent, 
apoptosis in responder T cells (Gondek, et al, 2005). In humans CD4+ CD25+ Foxp3 
expressing T cells can be activated by a combination of antibodies to CD3 and CD46 to 
express granzyme A and kill activated CD4+ and CD8 + T cells by a perforin-dependent 
mechanism in a reaction that does not involve Fas-Fas ligand binding (Grossman, et al,
2004). Other studies have also shown contact-dependent mechanisms using antibody- 
mediated crosslinking of T reg TCR either before or during the suppression assay, in 
vitro. However these experiments may not accurately reflect the physiological level of 
activation of T reg effector function. The interplay between cell-contact-dependent and 
cytokine-dependent mechanisms, the extent of their redundancy and their relative 
involvement in the prevention of autoimmune disease in a specific tissue or organ need 
to be further explored (Kronenberg and Rudensky, 2005).
Many in vitro and in vivo models of immunosuppression have been developed to 
establish the mode of suppression by T reg cells. It appears likely that CD4+ CD25+ 
suppressor T cells suppress immunity by several distinct mechanisms. With the 
knowledge that CD4+ CD25+ T reg cells are able to localize and expand together with
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effector T cell populations in antigen-draining lymph nodes and inflamed tissue, this 
could result in ‘specific9 suppression that is initiated by antigenic stimulation and the 
local recruitment of T reg cells together with effector T cells. Suppression may then be 
mediated over a short range by cytokines such as IL-10 and TGF-P, either by contact 
between effector and suppressor cells, or alternatively, via the interaction of CTLA4 
with CD80/86 on APC’s. The binding of CTLA4 with CD80/86 on APC’s results in 
the activation of indoleamine 2,3-dioxygenase (IDO) which causes increased tryptophan 
metabolism by APC’s, subsequently reducing amounts of free tryptophan associated 
with decreased activation of T effector cells (Mellor and Munn, 2004).
It may be observed that CD4+ CD25+ T reg cells can selectively affect distinct effector 
functions of T cells such as cytokine secretion, chemokine receptor expression and 
cytolytic activity. The common factor of all these functions is that each require TCR 
signaling, possibly of different intensity, at different stages of T cell differentiation 
making it plausible to suggest that immunosuppression mediated by CD4+ CD25+ 
reversibly interferes with TCR signaling proximally of different transcription factors 
that induce the diverse effector functions (von Boehmer, 2005).
12.44 . Foxp 3
A major advance in T reg cells was the identification of the forkhead family 
transcription factor Foxp3 along with the expression of CD25+, the IL-2Ra chain 
(O’Garra and Vieira, 2003). Foxp3 has been shown to interact with NFAT and NFkB 
to prevent gene activation by these transcription factors (Bettelli, et al, 2005). This 
interference with the transcription factors is thought to be associated in the switching 
off of inflammatory cytokines by the T reg cells (Ahem and Robinson, 2005).
It has beat suggested that T Reg cells expressing Foxp3 develop both extrathymically 
and intrathymically. The study by Kretschmer et al, (2005) revealed the possibility of 
converting truly naive CD4+ T cells into suppressor cells expressing Foxp3 by targeting 
of peptide-agonist ligands to DCs. The converted CD4+ CD25+ T cells exhibited potent 
in vitro as well as in vivo regulatory functions occurring as a consequence of interfering 
with the accumulation of cytokine secretion from CD4+ effector T cells in antigen- 
draining lymph nodes. Additionally the expression of Foxp3 in both induced and 
‘natural’ CD4+ CD25+ suppressor cells was the same. When the conversion of naive T 
cells into Foxp3 expressing CD4+ CD25+ T cells by ‘subimmunogenic’ antigen
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application is complete the Foxp3 expressing population can be expanded by 
immunogenic presentation of antigen without altering their phenotype in terms of the 
expression of Foxp3 and CD25. Such activated and divided cells are even more 
suppressive than non-expanded CD25+ cell populations (Klein, et al, 2003). However 
the mechanisms of extrathymic induction require further investigation particularly as 
proliferation and/or phenotypic changes of preexisting suppressor cells need to be 
distinguished from T reg cells generated de novo (Kretschmer, et al, 2005).
A recent study by Fontenot et al (2005) defined the biology of Foxp3 using a number of 
different transgenic mouse models. With a green fluorescent protein (GFP)-labelled 
Foxp3 construct, to demonstrate that Foxp3 expression was restricted to a (3 T cell 
receptor T cells, mainly arising on CD4+ T cells, and this expression correlated closely 
with regulatoiy function for both CD25+ and CD25' T cells. CD2510 Foxp3-expressing 
T cells made up to 50% of the Foxp3-expressing T cells in tissue. Additionally, the 
generation of Foxp3 GFP-OT-H T cell receptor transgenic mice on RAG 1 -deficient 
background was useful in showing that Foxp3 did not play a role in limiting effector 
cell function and that ‘adaptive/inducible’ Foxp3 T cells were not generated during 
acute immune responses (Fontenot et al, 2005). Other researchers have published data 
from the analysis of human T cells suggesting that Foxp3 expression may be induced de 
novo in CD25* T cells (Fahlen, et al, 2005). It is probable that such cells expand from 
the human equivalent of the CD2510 Foxp3 cell population as defined by Fontenot et al 
(2005). The Fontenot study addressed many important issues about Foxp3 biology and 
suggested that both CD25+ and CD25' T cells can express Foxp3 and that Foxp3 
expression defines regulatory function. They also pointed out that T reg cells do not 
develop de novo Foxp3 expression as part of an ongoing immune response. Recently, 
Foxp3 expressing CD4+ CD25+ T reg cells in inflamed synovium were identified as 
CD27+ (Ruprecht, et al, 2005).
The recent study described above (Fontenot et al, 2005), utilizing mice expressing green 
fluorescent protein ‘knocked into’ the Foxp3 locus suggests that Foxp3 is a T reg cell 
lineage specification factor. This idea arises from the observation that Foxp3 
expression is uniquely restricted to a subset of peripheral and thymic ap  T cells 
primarily composed of CD25+ CD4+ T cells with potent suppressive activity and share a 
transcriptional signature CD25+ CD4+ Foxp3' T cells (Fontenot, et al, 2005). These
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findings would suggest that Foxp3 is a dedicated genetic mechanism for the generation 
of T cells able to support dominant tolerance (Kronenberg and Rudensky, 2005).
13 General properties of cytokines
Cytokines are involved in virtually every facet of immunity and inflammation. Effects 
range from the induction of the innate immune response to the generation of cytotoxic T 
cells and the development of antibodies by the humoral immune system The 
combination of cytokines produced in response to an immune insult determines which 
arm of the immune system will be activated (reviewed by Steinke and Borishu 2006).
Most cytokines are glycoproteins produced in response to cellular activation rather than 
being secreted constitutively (Fraser et al, 1993). Cytokines range from approximately 
8  -  80kDa in molecular weight Over one hundred cytokines have been identified to 
date. They function in an autocrine or paracrine manner binding to specific cell surface 
receptors triggering a cascade of events regulating cell viability, proliferation 
differentiation and death. Their function is highly regulated at both transcriptional and 
posttranscriptional levels (Dendorfer, 1996) Figure l.ii  illustrates the biological 
activities of cytokines.
Cytokines are soluble mediators involved in the generation of immune responses 
produced by several cells including activated lymphocytes and APCs. Cytokines have 
pleiotropic actions with effects on many different cell types and can have multiple 
effects on these cells (House, 1999). In vitro for example IL- 6  has multiple functions 
such as inducing B cell differentiation, promoting the growth of hybridomas, 
stimulating acute-phase proteins from hepatocytes and differentiation of CTL’s 
(Hamblin, 1993). Other cytokines such as TNF-a and TNF-(3 have similar biological 
functions (Feghali and Wright, 1997). In addition, cytokines often work via cascading 
mechanisms, allowing them to interact with each other synergistically as well as 
antagonistically. Another prominent feature of cytokines is that they primarily act at a 
local level and then rapidly cleared up from the circulation.
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Figure l.ii. Biological roles o f cytokines
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Figure 1.ii. Role of Th1 and Th2 cytokines in the regulation of cellular and humoral immunity. With cellular 
immunity providing protection against intracellular bacteria, protozoa, fungi and viruses. Humoral immunity 
provides protection against multicellular parasites, extracellular bacteria, some viruses, soluble toxins and 
allergens. Solid lines represent stimulation, dashed lines inhibition. Abbreviations; Ag, antigen, APC, 
antigen-presenting cell, B, B cell, Eo, eosinophil, IFN, interferon, IL, interleukin, NK, natural killer cell, Tc, T 
cvtotoxic cell. Th. T helDer cell. TNF. tumor nerosis factor. (Adaoted from Elenkov and Chrousos. 1999).
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13.1. Cytokine subsets
Cytokines can be divided on the basis of their mode of action into pro-inflammatory 
cytokines and immunoregulatory cytokines. Many cytokines may be classified as being 
pro-inflammatory whereas others are classified as being anti-inflammatory. However, 
only the cytokines of relevance to this study shall be discussed.
133. Interleukin 2
IL-2 was one of the first cytokines to be discovered. EL-2 was first purified from the 
culture supernatants of mitogen or alloantigen-activated T cells and the leukaemic cell 
line Jurkat (Gillis, 1991; Smith et al, 1991). Human IL-2 is a glycoprotein with a 
molecular weight of 15.5kDa (Waldmann et al, 1998).
When APCs present antigen to CD4+ T cells they simultaneously secrete IL-1 which 
facilitates the expression of DL-2R on the T cells. Following T cell activation IL-2 is 
secreted which binds to its own IL-2 receptors as well as those on neighbouring 
activated T cells. IL-2 is the principle cytokine involved in the propagation of immune 
responses. IL-2 is responsible for die induction of T cell proliferation as well as 
having a role in a negative feedback mechanism in order to control the expansion on T 
cells. Activated CD4+ T cells are the major source of IL-2, though it is also produced 
by immature CD4+ T cell precursors, differentiated Thl and ThO cells.
IL-2 interacts with cells by binding to a receptor (IL-2R) of which there are two forms 
with high and low affinities for IL-2 (Hamblin, 1993). The IL-2R is made up of at least 
three subunits, the IL2Ra which shares homology with the a  chain of IL-15Ra, the IL- 
2RJ3 that is shared with IL-15R and the EL-2Ry chain (yc) which participates in the 
receptor formation of five cytokines (IL-2, IL-4, EL-7, IL-9 and IL-15), as well as 
having similar biological effects (Theze, 1999). The high affinity IL-2R is formed from 
two non-covalently linked polypeptides, IL-2RJ3 (75kDa), and IL2Ra (55kDa). The 
IL-2Rp contains a longer intracytoplasmic section and is thought to be involved in 
signalling. The IL2Ra is also known as CD25 (Waldmann et al, 1998). Each subunit 
of die receptor may interact with a different region of the IL-2 molecule and the binding 
of IL-2 to both IL2Ra and IL-2R0 results in the biologically active high affinity 
receptor (Wang and Smith, 1987).
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133. Interferon gamma
The term interferon was first coined in 1957 by Isaacs and Lindenmann (Isaacs and 
Lindenmann 1987) to describe the protective component in supernatants from virally 
infected cells capable of protecting other cells from subsequent infection by a variety of 
different viruses. Interferons are inducible proteins important in defence against a wide 
range of viruses as well as involvements in the regulation of immune responses and in 
haematopoietic cell development. Interferons can be subdivided into type I and type II 
interferons on the basis of their structural and functional properties. Type I interferon 
produced by leucocytes is referred to as EFN-a whereas IFN-J3, also a type I interferon, 
is produced by fibroblasts. Type I interferons are induced following viral infection of 
cells. Type II interferon consists of IFN-y is secreted from human T cells and NK cells 
following activation and antigenic stimulation but not directly in response to viral 
infectioa IFN-y was found to have a more diverse range of protective cellular 
responses than Type I interferons (Theze, 1999).
Human OFN-y is secreted in two different forms from peripheral blood leucocytes 
following mitogenic stimulation, with molecular weights of 20 and 25kDa The two 
forms of IFN-y are products of a single gene on chromosome 12 (Naylor et al, 1983 ). 
The differences in size arise from differences in glycosylation at residue 25 (both 
forms) and 97 (25kDa form) of the polypeptide sequence. IFN-y secreted from 
activated T cells is mainly as a homodimer of 25kDa subunits (Gray and Goeddel, 
1982). The synthesis of IFN-y is highly regulated and mainly secreted by CD8 + T cells, 
ThO cells and Thl subsets of CD4+ T cells. In contrast the NK cells are able to produce 
IFN-y rapidly in a MHC-unrestricted manner, acting as a first line of defense against 
infectious agents until the generation of a specific immune response (Thdze, 1999).
In vivo, the interaction of the TCR with cells bearing antigen incorporated into MHC 
molecules along with other co-stimualtory signals leads to the production of EFN-y as 
well as other T cell derived cytokines. In vitro T cell activation can be induced by 
antigen or mimicked by antibodies to CD3, mitogens such as concanavalin A (ConA) 
and phytohemagglutinin (PHA), or pharmacological stimuli such as the combination of 
phorbol myristate acetate (PMA) and calcium ionophore. Following activation IFN-y 
gene transcripts can be detected within 6 - 8  hours (hrs) reaching maximal levels between 
12 - 24 hrs. The IFN-y protein is secreted directly into the extracellular environment.
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Macrophages produce low levels of TNF-a and IL-12 following interaction with 
bacterial products and these in turn stimulate NK cells to secrete low levels of IFN-y. 
IFN-y from NK cells acts to activate additional macrophages thereby enhancing TNF-a 
and IL-12 production and the subsequent enhancement of IFN-y from NK cells. The 
cumulative effects of these mechanisms generate a positive amplification loop 
producing large amounts of IFN-y in the beginning of an immune response in order to 
facilitate increased numbers of macrophages with antimicrobial activity.
IL-18, a member of the IL-1 cytokine family, was initially identified as an IFN-y 
inducing factor (Okamura et al, 1995). It is capable of inducing IFN-y and GM-CSF 
whilst inhibiting IL-10 by PBMC’s (Bazan and Allan, 1997). In the case of human T 
cells IL-18 enhances Thl cytokine production and simulates cell proliferation via an IL- 
2- dependent pathway (Ghayur et al, 1997). IL-18 has the capacity to inhibit the 
synthesis of IgE by B cells thereby playing a major role in inflammatory responses 
(Yoshimoto et al, 1997).
IFN-y has potent immunoregulatory effects on several different cell types. The range of 
biological actions of EFN-y is shown in Table I.e. (adapted from Hamblin, 1993). 
Activated Thl and NK cells, are often described as being potent activators of 
macrophages through the secretion of EFN-y (Hiromatsu et al, 2000). EFN-y is also 
involved in the upregulation of HLA class I and class II molecules and the inhibition of 
Th2 cells generation (Roitt et al, 1998). As mentioned earlier, EFN-y has been 
implicated in a variety of autoimmune and chronic inflammatory conditions including 
systemic lupus erythematosus (Jacob et al, 1987), insulin-dependent diabetes mellitus 
(IDDM), (O’Garra et al, 1997), along with involvement in several other pathological 
conditions.
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Table I.e. The biological actions of IFN-y
Enhancement or inhibition of cell differentiation
Enhancement of MHC class I expression
Regulation of MHC class D expression on many cells
Activation of macrophages
Enhancement of NK cell activity
Enhancement of B cell proliferation and maturation
Increase the secretion of other cytokines
Increase cell surface receptors for Fey and cytokines
Inhibit normal and transformed cell growth
Protect cells from viruses
Counteract die effects of IL-4 on B cells
Table 1 .c. List the various biological effects of IFN-y (Adapted from Hamblin, 1993)
The IFN-y response is mediated by a specific receptor with two functionally distinct 
subunits, the IFN-yRa (90kDa) subunit, also known as IFN-yRl (CDwll9), is encoded 
on chromosome 6  and is involved in binding IFN-y. The IFN-yRp subunit, a 62kDa 
receptor, also known as EFN-yR2 or accessory factor 1 (AF-1), is encoded on a gene on 
chromosome 21 and functions in signal transduction (Soh etal, 1994).
13.4. Interleukin 12
IL-12 is a heterodimeric cytokine that has an important role in the initial induction of 
innate and adaptive immune responses. IL-12 has the ability to drive multiple immune 
functions, for example IFN-y production, macrophage activation, NK cell cytotoxic 
activity and the differentiation of Thl cells from naive precursors (Gately et al, 1992). 
It is secreted by monocytes, activated B cells and other APC’s. IL-12 is produced 
within the first few hours of infection, enhancing the phagocytic and bacteriocidal 
activity of phagocytic cells and their ability to release pro-inflammatory cytokines. It 
also functions in the perpetuation of antigen-specific Thl responses. Additionally, IL- 
1 2  has effects on hematopoietic progenitor cells in combination with other 
hematopoietic growth factors and mediates both direct and indirect actions on B-cell 
functions.
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Bioactive IL-12 is composed of two subunits, p35 and p40 (Trinchieri, 1998), and binds 
to the IL-12 receptor, which is composed of two subunits (IL-12Rpl and 1L12RP2 
(Gately et al, 1992). Multiple cell types constitutively express the p35 subunit, whereas 
p40 expression is inducible in DC’s, macrophages and B cells and is responsible for the 
regulation of EL-12 production. The major inducing signal for EL-12 production is 
thought to involve the crosslinking of CD40 on the surface of the responding cell by 
CD40-ligand (CD-40L) bearing T cells. IL-12 inadvertently blocks the production of 
IL-4, thus the development of Th2  cells, via the induction of IFN-y production by NK 
and Thl cells (Scott, 1993), hence favouring Thl differentiation and function of Thl 
cells.
1.3.5 Interleukin 4
IL-4 is a 15-19kDa glycoprotein first identified in 1982 as a B lymphocyte proliferation 
factor and, in 1986, following the cloning of human cDNA library prepared from a 
ConA-stimulated T cell line, the term IL-4 was adopted (Yokota et al, 1988). IL-4 is 
now recognized as having numerous biological functions on several different cell types.
A list of the biological activities IL-4 has on cells is highlighted below in Table l.d.
Effects on B lvmphocvtes
• Induces MHC class II expression
• Increases cell volume
• Induces proliferation in the presence of anti-IgM or Staphylococcus aureus
Cowan strain 1
• Induction of low affinity IgE receptor (CD23)
• Stimulates IgGl and IgE synthesis
• Inhibits IgM, IgG3, IgG2a and IgG2b synthesis
Effects on T lvmphocvtes
• Induction of proliferation of thymocytes
• Enhancement of proliferation of PHA-activated mature lymphocytes
• Enhancement of cytotoxic activity of CTL’s
• Inhibits IL-2-induced CTL and LAK activity.
• Suppresses the generation of Thl cells
Effects on other cell tvpes
• Stimulates mast cell growth
• Activation of haemopoietic progenitor cell growth
• Induction of macrophage aggregation, migration inhibition and cytotoxicity
• Induction of MHC class I and II expression and tumoricidal activity of
macrophages
• Inhibition of stromal cell support for haematopoietic colon formation
• Downreulation of the expression of CD23 on macrophages
• Blocks EL-1, EL-6 , IL- 8  and TNF-a production and stimulates G-CSF and M-
CSF production by monocytes.
Table 1 .d. Biological effects of IL-4 (adapted from Hamblin, 1993)
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The human IL-4 gene is located on chromosome 5 as are the genes coding for several 
other cytokines such as IL-13, IL-5, IL-3, GM-CSF and M-CSF. The major source of 
IL-4 is the CD4+ Th2 subset of cells and is involved in the secretion of antibody by B 
cells in response to T-dependent antigens. However is also produced by other cells 
such as mast cells and eosinophils. IL-4 also plays a major role in the specific induction 
of IgE from B cells, hence has an indirect role in the activation of mast cell and 
subsequently eosinophil recruitment. A dysfunction in IL-4 secretion and the regulation 
of mast cells and eosinophils results in certain inflammatory disease states such as 
allergic reactions, ie asthma is well accepted. IL-4 and IL-13 have similar biological 
properties and use a common receptor, EL-4Ra for signal transduction (Obiri et al, 
1997). It must be highlighted that there is a key difference between IL-4 and IL-13 
which is that EL-13, does not act on T cells whereas IL-4 does. Both IL-4 and IL-13 are 
produced by activated CD4+ Th2 cells as well as by basophils and mast cells. The 
cytokines act on monocytes, DCs endothelial cells and other cells such as keratinocytes 
and fibroblasts. The joint activities of IL-4 and IL-13 upon the afore-mentioned cell 
types result in an augmentation of humoral responses (Jacques et al, 1999)
13.6. Interleukin 10
IL-10 was first described as a soluble factor produced by mouse Th2 cells able to inhibit 
the activation and the cytokine production of Thl cells and therefore originally named 
cytokine synthesis inhibitory factor (CSIF) (Moore et al, 1990). Human IL-10 was 
subsequently isolated from a T cell clone derived from a patient with severe combined 
human immunodeficiency (SCID) that developed long term tolerance to stem-cell 
allograft (Vieira et al, 1991). Since these early findings an extensive amount of 
research has been conducted to further characterize IL-10. IL-10 is now recognized as 
playing a central role in the control of inflammatory processes and in the maintenance 
of immunological tolerance (Moore et al, 2001). T-cell response in IL-10-mediated 
peripheral tolerance functions in the same way as the original definition of anergy, 
originally proposed in 1980 (Nossal and Pike, 1980), because costimulatory signals are 
suppressed, and T cells receive a weak signal only through the T-cell receptor without 
costimulation (Adkis, 2005).
Human IL-10 is a protein of 160 amino acids and a molecular weight of 18.5kDa which 
exists as a homodimer in soluble form Structurally it belongs to die a-helical class of
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cytokines as do IL-2 and IL-4 as well as IFN-{3 and IFN-y. The IL-10 gene in humans is 
located on chromosome 1. The receptor for IL-10 is composed of two different chains, 
the a-chain (hIL-lORl) and the p-chain (hIL-10R2). hIL-lORl has been mapped to 
chromosome llq23.3 and is expressed mainly in haematopoietic cells. Certain 
compounds can modulate the mRNA expression of hIL-10R:anti-CD3 mAb and 
phorbol esters cause a reduction in mRNA levels in human T cell clones whereas 1,25- 
(OFTh-vitamin D3 has been shown to increase die mRNA expression of EL-10R1 in 
human epidermal cells (Pretolani et al, 1999).
IL-10 is a product of numerous cells, including Thl and Th2 cells, TC cells, B cells, 
mast cells, mononuclear phagocytic cells and DCs. The primary sources of IL-10 
include T reg cells and in humans as well as T regs cells, major sources of IL-10 are 
produced from monocytes and B cells (review by Steinke and Borish. 2006).
IL-10 is a potent suppressor of several effector functions of macrophages, T cells, NK 
cells and contributes to regulate proliferation as well as differentiation of B cells, mast 
cells and thymocytes (Moore et al, 2001). IL-10 inhibits the production of EFN-y and 
IL-2 from Thl cells; IL-4, and IL-5 from Th2  cells; IL-ip, IL-6 , IL- 8  (CXCL8 ), IL-12, 
and TNF-a, from mononuclear phagocytes; and IFN-y and TNF-a from NK cells 
(Steinke and Borish, 2006 (review)). IL-10 also inhibits cell-mediated immunity by 
blocking several functions of APCs, including the inhibition of IL-12 production and 
the delivery of accessory signals, such as MHC class n, CD23, intracellular adhesion 
molecule I, and CD80/86 expression to CD4+ Th cells. One mechanism of direct T-cell 
suppression by IL-10 is due to the inhibition of CD28 costimulation (Fiorentino, et al, 
1989; Moore, et al, 1990; Fiorentino, et al, 1991). It has been shown that the 
constitutive expression of IL-10 by immature DCs and monocuclear phagocytes in the 
respiratory tract of healthy individuals has an important role in the induction and 
maintenance of tolerance to allergens. Whereas, in contrast both asthma and allergic 
rhinitis are associated with reduced levels of IL-10 expression by alveolar macrophages 
and DCs, which in turn contribute to the inflammatory milieu (Borish, et al, 1996).
IL-10 does not affect the proliferative responses of T cells stimulated with anti-CD3 but 
significantly inhibits the anti-CD28-stimulated proliferation. Consequently, EL-10 
suppresses only those T cells with low numbers of T-cell receptors triggered and that 
require CD28 for proliferation (Akdis, 2000). Ligation of IL-10 receptor at the time of
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CD28 stimulation inhibits tyrosine phosphoiylation of CD28. Subsequently the 
association of CD28 with phosphatidylinositol-3-kinase p85 molecule is inhibited.
IL-10 is involved in the regulation of specific isotype formation and skews the specific 
response from an IgE- to an IgG4-dominated phenotype in response to allergens in 
healthy individuals. The increase of specific IgA and IgG4 levels in serum coincides 
with increased TGF-0 and IL-10 levels, respectively (Akdis, 2005). IL-10 is associated 
with the reduction of proinflammatoiy cytokines released from mast cells (Marshall et 
al, 1996) the downregulatation of eosinophil function and activity (Schandane et al, 
1994), and the suppression of IL-4-induced IgE synthesis. Hence, IL-10 inhibits 
cytokines associated with cellular immunity and allergic inflammation while 
stimulating humoral and cytotoxic immune responses (Steinke and Borish, 2006). It has 
recently also been shown that T reg cells can inhibit cytokine secretion of allergen 
specific Th2 cells in an IL-10 dependent manner (Xystrakis, etal,2006).
Recent research has revealed the relationship between IL-10-induced antigen specific 
CD4+ T reg cells with antigen-specific immune tolerance. This specific regulation is 
partially controlled via IL-10 secretion, as anti-IL-10 treatment reverts the inhibitory 
effects of T reg cell clones Experiments conducted with the exogenous application, 
transgenic expression and endogenous stimulative agents of IL-10 have been 
administered for a variety of inflammatory diseases, autoimmune diseases and allograft 
rejection in patients and experimental models. EL-10 upregulatory agents have shown a 
promising future for remission of autoimmune diseases and inflammatory diseases and 
have even induced antigen specific immune tolerance (Zhou et al, 2005).
Several transcription factors have been associated with the enhancement of IL-10, 
however, the molecular mechanism for the initiation of IL-10 transcription remains 
unknown. At the transcriptional level Spl and Sp3 (Tone et al, 2000), 
CCAAT/enhancer binding protein 0 (Liu et al, 2003.), IFN regulatory factor-1 and 
STAT3 (Ziegler-Heitbrock et al, 2003) transactivate several constructs of the IL-10 
promoter in reporter assays in both mouse and human cell lines. Smad-4 (Kitani et al, 
2003) and jun proteins (Wang, et al, 2005) regulate IL-10 expression in primary Thl 
and Th2  cells respectively. Additionally Ets-1 has been noted to play a role in 
repressing IL-10 production in Thl cells and that Ets-1-deficient mice show a 
considerable increase in IL-10 production (Grenningloh et al, 2005). Though the master
48
N. Akiitar PhD Thesis
regulator involved in the expression of the IL-10 gene causing the remodelling of the 
IL-10 locus has not yet been identified (Shoemaker et al, 2006).
The recent study by Shoemaker and colleagues (2006) sought to investigate the role of 
transcription factor, GATA-3, in relation to the expression of IL-10. Their findings 
revealed that the expression of GATA-3 correlated with levels of IL-10 in six distinct 
primary CD4+ T cell populations. They also observed that die ectopic expression of 
GATA-3 in naive primary CD4+ T cells enhanced the expression of EL-10 in these cells. 
It was discovered that GATA-3 induced changes of the chromatin structure at the EL-10 
locus even in the absence of IL-4. The study claims to have shown, for die first time 
that GATA-3 acts directly as a regulator of the IL-10 locus instructing IL-10 gene 
expression in primary CD4+ T cells potentially by switching and stabilizing die IL-10 
locus into a transcriptionally competent status. They also observed that GATA-3 is 
differentially expressed in resting and activated DL-10-producing cells. In primary T 
cells GATA-3 plays a direct role in the remodelling and acetylation of histones H3 and 
H4 at the IL-10 locus thereby switching its transcriptional status to a competent one 
(Shoemaker et al, 2006).
It has recendy been reported that EL-10 belongs to a family of cytokines which include 
newer members such as IL-19, IL-20, IL-22, DL-24, EL-26 and possibly IL-28 and EL- 
29. These cytokines and their receptors loosely share homologies with EFN receptors 
and have antiviral activity. In contrast to EL-10, none of these cytokines has the ability 
to inhibit cytokine synthesis significantiy, a function that remains unique to IL-10 
(Steinke and Borish, 2006).
Currendy there are several biotechnology companies and researchers investigating the 
potential use of T reg 1 cells in inflammatory diseases. Laboratory grown Tregl cells, 
generated ex vivo by triggering CD46 and CD3, are being investigated for die treatment 
of autoimmune diseases such as lupus and RA and for organ rejection following 
transplantation The use of CD4+ CD25+ and Tregl cells is being explored by the 
European vascular genomics network (EVGN) to improve the treatment of 
cardiovascular diseases such as athrosclerosis and envisage the use of T reg cells, 
producing IL-10. to inhibit the formation of atheroma plaques (Battaglia et a l 2006). 
The therapeutic potential of IL-10 shall be discussed later in this chapter.
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13.7. Transforming growth factor beta
TGF-p is a major pluripotential cytokine that regulates diverse biological processes 
during development and homeostasis. One of its functions is having a pronounced 
immunosuppressive effect and its deficiency results in lethal autoimmunity in mice, it 
has the capacity to inhibit Thl and Th2 responses (Chen et al, 1995). However, the 
immunosuppressive mechanisms of this cytokine are not fully understood (Marie et al, 
2005). Another function of TGF-p, secreted from Th3 cells, is to promote IgA 
responses in the gastrointestinal tract (Coffman et al, 1989). TGF-p, is a potent 
regulator of fibroblast and myofibroblast function and controls the production of several 
extracellular matrix proteins, including collagens, proteoglycans, and tenascin. 
Sources of TGF-p include eosinophils, macrophages, mast cells, neutrophils, 
endothelial and epithelial cells, and smooth muscle cells and fibroblasts themselves 
from allergic inflammatory sites. (Duvemelle, 2003). TGF-p interacts with several 
other cytokines, such as activin for the efficiency of remodeling in response to lung 
damage in asthma (Rosendahl, 2001). The thickening of die subepithelial lamina 
reticularis in bronchial asthma, which may occur due to excessive repair processes after 
repeated airway injury, has been related to an increase in fibroblasts in correlation with 
TGF-p expression (Hoshino, 1998).
A recent study was conducted to examine the role of TGF-P in T reg cells. The study 
analysed T reg cell subsets in young TGF-p I-7' mice. Findings of the study suggested 
Foxp3 expression, the size of peripheral T reg cell compartment and suppressive 
activity are dependent on signals induced by TGF-p in T reg cells (Marie et al, 2005). 
The findings of this study included die indication that TGF-p 1 is required for peripheral 
T reg cell homeostasis, that TGF-pl is required to maintain Foxp3 expression in T reg 
cells and showed that peripheral, thymus and spleen derived CD4+ CD25+ in TGF- 
p_/" mice displayed a significant decrease in levels of Foxp3 expression compared to 
wildtype mice controls (Marie et al, 2005). Additionally TGF-P may convert 
conventional T cells into Foxp3+ natural T reg cells which act to modulate lesions in an 
experimental asthma model (Chen et al, 2003). The study by Marie and colleagues 
(2005) also highlighted that TGF-pl is necessary to maintain T reg cell suppressive 
functions and that wildtype T cells and APCs caused significantly greater suppression 
compared to TGF-p-7- T reg cells in the presence of TGF-p-7- APCs suggesting that
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TGF-pl production by T reg cells is dispensable for their suppressor function as APCs 
are able to produce sufficient amounts of TGF-pl to support T reg cell-mediated 
suppression (Marie et al, 2005).
Finally the study by Marie and colleagues (2005) demonstrated that TGF-pl-mediated 
signalling in T reg cells is needed to maintain suppressor function. However it is 
unclear as to whether the T reg cells require TGF-pl signalling to maintain their 
functionality or whether the T reg cells have receptor-bound TGF-pl produced either 
endogenously or secreted by APCs. The latter possibility was suggested by two reports 
postulating that receptor-bound TGF-P 1 displayed on the surface of T reg cells may act 
as an effector molecule in T reg cell-mediated suppression as observed in an in vitro 
assay (Nakamura et al, 2001; Annunziato et al, 2002). Therefore in this respect the 
results from this study indicate that the role of TGF-P is not as an effector molecule of 
suppression, by as a mediator of signaling in T reg cells assisting in their suppressor 
function (Marie et al, 2005). In fact TGF-p has been shown to inhibit GATA-3 
expression and IL-4 synthesis hence Th2  development (Gorelik et al, 2000) as well as 
preventing Th2 induced airway inflammation (Zuany-Amorim et al, 2002). The 
inhibition of Th2 cells is augmented by TGF-p via the generation of IFN-y producing 
cells (Smeltz et al, 2005). It has also been shown that the deletion of TGF-pRII in 
mice renders them susceptible to Thl pathogens such as Leishmania (Gorelik, et 
al,2002) also they suffer from impaired immunity to tumours, (Gorelik and Flavell, 
2001). Additionally, TGF-p has been shown to promote Thl cell differentiation under 
certain circumstances (Smeltz et al, 2005). In contrast, another study proposed that the 
role of TGF-p plays a part in the induction phase of regulatory processes but is not 
necessarily involved in the suppression itself (Jonuleit et a l 2002).
High concentrations of rTGF-p have been used to activate, through in vitro studies, 
populations of murine and human CD4+ CD25' T cells and result in the acquisition of 
suppressor activity and Foxp3 expression (Chen et a l 2003; Zheng et al, 2004). These 
studies have important implications for pharmacologic in vitro manipulation of T cell 
function for potential therapeutic use. However there is no experimental evidence to 
suggest that such high concentrations of TGF-p 1 could ever be attainable in vivo and a 
conversion of CD4+ CD25" into CD4+ CD25+ T cells expressing Foxp3 could occur
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under physiological conditions or in the course of immune inflammation (Marie et al,
2005).
In light of research conducted recently it is feasible to conclude that TGF-pl has an 
important role in T reg cell biology and one could postulate that applications targeting 
TGF-pl signaling pathway for therapeutic immunomodulatioa However, it is also 
important to bear in mind that TGF-p is involved in the activation of tissue-resident 
cells such as epithelial cells and fibroblasts and it has been demonstrated to be produced 
at the sites of active fibrosis, with expression from activated inflammatory cells, such as 
macrophages and eosinophils, and is therefore implicated in die fibrotic process in vivo. 
TGF-p is probably the most important cytokine to impact on tissue fibrosis. However, 
there is much evidence to indicate that the situation is much more complex than any one 
single cytokine being solely responsible for the fibrotic response. This means that it is 
the balance of positive (profibrogenic) and negative (antifibrogenic) forces generated 
from interaction among the various cytokines may finally determine the outcome of 
chronic inflammation (Zhang and Pang, 1996). In light of this it would perhaps be 
unwise to use TGF-p in therapy but potentially beneficial to pre-treat cells in vitro, then 
to transfer them in vivo with the hope of increased CD4+ CD25+ T cells with regulatory 
properties.
1.4. T cell signalling pathways involved in cytokine production
Cytokine receptors can be classified into several groups. The largest family of cytokine 
receptors have specifically conserved cysteine residues in the extracellular domain with 
a characteristic tryptophan-serine-x-tryptophan-serine (WSXWS) motif proximal to the 
membrane spanning region and belong to the haematopoietin receptor, also known as 
die type I cytokine receptor family. This group of receptor functions in binding the 
following cytokines IL-2, IL-3, IL-4, IL-5, IL-6 , EL-7, GM-CSF, G-CSF along with 
several others. Type II cytokine receptors, also know as the IFN-receptor family, 
include receptors for IFN-a, IFN-p, IFN-y and IL-10. The type I and type II receptors 
have structural similarities and may have evolved from a common ancestor, the 
fibronectin type in  domains. Other groups of cytokine receptors include the TNF 
receptor family, the IL-1 receptor family, also the immunoglobulin superfamily type of 
cytokine receptors (Theze, 1999).
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Most of the cytokine receptors are expressed at low density (100-1000 receptors per 
cell) although numbers may increase when the cell is activated and may be more 
frequent on some cell lines (Nicola and Metcalf, 1991). Cytokine receptors exist not 
only in the cell-bound form but also in a soluble form in serum, for example TNF-R, IL- 
1R, EL-2R, IL-4R, IL-5R, EL-7 R and IFN-yR. The soluble form of receptor arises from 
proteolytic cleavage of the membrane receptor or from alternative splicing of receptor 
mRNA to produce a truncated version lacking the membrane spanning and the 
cytoplasmic domain (Gillis, 1991). The levels of soluble receptors increase 
dramatically with active immunological or inflammatory processes. The production of 
soluble cytokine receptor is thought to be inhibitory, a negative feedback mechanism, 
limiting the cytokines biological activity in vivo (Theze, 1999).
Many cytokine receptors are associated with molecules called Janus kinases (Jaks). 
Stimulation of these cytokine receptors involves rapid tyrosine phosphorylation of 
intracellular proteins, including signalling proteins such as the signal transducers and 
activators of transcription (Stats), along with die activation and aggregation of Jaks. Jak 
activation is essential in virtually all receptor functions. Stat dimers translocate to the 
nucleus and bind to DNA. The overlapping yet unique functions of individual 
cytokines arise from the involvement of different intracellular signalling pathways.
In T cells, the EL-2y chain utilized by several cytokines, IL-2, IL-4 and IL-9 activate 
Jakl and Jak3 whereas IL-10 activates Jakl and Tyk2 and EL-12 activates Jak2 and 
Tyk2. The Stats also have a large range of responses, with each cytokine activating a 
different set of Stats. Other signalling pathways, in particular the Ras /MAP kinase, are 
involved in the stimulation of cell proliferation by the same cytokines. Some cytokines 
activate pathways leading to apoptotic cell death. Adding to the plasticity of signalling 
systems, other kinases as well as Jaks function in the activation of Stats. Certain 
cytokines such as TNF-a and IL-lp do not use the Jak-Stat pathway. Instead they 
activate members of the MAP kinase family, resulting in increased binding of the 
transcription factors AP-1. NF-kB and NFTL- 6  to DNA (Roitt et al. 1998).
1.4.1 NF-kB
The transcription factor NF-kB is widely recognized as a critical mediator of immune 
and inflammatory reactions. It is found in the cytoplasm of most cell types, where it is
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associated with an inhibitory protein known as I-kB. A wide array of stimuli such as 
TNF-a, IL-1, T-cell activation signals, bacterial endotoxins, viral transforming proteins, 
certain growth factors and reactive oxygen intermediates lead to the rapid nuclear 
accumulation of NF-kB following the phosphorylation of IKK and the subsequent 
degradation of I-kB (Vandenabeele et al, 1995). Within the nucleus NF-kB regulates 
genes encoding cytokines, cytokine receptors, cell adhesion molecules, proteins 
involved in coagulation and genes involved in cell growth control (Baldwin, 1996). A 
dysfunction of NF-kB may be involved in a number of diseases including arthritis, 
Alzheimer’s disease atherosclerosis, and cancer as well as in other inflammatory 
diseases.
The molecular events occurring from the IL-1R signalling complex through to the 
induction of NF-kB and c-jun, follow a series of biochemical cascades of protein- 
protein interactions involving the adapter molecule MyD8 8  and two ser/thr kinases, 
IRAK and IRAK2. Downstream from these kinases exist the adapter molecule TRAF6  
and protein kinases, TAK-1 and NIK. It is NIK that activates the I-kB kinase complex 
resulting in the activation of NF-kB (Daun and Fenton, 2000).
NF-kB is formed through the association of multiple subunits, either as a homodimer or 
heterodimer. The subunits that have been identified indude p50 (NFkBI), p65 (RelA), 
c-Rel, RelB and p52 (NF-kB2). The classic NF-kB form exists as a p50-p65 
heterodimer and predominates in many cell types. There is growing evidence that many 
different combinations of homo and heterodimers exist and that the different forms of 
NF-kB have different functions in cells (Baldwin, 1996).
1.4.2 NF-AT
As with NF-kB, NF-AT becomes activated in the cytoplasm and migrates to the 
nucleus, following signals from the TCR and CD28. These signals then induce the 
expression of certain genes including IL- 2  and IL-2R genes (Roitt et al, 1998). NF-AT 
is additionally involved in the promotion of several Th2 cytokines including IL-4, IL-5 
and IL-13. In mice the inactivation, or in some cases the overexpression, of NF-AT 
results in the impaired synthesis of Th2 cytokines, though no defects in the synthesis of 
IL-2 were reported (Serfling et al, 1999).
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It has recently been reported that as well as NF-AT having a role in activated T cell 
gene expression the transcription factor is also involved in triggering a distinct genetic 
programme that results in the T cell becoming anergic. However the mechanisms 
involved in this pathway are not fully understood, although it has been suggested that 
die interaction of NF-AT with nuclear factor AP-1, essential for the transcription of 
effector cytokine genes during T-cell activation, is not required to render die T cell 
anergic (Bell, 2002).
1.5 Chemokfnes
Chemokines are 8-12 kDa heparin binding cytokines with the ability to attract leucocyte 
subsets to specific sites. In humans more than 50 chemokines have been identified and 
are classified into four groups according to their conserved cysteine residues as follows: 
CXC, CC, C and CX3C. Chemokines activate seven transmembrane spanning, G 
protein linked receptors resulting in activation of downstream signals which act to 
determine the response of a cell (Murdoch and Finn, 2000). The most important 
function of chemokines is their ability to regulate leucocyte recruitment, retention and 
positioning in tissue. This process is done by stimulating directional migration and by 
activating leucocyte integrins to bind to other cells and extracellular matrix. On of the 
many critical roles chemokines function in is in the control of effector cell recruitment 
to sites of infection or tissue damage (Moser and Loetscher, 2001).
Chemokines are structurally homologous cytokines that have the ability to stimulate 
chemokinesis and chemotaxis. Rantes is a chemokine produced by activated T cells 
that is chemotactic for eosinophils and basophils has been implicated in the late-phase 
of allergic reactions (Alam et al9 1992). Other factors involved in allergic 
inflammation include adhesion molecule ICAM-1, expressed on conjunctival epithelial 
cells in allergic but not on non-allergjc individuals cells (Ciprandi et al, 1993) and 
cytokines IL-4 and IL-13 suggested to play a role in the prolonged release of IgE in 
allergic disease (Fujishima et al, 1997).
1.6 Thl/Th2 balance and cytokine environments
The outcome of microbial infections is a dynamic process that depends on factors 
derived from both the host and the microorganism. In chronic human infections, the 
specific immune response to the pathogen may be of vital importance in the hosts’
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defence. Thus an inappropriate immune response may result in the lack of protection 
against pathogens and also contribute to die pathology in certain diseases such as 
allergic and autoimmune conditions.
It is well established that during an immune response the cytokines generated by Thl 
and Th2 and, in many cases, cytotoxic T cells (Tel and Tc2), are critical to the efficacy 
of the response. An imbalance of cytokines occurs in patients with acute lymphoblastic 
leukaemia where there is a reduction in type 1 cytokines, including IFN-y and an 
expansion in type 2 cytokines (Zhang et al, 2000).
A classic example of dysfunctional T cell responses, and the subsequent cytokine 
profiles generated to combat the spread of infection, has been highlighted in individuals 
with leishmaniasis. Following the entry of leishmania parasites in a mammalian host 
they are taken up by macrophages and here they undergo intracellular multiplication. 
Within a few hours of the parasites’ entry a massive cellular infiltration occurs 
(Benjamin et al, 1994). In cutaneous leishmaniasis it has been observed that a Thl cell 
response is protective and that a Th2 cell response is ineffective in controlling the 
spread of the infection. Cells from lymph nodes of mice resistant to leishmaniasis 
produce high levels of IFNy with virtually no IL-4 during infection; however, the 
reverse is seen in mice such as BALB/c, which are extremely susceptible to infection 
(Nabors, 1997).
Therefore the T cells play a central role in determining whether the host will develop a 
healing or progressing disease in response to the parasite (Titus et al, 1987). The CD4+ 
Thl or Th2 subsets have a critical role in determining the outcome of the disease. 
Protective immunity to leishmaniasis is mediated by the Thl cells that produce IFN-y, 
which has the ability to promote the resolution of skin lesions through its capacity to 
activate macrophages within which the parasites multiply (Moll et al, 1996). Other 
cytokines such as IL-2, GM-CSF or TNF-a all synergize with IFN-y to restrict the 
growth of Leishmania parasites. Natural killer and CD8+ cells are also important at 
promoting the development of Thl cells, leading to the immunological control of 
leishmaniasis (Hill et al, 1989). It has been demonstrated that leishmania major 
infected mice of resistant strains contain higher numbers of parasite-specific CD8+ T 
cells compared to susceptible mice. It has also been shown, by the elimination of CD4+
T cells, that CD8+ T cells can exert a protective role in the absence of CD4+ cells (Wang 
etal, 1993).
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Many allergic disorders arise due to environmental and genetic factors. Individuals 
with atopic disorders (genetic predisposition to generate IgE mediated type-1 
hypersensitivity reactions) generate allergen-specific CD4+ Th2 cells, the effects of 
which are associated with the clinical symptoms observed in allergic diseases. With the 
knowledge that Th2 cells are the major culprits, therapeutic strategies are being 
designed to shift the balance of cytokine profiles towards a more Thl-like profile to 
ameliorate symptoms. Likewise, autoimmune conditions such as RA and TAO result in 
a skewed Thl-like cytokine responses. Thus therapeutic strategies altering a Thl 
cytokine profile towards a more Th2-like profile could prove beneficial for improving 
chronic inflammation observed in diseases associated with Thl cytokine production. 
IL-12 is produced by APCs and drives Thl cells. The time, localization and magnitude 
of IL-12 production ultimately have a major influence upon die fate of the response. 
Disturbances in this rigorously maintained ‘balance of power” of EL-12 are frequently 
associated with immunological disorders (Ma and Trinchieri, 2001).
It is the cytokines themselves that play the most critical role in T helper cell 
polarizatioa Whilst differentiation to Thl and Th2 subsets involve IL-12 and IL-4 
respectively, they also simultaneously inhibit the production of die opposing subset 
(Glimcher and Murphy, 2000). Whilst theoretically, and in many cases practically, 
altering the balance of cytokine profiles may give desirable results, a note of caution 
must be enforced as there is a fine balance that needs to be achieved to avoid causing 
further inflammatory disease states from the reversing cytokine profiles. It is also 
important to note that in disease states, whether Thl or Th2, it is the prolonged cytokine 
bias that is detrimental. Therefore a balanced, rather than a biased, immune response is 
necessary for host protection (Rhodes and Graham, 2002).
There have been several research papers published investigating ratios of IFN-y:IL-4 to 
determine skewed cytokine profiles (Giannakoulas et al, 2004 and Shimada et al, 2003). 
The first such paper by Cohen and Feldmann (Mullins et al, 1995) classified ThO T cells 
as such if there were similar ratios of IL-4 and IFN-y (approx 1:1). Classification of Thl 
cells was determined if the level of expression of IFN-y was greater than that of IL-4. It 
was observed that different T cell clones displayed differential IL-4:IFN-y ratios, 
ranging from 1:2 to 1:450. Similarly T cell lines classified as Th2 type would express 
greater levels of IL-4 than EFN-y.again at least twice (1:2) IFN-y:IL-4 (Mullins et al,
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1995). Therefore, for T cell lines classified as Thl and Th2 the predominant cytokine 
(IFN-y and IL-4 respectively) would be expressed at significantly greater levels than the 
other. Others have studied the cytokine balance in terms of percentage increases and 
decreases (Knutsen et al, 2004) or by statistically significant greater or lower levels of 
cytokines (Moverare et al, 2000). It has also been recognised that individual T cells and 
clones display considerable diversity with a mix of both Thl and Th2 cytokines in their 
cytokine profiles, with Thl and Th2 cells being extreme phenotypes (Kelso, 1995).
1.6.1. Thl lineage
Stat4 is associated with the development of CD4+ Thl cells and has a role in regulating 
the expression of other transcription factors. Other components are also involved in the 
development of Thl cells such as the IL-12R|32 expression. The otokine IL-23 is 
related to IL-12 and is also capable of activating Stat4 in T cells. However, Stat4 
appears to be a less absolute gateway in Thl development than Stat6 appears to be in 
Th2 development (Asnagli and Murphy, 2001). It is recognised that the transcription 
factor T-bet is the major transcription factor that drives die cytokine expression, 
chromatin remodelling and epigenetic changes associated with Thl differentiation. 
Additionally T-bet is involved in the commitment and maintaining stability of the Thl 
phenotypes. During die course of commitment of Thl cells complimentary changes 
occur at the IFN-y locus however, these are less defined than those in Th2 cells 
(O’Garra and Arai, 2000). Also the stability of Thl phenotypes is questionable as in 
vitro studies the frequency and intensity of intracellular IFN-staining in Thl clones and 
cell lines can diminish after passage in the absence of IL-12 (Murphy et al, 1996). 
Also in vivo studies have revealed a requirement for continuous IL-12 action in 
maintaining the effectiveness of a Thl response. It has also been reported that fully 
differentiated Thl cells transferred into IL 12-40-deficient recipients were inadequate to 
protect against L. major demonstrating a need for IL-12 beyond the induction of Thl 
ceils (Park et al, 2000).
1.6.2. Th2 lineage
The development of CD4+ Thl and Th2 cells is required for die eradication of 
pathogens, however they can also be responsible for various pathological disorders. 
The Th2 cells, as discussed previously, produce IL-4, IL-5 and EL-10 are involved in 
humoral immunity and allergic responses. Human Thl and Th2 clones have been 
described as being less polarized than their murine counterparts and can both produce
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IL-4 and IFN-y depending on their mode of activation (Yssel et al, 1992). In the 
presence of IL-12 (Yssel, et al 1994) or when stimulated with phorbol ester and calcium 
ionophore (Yssel et al, 1992) human Th2 clones are capable of producing significant 
amounts of IFN-y highlighting that the IFN-y gene is not permanently silent in these 
cells (Somasse, et al, 1996). However it is also accepted that the presence of IL-4 
(Chatelain, et al, 1992) and IL-12 (Hsieh, et al, 1993) at the onset of an immune 
response induces Th2 and Thl responses, respectively in humans in vivo.
IL-12 is known to drive the differentiation of naive T cells towards IFN-y-producing 
cells (Hsieh, et al, 1993) and has also been associated with enhancing the production of 
IFN-y from Leishmania major-specific Th2 cells in the presence of rIFN-y and rlL- 
12 (Mocci and Coffman. 1995) however, unable to induce a complete conversion into 
Thl type cells. Conversely, Th2 populations derived from transgenic mice were not 
reversible when stimulated by rIL-12 (Perez, et al, 1995). This may be explained by the 
resistance of murine CD4+ Th2 cells to the effects of the downregulation of IL-12R on 
these cells (Szabo, et al, 1995). The loss of IL-12 signaling in Th2 cells is via the 
inhibition of IL-12Rp2 due to the activity of GATA-3 (Ouyang. et ah 1998/
A stud} monitoring the in vitro effects of cytokines IL-4 and IFN-y on the development 
of Thl and Th2 subsets from naive human neonatal CD4+ T cells assessing the 
development and reversibility of these cells was conduced by Somasse and colleagues 
(1996). They found that repeated stimulation of neonatal CD4+ T cells results in the 
development of Thl or Th2 when cultured with IL-12 and IL-4 respectively, when 
administered during the priming of the cells. However, the differentiation requirements 
and stability in relation to cytokine production profiles differ between subsets. The 
generation of a Th2 population producing low levels of IFN-y with high levels of IL-4, 
IL-5, IL-10 and IL-13 occurred through cross-linking anti-CD3mAb with CD32+ on 
mouse L cells expressing CD80 and CD58. It was observed that the differentiation of 
neonatal CD4+ T cells into Th2 cells occurs slowly requiring both priming and 
restimulation in the presence of IL-4 and showed that blocking IFN-y did not accelerate 
Th2 differentiation (Somasse et al, 1996). In comparison IL-12-induced development 
of neonatal CD4+ T cells into Thl cells occurred rapidly with the generation of high 
frequencies of IFN-y-producing cells. In Thl culturing conditions half the number of 
samples were observed as having significant levels of IL-4, and IL-13. However, it was 
shown that no Th2 differentiation of neonatal CD4+ T cells was detected in the presence
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of rIL-12 and that IL-4 detected in cultures had been generated from ThO cells 
(Somasse et al, 1996).
The study also revealed that both IL-12 and EL-4 directly induce human neonatal CD4+ 
T cells, activated via CD3 and CD28, to enable the differentiation into Thl and Th2 
cells. Additionally the neonatal CD4+ T cells in both Thl and Th2 culturing conditions 
produced large amounts o f IL-10 and not solely by Th2 type cells. They concluded that 
Thl differentiation occurred by day 4 of the neonatal CD4+ T cells in the presence of 
EL-12 and was stable not being affected with repeated stimulation with rIL-4. In 
contrast differentiation of the neonatal CD4+ T cells into Th2 phototype was slower, 
requiring 6 days of priming. It was also noted that die IL-4 Th2 type cells woe not 
stable and could easily be reverted into a population containing ThO and Thl cells 
following a single restimulation with rIL-12 which they regarded as a possible 
hindrance for cytokine-based therapies (Somasse et al, 1996).
Research by Asnagli and Murphy (2001) highlighted that the activation of GATA-3 in 
Th2 development is essential and has an autoactivation positive feedback mechanism 
which is involved in stabilizing Th2 and postulate that the molecular analysis of GATA- 
3 will be important in controlling and reversing Th2 commitment. On the other hand 
the stability of Thl was questioned as it has been observed that the frequency and 
intensity of intracellular IFN-y staining in Thl clones and lines can diminish after 
passage in the absence of IL-12 (Murphy et al, 1996). In vivo studies have also 
indicated that the continuous requirement of IL-12 in maintaining an effective Thl 
response against several pathogens (Asnagli and Murphy, 2001). Fully differentiated 
Thl cells transferred into IL-12p40-deficient mice woe inadequate in protecting against 
LMajor, demonstrating the necessity of IL-12 beyond the induction of Thl 
development (Park, et al,2000) and that IL-12 is required to prevent reversal of the Thl 
phenotype (Asnagli and Murphy, 2001).
A speculative model of establishing and maintaining lineage-defining gene activity 
during T cell differentiation is illustrated below in figure l.iii. Illustrating the potential 
induction of type 2 cytokines, IL-4, IL-5 and EL-13 become induced or repressed during 
Th2 and Thl differentiation respectively.
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Figue l.iii. Mechanisms involved in the establishment and maintenance configuration of naive cells in 
blue, Th1 cells in red and Th2 cells in green, the three distinct cytokine promoters are looped into 
proximity of the Th2 locus control region within the lineage-nonspecific Rad50 gene.
Sequence-specific activators, illustrated above, are STAT6 and GATA-3 that control the 
induction o f  chromatin remodelling for the establishment o f  the transcriptionally 
permissive state o f the locus. With the emergence o f subsequent generations o f  Th2 
lineage the maintenance o f an overall permissive state appears to become independent 
o f both inducing factors. However mature Th2 cells still require GATA-3 to trans- 
activate the IL-5 and IL-13 promoters whilst other transcription factors, such as NFAT 
and c-m af are considered to drive the IL-4 promoter. GATA-3 and T-bet, in Thl cells, 
are required to establish but not to maintain permissive chromatin structure for the IFN- 
y and IL-4 loci. During the differentiation towards T hl type cells a sequence next to IL- 
4 acts to silence and repress IL-4 expression. The sequence-specific repressor acting at 
the silencer has not yet been identified also it is unclear whether this repression is 
heritable or stably independent o f  the initial repressor silencer interaction. Despite 
figure l .iii depicting Th2 type cell cytokines it is thought a similar process o f successive 
epigenetic induction and silencing is likely to occur at the IFN-y locus in Thl and Th2 
cells, respectively. During the transition from naive to mature effector cells the 
forbidden cytokine gene, IFN-y in Th2 cells and IL-4 in Thl cells, is made more silent 
(Sallusto and Reiner, 2005). However, in the Thl cells the locus o f Th2 cytokines 
appears to remain poised, this lack o f global restriction in the Th2 cytokine cluster may 
support the theory IL-4 is actively repressed as opposed to being irrevocably silenced. 
This would agree with findings that Thl cells can be reprogrammed to express IL-4 as 
well as IFN-y (Messi et al, 2003).
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It is intriguing why some lineage-specific genes of Thl and Th2 cells remain depend sit 
on continuous expression of fate-detennining transcription factors, whereas others do 
not. This diversity in stabilization strategies may explain some of the apparent 
heterogeneity in the stages or subsets of memory T cells (Sallusto et al, 2004).
1.7. Role of T cells in allergy
As mentioned earlier specific immune responses are characterised by specific antigen 
responses along with the ability to display an enhanced immune response on secondary 
and subsequent exposures to the same antigen. When secondary responses occur in an 
exaggerated or an inappropriate manner they are termed as being hypersensitivity 
reactions. Hypersensitivity reactions can be classified into five major groups.
Type I, or anaphylactic, reactions, begin almost immediately following exposure with a 
causative allergen. Consequently, the allergen binds to specific IgE antibodies attached 
to basophils or mast cells resulting in the degranulation of these cells and the release of 
numerous inflammatory mediators e.g. histamine. Allergic reactions fall into this 
category, characterized by localised oedema for example during seasonal conjunctivitis. 
Antibody-dependent cytotoxic reactions (ADCC) are also known as Type II 
hypersensitivity responses. An example of this type of reaction may be seen if 
mismatched red blood cells are transfused resulting in agglutination of the cells by 
antibodies followed by complement-mediated lysis. An example of this type of 
hypersensitivity response includes autoimmune thyroiditis. Systemic lupus 
erythematosus (SLE) is a type III hypersensitivity reaction characterised by the 
formation of immune complexes (antigen-antibody complexes) that fail to be cleared 
resulting in intense inflammation and local tissue damage through complement and 
neutrophil-mediated cell destruction. Delayed type hypersensitivity responses (DTH), 
also know as Type IV hypersensitivity reactions, are mediated by previously sensitised 
CD4+ and CD8+ T cells. This type of response takes longer to generate because of the 
involvement T cells. An example of this type of response is contact dermatitis (Marieb, 
1992). Graves Disease is a Ty pe V hypersensitivity response caused by the generation 
of inappropriate self-responsive antibodies. Ocular allergic reactions involve ty pe I 
and type IV hypersensitivity responses (Tuft et al, 1991; Bonini, 1993). The chronic 
inflammation observed in allergic eye disease is a consequence of the interaction and
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subsequent cytokine secretion of activated CD4+ T cells, mast cells and eosinophils that 
infiltrate the conjunctiva (Calder et al, 1999).
1.7.1 T reg cells in allergy
Naturally occurring CD4+ CD25+ Foxp3+ T reg were originally described in mice where 
they were found to be responsible for protection against various autoimmune diseases 
such as gastritis or thyroiditis (Sakaguchi et al, 1995). Since then it has been 
acknowledged that the development of allergic diseases such as rhinitis, asthma and 
atopic eczema is controlled by several populations of regulatory T cells, (Umetsu, et al,
2003). Individuals lacking CD4+ CD25+ T cells display X-linked autoimmunity-allergic 
dysregulation (XLAAD), which is characterized by diabetes mellitus, high serum IgE 
levels, eosinophilia and food allergy (Wildin, et al, 2002).
Both naturally occurring CD4+ CD25+ T reg cells and inducible populations of allergen- 
specific IL-10 secreting TrI cells inhibit allergen-specific effector cells in experimental 
models by reducing allergic inflammation. The skewing of allergen-specific effector T 
cells to a T reg phenotype appears to be an important aspect in the development of a 
healthy immune response to allergens and on the successful outcome in allergen- 
specific immunotherapy (Akdis 2005). It has also been reported that subsets of CD8+ T 
cells, y8 T cells, DCs, IL-10-producing B cells, natural killer cells, and tissue resident 
cells, may contribute to the generation of T reg cells, and could be involved in the 
suppressive and regulatory events (Akdis, et al, 2004).
A recent study demonstrated that CD4+ T reg cells from grass-pollen-allergic donors do 
not inhibit proliferation of CD4+ CD25' responder cells and fail to suppress cytokine 
production from the CD4+ CD25' cells at high concentrations of allergen. However, in 
contrast T reg cells from non-atopic donors retain their regulatory capacity even at high 
concentration of allergen (Bellinghausen, 2005). The addition of IL-2, increased 
costimulation, or activation with superantigens breaks CD4+ CD25+ T reg-mediated 
suppression (Baecher-Allan et al, 2002). Another study sought to investigate whether 
under certain conditions CD4+ CD25+ T reg cells suppressor function is inactivated or 
whether increased stimulation causes responder cells to escape suppressioa This study 
demonstrated in a murine model with different T cell receptor transgenic T cells which 
with strong antigen-specific stimulation caused the CD4+ CD25+ to remain partially
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functional however did reduce cytokine levels and CD25 expression of the cells in 
cocultures but no longer inhibited proliferation (George et al, 2003). These results 
suggest that potently stimulated Th cells may partially escape T reg cell mediated 
control possibly by producing large amounts of IL-2 (Bellinghausen, 2005).
Studies to investigate immune responses to allergens in healthy (non-allergic) 
individuals have demonstrated that a peripheral T-cell repertoire to allergens exists that 
recognizes the same T-cell epitopes as with allergic patients (Nelson, 2005 and Till et 
al, 2004). This active regulation is an essential mechanism for both inducing and 
maintaining peripheral tolerance to allergens. Allergen-specific T cells constitute less 
than 0.1% of die whole CD4+ T-cell repertoire and can be isolated from die peripheral 
blood of human subjects according to their cytokine profile. Freshly purified IFN-y, IL- 
4, and IL-10 producing allergen-specific CD4+ T cells display characteristics of Thl, 
Th2, and IL-10-secreting T reg cells (T reg l-like cells), respectively (2Akdis et al,
2004). The dominant subset of T cells, against common environmental allergens, in 
healthy individuals is the specific T regi cells, in contrast to the high frequency of 
allergen-specific IL-4- secreting T cells in allergic individuals (Akdis et al 2005). The 
T regi cells’ activity is related to the secretion of cytokines, such as IL-10 and TGF-p, 
but contact-dependent signals, such as programmed death-1, glucocorticoid-induced 
TNF receptor (GITR), membrane TGF-p and CTLA4, appear to be important in healthy 
individuals for regulating the immune response (2Akdis, et al, 2004).
Allergen-specific T cell subsets are prevalent in healthy and allergic individuals 
although they have been observed as existing in different proportions. Hence, a change 
in the dominant subset may result in the development or recovery of allergy and it is the 
ratio between the specific Tr 1 and Th2 cells that determines the development of a 
healthy or an allergic immune response (Akdis et al,2005). A recent study has 
suggested that the suppressive activity of CD4+ CD25+ Treg cells is dependent on the 
allergen concentration and type of allergen with different thresholds for different 
allergens and individuals correlated with their sensitization/atopy status (Bellinghausen, 
etal, 2005).
Therefore it is essential to understand the immune mechanisms that prevent disease 
occurrence in healthy individuals. There is evidence of altered regulatory pathways in 
allergic disease and that die induction of allergen-specific T reg cells provides hope for
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new interventions. It is postulated that the anti-inflammatory and immunological 
properties of IL-10 make it an attractive cytokine for the control of allergic, asthmatic 
responses (Hawrylowicz and O’Garra. 2005) and probably autoimmune diseases. It has 
been postulated that naturally occurring T reg cells and IL-10 secreting T reg cells are 
capable of regulating low grade inflammation independently of cytokines, however, IL- 
10 and TGF-p may be needed to control acute inflammation with the activation of the 
innate immune response (O’Garra and Vieira, 2004). Clinical trials using recombinant 
IL-10 so far have shown that it is very well tolerated.
It must be stressed that IL-10 may help to regulate peripheral T cell responses but the 
localized effect must be investigated in chronic disease therapy when significant tissue 
damage has already occurred as it activates other tissue-resident cells, which are 
probably deleterious. It has recently been reported that patients with stationary liver 
cirrhosis have significantly higher serum levels of IL-10 than that in the normal control 
group. The study further concluded that T cell immune responses correlated with 
fibrosis and hepatic inflammatory activity and may play an important role in liver 
cirrhosis (Tang et al, 2006). It is also known that IL-10 activates cells such as myo­
fibroblasts which could excerbate collagen deposition and tissue re-modelling in CAED 
therefore would not be a good idea to inject IL-10 directly but option to overcome this 
problem may be to treat T cells in vitro to make them anti-inflammatory and then utilize 
these T cells. For example the local delivery of inhibitory signals through the induction 
of allergen-activated IL-10 secreting T reg cells. Another disadvantage with using IL- 
10 therapeutically is that it has a relatively short half-life in vivo (Hawrylowicz and 
O’Garra, 2005).
1.8. Role of T cells m organ-specific autoimmunity
Autoimmunity refers to a phenomenon involving the immune attack of one’s own cells 
and tissues. Autoimmune diseases occur as a result of either a failure or due to a 
breakdown in the mechanisms normally responsible for maintaining self-tolerance 
(Abbas et al, 1996). Ocular tissues may become the target for autoimmune attack via 
mimicry with antigens on microorganisms or one’s own tissues or possibly by both. 
Autoimmune attack of organs and tissues is characterised by cellular infiltration and 
inflammation in the target tissue (Koevary, 1999).
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Autotolerance is established in the thymus early in development, resulting from the 
confrontation of cells of the immune system with the large collection of autologous 
protein and glycoprotein molecules -  ‘thymic education’. The primary mechanism of 
self-tolerance is via the deletion of autoreactive T cells. However, some self-reactive T 
cells do escape to the periphery. These are then subject to mechanisms of peripheral 
tolerance including T cell anergy (Schwartz, 1990) and T cell ignorance (Miller and 
Heath. 1993). Though anergy may be reversed, naive T cells also have the potential to 
become activated either when their target self antigens are exposed during an 
inflammatory response or when they recognize cross-reactive epitopes from an 
infectious agent (Wucherpfennig and Strominger, 1995). There are several other ways 
in which self tolerance is broken: firstly, through the aberrant expression of MHC class 
II molecules that had not been expressed in early life (Rajan, 1987); secondly, tolerance 
may be broken by the expression of new autoantigens arising due to a mutation (Rajan, 
1987); thirdly, through alterations in the processing of auto antigens. This may be 
brought about by changes in the proteolytic enzymes in die processing compartment of 
APCs resulting in the creation of new epitopes. To summarise, this autoimmunity 
occurs via:- molecular mimicry, bystander activation, through the loss of tolerance.
Over the past decade investigations into the mechanisms of immune suppression 
regulating autoreactive T cells have revealed distinct subsets of T cells with 
immunoregulatoiy properties (Moller, 1996). The role of a subpopulation of suppressor 
T cells coexpressing CD4+ and CD25+ (IL-2Ra-chain) in preventing autoimmunity in 
vivo is now well established (Sakaguchi et al, 1995), following extensive research by 
several groups into autoimmune gastritis (a model of organ-specific autoimmunity) 
(Taguchi and Takahashi, 1996: Powrie et al 1996). The major pathway by which the 
CD4+ CD25+ T cells exert their suppressive actions is by die physical interaction with 
responder CD25' T cells.
The preventative mechanisms in certain autoimmune conditions involve cytokines such
as IL-4, IL-10 and TGF-p (Krause et al, 2000; Homann et al, 1999). It has been
reported by Powrie and colleagues that inflammatory bowel disease (IBD) induced by
die transfer of CD45RBhigh T cells to immunocompromised animals may be suppressed
with the co-transfer of CD45RBlow cells. Anti-TGF-p or anti-IL-lOR treatment in the
animals resulted in the complete reversal of suppression seen with transfer of
CD45RBlowcells, yet IL-4 appeared to play no role in this model (Powrie et al, 1996).
The role of IL-10 in the prevention of IBD has been demonstrated by the activation of
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an antigen-specific regulatory T cell population (Trl) that secretes large amounts of IL- 
10 in the gut (Groux et al, 1997).
There is little doubt the CD4+ CD25+ T cells have a protective element against a large 
spectrum of organ-specific autoimmune diseases including IBD and diabetes. The 
identification of CD25 as a marker for regulatoiy and suppressor T cells will enable 
future investigations into the mechanisms by which they mediate their suppressive 
actions. It is possible to envisage the augmentation of the function of these cells to treat 
ongoing autoimmune diseases (McHugh et al, 2001).
Many of the organ-specific autoimmune diseases such as insulin-dependent diabetes 
mellitus (IDDM), autoimmune thyroid diseases and systemic autoimmune diseases like 
RA and EAE are CD4+ Thl dominated. In contrast other autoimmune conditions like 
SLE are associated with CD4+ Th2 cell activation (Groux and Powrie, 1999). The 
processing of antigens whether self or foreign follows an identical cascade of events 
prior to the incorporation of antigens into MHC molecules.
1.8.1. T regs in autoimmimity
Immunological tolerance to self-antigens is a tightly regulated process. A primary 
mechanism for self-tolerance is deletion of selfreactive cells in the thymus. However, 
this mechanism is not perfect, and autoreactive clones do escape into the periphery. 
Tolerance is maintained in the periphery through a variety of mechanisms, including a 
population of regulatory T cells that actively suppress the function of autoreactive T 
cells.
The T cell repertoire of natural CD25+ CD4+ is just as broad and diverse as the CD4+ 
CD25' T cells but is more skewed towards recognising complexes of self peptide and 
MHC expressed in the thymus and the periphery (Hsieh et al, 2004). They are able to 
recognize self antigens targeted in autoimmune disease (Reddy et al, 2004), tumour- 
associated antigens (Nishikawa et al, 2003) and allogeneic transplantation antigens 
(Nishimura et al, 2004). Upon stimulation with their respective antigens they are able 
to suppress autoimmunitv. hamper tumour immunity and inhibit graft rejection. These 
cells exhibit antigen-specific proliferation, though this is to a lesser degree than the 
proliferation of effector T cells, following strong antigenic stimulation in vivo and in 
vitro with antigen in combination with a high dose of IL-2 (Takahashi et al, 1998;
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Thornton and Shevach, 1998,). However, in a steady physiological state these cells are 
overall more proliferative than other T cells through their recognition of self-antigens 
(Setoguchi et al, 2005; Fisson et al, 2003). Despite autoreactive cells being present in 
both healthy individuals and patients with autoimmune disorders, the autoreactive T 
cells found in patients with autoimmune disease are more easily activated compared to 
those from normal individuals (Scholtz et al, 1998).
The depletion or dysfunction of natural CD25+ CD4+ T reg cells is sufficient to cause 
autoimmune disease in otherwise normal animals despite the presence of other types of 
T reg cells and with the possible capacity of naive CD4+ or CD8+ T cells to differentiate 
into T reg cells in certain conditions, (Fontenot and Rudensky 2005). For example the 
depletion of CD4+CD25+ cells from young NOD mouse model results in the 
development of diabetes (Salomon et al, 2000). This would suggest that any genetic 
abnormality or environmental insult may be a cause of or predisposing factor for 
autoimmune diseases, in particular organ-specific autoimmunity if numbers or 
functional effectiveness or disturbed balance between decreased natural CD25+ CD4+ T 
reg cells with increased levels of self-reactive T cells (Baecher-Allan and Hafler, 2004; 
Sakaguchi, 2004). A deficiency or functional alteration or costimulatory or accessory 
molecules such as CTLA-4 of (HTR on T cells or APCs, or cytokines such as IL-2 may 
break self-tolerance and result in autoimmune disease through the effects on natural T 
reg cells (Sakaguchi, 2005). Autoimmunity in both humans and rodents may arise as a 
result of polymorphisms of genes encoding for the molecules CTLA-4, IL-2 (Ueda, et 
al 2003).
Approaches to treat autoimmunity have, in the past, focussed on the use of potent 
immunosuppressive drugs that block the activation and expansion of antigen-specific T 
cells before they differentiate into pathogenic T cell responses. Despite these therapies 
being very effective in reducing clonal expansion and altering early signalling 
pathways, once pathogenic responses are established such as in autoimmunity the 
interventions are less effective on activated and differentiated T cell subsets or to act in 
the presence of an inflammatory environment to terminate immune responses at the 
target tissue and systemically. Additionally, traditional immunotherapies require 
continuous usage as they do not redirect the immune system to a state of tolerance. 
Recent advances in the identification of a dedicated T reg subset has shown enormous
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potential in suppressing pathologic immune responses in autoimmune disease, graft 
versus host disease (Bluestone and Tang, 2004) and probably allergic diseases.
T reg cells have the ability to inhibit the development of autoimmunity when transferred 
into an appropriate host. The cotransfer of CD25+ CD4+ suppressor cells with CD25' 
CD4+ cells prevents the development of experimentally induced autoimmune disease 
such as colitis, gastritis, insulin-dependent autoimmune diabetes, and thyroiditis 
(Sakaguchi, et al, 1995). Chalenoud and colleagues (2003) demonstrated that the 
protection of autoimmune diabetes in the NOD mouse model was dependent on the 
production of TGF-p from co-transferred CD25+ CD4+ cells. This was demonstrated by 
the reversing of protection from diabetes by treatment with anti-TGF-p at the time of T 
reg transfer (Belghith et al, 2003).
There exists increasing evidence that natural CD25+ CD4+ T reg cells expanded both in 
vivo and in vitro may not only be used in preventing autoimmune diseases but also to 
treat ongoing autoimmune responses by suppressing the population expansion of 
effector T cells (Tang, et a I, 2004). Additionally several reports have described die 
existence of a population of CD4+ CD25W T reg cells in die thymus and periphery in 
both mice and humans which are anergic to in vitro antigenic stimulation and strongly 
suppress the proliferation of responder T cells upon coculture (Thornton and Shevach,
1998). However, it has been noted that T reg cells are particularly sensitive to both 
TCR and CD28 signals. Hence, it was hypothesised that a strong TCR/CD28 signal 
plus a high dose of IL-2 would be required to enable proliferation The protocol that 
has been most successful for the proliferation of T regs has combined anti-CD-3 and 
anti-CD28-coated beads in the presence of 1,000-2,000 units of recombinant IL-2. In 
such conditions T reg cells expanded as much as 200-250-fold within 14 days with the 
retention of high levels of Foxp3 expression and produce both IL-10 and TGF-p 
(Bluestone and Tang, 2004).
It was postulated by Viglietta {et al, 2004) that either die deficient generation or 
reduced effector function of CD4+ CD25ta T cells play a role in regulating the 
autoimmune response in patients with MS. In the study to investigate their inclination 
they compared the frequency and function of CD25hi CD4+ T reg cells derived from a 
group of untreated patients with relapsing /remitting (RR) MS with those from age 
matched healthy control subjects. The study concluded that it was apparent that defects
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in different populations of T reg cells contributed to the induction of autoimmune 
diseases. The study reported a significant reduction in the effector functions of CD25hi 
CD4+ T reg cells in subjects with MS compared to healthy donors and claimed to be the 
first study showing the involvement of this subset of T reg cells in a human 
autoimmune disease (Viglietta et al, 2004). A similar study investigating the levels and 
the in vitro suppressive ability of CD4+ CD25bi T cells comparing normal controls and 
chronic type 1 diabetic individuals concluded that no significant differences existed for 
the two parameters monitored (Putman, et al 2005).
Rheumatoid arthritis (RA) is a systemic inflammatory disease with autoimmune 
eitiology in which CD4+CD25+ T reg cells are present and functional with higher 
numbers and increased suppressive activity found in the synovial fluids compared to 
peripheral blood (PB) (van Amelsfort, 2004). This finding would suggest a negative 
feedback mechanism that is active at die site of inflammation probably due to ongoing 
inflammation. In this situation the immune regulation by CD4+CD25+ T reg cells in RA 
may be determined, at least in part, by the activation status of the responder T cells 
Hence, die balance between activated responder and T reg cells appears to influence the 
extent of immunoregulahon in RA A failure in immunoregulation in die synovial fluid 
could arise due to a shift in balance between activated CD4+CD25+ T reg cells and 
inflammatory cells at the site of inflammation (van Amelsfort, 2004).
T reg cells are induced under certain therapeutic interventions, such as with the 
treatment with anti-CD3 antibodies in early onset diabetics and islet transplantation as 
well as certain altered antigenic stimuli (Apostolou and Von Bohemer, 2005). These 
manipulated cells have similar properties to pre-existing CD4+CD25+ T cells and may 
influence the long-term effects of these therapies (Bluestone and Tang, 2004). 
Increasing evidence in animal models suggest that CD4+ CD25+ T reg cells are involved 
in the prevention of autoimmune diseases (Sakaguchi, et al 1995) and transplant 
rejection (Wood and Sakaguchi. 2003). however, the role and properties of this CD4+ 
subpopulation in the pathogenesis of human autoimmune diseases such as type 1 
diabetes mellitus, remain unclear (Putnam, et al, 2005). Nevertheless, the T reg cells 
represent an important population of suppressor T cells that appear to be essential in the 
prevention of autoimmune diseases.
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1.9. Ocular Allergy
The eye is a common site of allergic inflammation in both local and systemic 
hypersensitivity reactions. It is estimated that up to 20% of the population suffer from 
allergies and of these individuals more than a third have ocular manifestations, 
(Seamone and Jackson, 1996), associated with conjunctival involvement in the majority 
of ocular allergies (Friedlaender, 1992). The following types of clinical phenotypes of 
ocular allergy exist: seasonal allergic conjunctivitis (SAC), atopic keratoconjunctivitis 
(AKC), vernal keratoconjunctivitis (VKC) and contact lens-associated allergic 
conjunctivitis or giant papillary conjunctivitis (GPC) (Allansmith and Ross, 1988). T 
cell lines derived from patients with AKC, VKC and GPC have been grouped together 
in this study and referred to as chronic allergic eye diseases (CAED).
The immunopathology of ocular allergy involves multiple mechanisms partially relating 
to the release of pharmacological mediators from mast cells, such as histamine and 
tryptase. which have both been detected in the tear fluid of allergic patients (Abelson et 
al, 1980; Butrus et al, 1990). The release of these mediators causes the signs and 
symptoms associated with ocular allergy such as itching, tearing, mucous discharge, 
conjunctival vasodilation, increased vascular permeability and in severe cases papillary 
hypertrophy of the tarsal conjunctiva and ocular surface alterations (Abelson and 
Schaffer, 1993; Smolin, 1998). An essential part of effective management is to avoid 
causative environmental allergens, such as grass pollen.
Ocular allergy is a disease affecting the entire ocular surface including conjunctiva, lids, 
cornea, lacrimal gland and tear film. A complex chronic inflammation is involved in the 
pathogenesis of many ocular allergies (reviewed by Messmer, 2005). There exists a 
paradigm that ocular diseases are either Thl mediated or Th2 mediated. A recent study 
stresses the importance of understanding the exact mechanisms of Thl and Th2 cells in 
the pathology of ocular allergy. Current research of Thl and Th2 cytokines in an 
animal model of ocular allergy demonstrates the intricate complex regulation by both 
subsets of cytokines of die disease process. The following components of Thl and Th2 
cells in the development of chronic inflammation associated with allergic conjunctivitis 
exist Th2 cells involvement in ocular inflammation and the role of IFN-y as the 
endothelium gatekeeper in the pathology of Th2-mediated allergic conjunctivitis and 
require further understanding of the intricate interactions of Thl and Th2 cytokines in 
ocular inflammatory disease (Stem, et al, 2005). Experimental mouse models of ocular
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allergic disease in which localised cells were skewed toward a Th2 cytokine profile 
display a decrease in disease intensity following the transfer of CD4+CD25+ suggesting 
that T regulatory cells may contribute to protection from allergic eye disease (Schopf et 
al, 2005).
Therapeutic intervention to alleviate s\mptoms in these conditions includes a range of 
pharmacological agents such as oral antihistamines, mast cell stabilizers, several 
nonsteroidal anti-inflammatory drugs and, in severe cases, the administration of 
corticosteroids and immunosuppressive agents. Therapeutic agents related to these 
studies are discussed later in this chapter following a description of the forms of ocular 
allergies focussed upon in this study.
1.9.1 Role of T regs in ocular disease
The control of inflammation in delicate tissue such as the eye may be of particular 
importance. In a model for severe keratitis, caused by herpes virus, inducing a CD4+ 
reaction, lesions were more severe in mice whose natural T reg cells had been depleted. 
Also in the absence of natural T reg cells, non-pathological doses of virus can readily 
induce keratitis whereas a low dose of virus infection protects mice from CD4+ T cell 
mediated pathology by promoting natural T reg cells (Suvas et al, 2004).
1.9JL Seasonal Allergic Conjunctivitis
Seasonal allergens such as pollens, grasses, moulds, along with perennial allergens, for 
example, house dust mite and animal dander, are all able to trigger an immediate 
hypersensitivity reaction in the nasal mucosa and ocular tissues of previously sensitised 
individuals (Reiss et al, 1996). Ocular symptoms in response to allergen exposure 
include ocular and periocular itching, excessive lacrimation and watery discharge, 
burning, stinging and photophobia (Friedlaender, 1992). Ocular symptoms directly 
correlate with the degree of allergen exposure. Initial allergen-induced production of 
IgE causes an elevation of allergen specific antibody levels in serum and in tear fluid 
(Hoffinann-Sommergruber et al, 1996). The generation of EL-4 from CD4+ Th2 cells 
plays an important role in the production of IgE (Finkelman et al, 1990).
Mast cells with high affinity FCsR in the substantia propria of the conjunctiva cross link 
when bound to allergen and trigger the release of a range of mast cell mediators 
including histamine. Histamine release is associated with ocular itching (Abelson and
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Udell, 1981) other effects include local vascular events such as increased vasodilation 
and vasopermeabiliy resulting in leakage o f plasma and iniltration o f cells such as 
eosinophils it also causes endothelial cells to contract (Koevary, 1999).
1.9.3. Venial Keratoconjunctivitis
VKC is relatively a uncommon ocular allergic disease predominantly occurring in 
children that causes in severe cases corneal scarring and visual impairment (Tuft et al 
1989). The upper tarsal surface in VKC displays a 'cobblestone' appearance, as shown 
in figures l.iv. The condition occurs throughout the year though is particularly 
prevalent during the months o f  April to August (Allansmith and Ross, 1988; 
Friedlaender, 1995). Overall VKC is not seasonal worldwide. There is a greater degree 
o f risk from this condition for those living in warm, dry climates (Tuft et al, 1991). The 
disease appears to affect adolescent boys twice as frequently as girls (Ehlers and 
Donshik, 1992). However, girls are affected to a greater extent than boys after puberty. 
Beyond the age o f  20 men and women are equally affected (Smolin and O ’Conner, 
1986). The age o f  onset o f VKC is generally before puberty and usually peaks between 
the ages o f  11 to 13, with 80% patients falling into this category (Allansmith et al, 
1986). However, the age range can be much broader with patients as young as one 
month old through to patients o f  75 years old and (Smolin and O ’Conner, 1986). VKC 
is a self-limiting disease lasting from 2-10 years, and has a high incidence (75-80%) o f 
a history o f  infantile eczema, allergic rhinitis or asthma (Allansmith and Ross, 1986; 
Allansmith and Ross, 1988).
Figure l.iv. Illustration o f the clinical effects o f chronic VKC.
Figures l.iv. The upper tarsal surface in chronic VKC displaying ‘cobblestone’ appearance, (source: (a) 
www.allergyclinic.co.nz (b) idinchildren.com)
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The late phase response, involving CD4+ T cells, resulting in eosinophilia and the 
mediators secreted such as ECP and major basic protein which are toxic to comeal 
epithelial cells (Trocme et al, 1997). Major basic protein is associated with severe cases 
o f  VKC and GPC. Elevated levels o f  ECP may be detected in serum (Tomassini et al,
1996) and tears (Montan and Hage-Hamsten, 1996; Hage-Hamsten et al, 2002) in the 
late phase o f allergic reaction and relate to the magnitude o f the clinical reaction o f 
these patients. In acute VKC following conjunctival provocation, mast cell mediators, 
including PGD2, PGE2, and PGF are present in tear fluid (Proud et al, 1990), with PGF 
levels correlating with clinical signs o f  inflammation in patients.
1.9.4. Giant Papillary Conjunctivitis
GPC is an inflammatory condition occurring usually amongst individuals who wear 
contact lenses. The clinical manifestations are similar to those seen in VKC and include 
giant papillae at least 1mm in size in the upper tarsal conjunctiva, increased mucus 
secretion, itching along with intolerance to the contact lens (figure l.v.), (Allansmith 
and Ross, 1986). Up to 15% o f contact lens users develop GPC (Donshik, 1994), o f 
these between 5-10% o f soft contact lenses wearers whereas only 3-4% o f hard lenses 
wearers are affected (Smolin and O'Conner, 1986). The incidence o f  GPC is far greater 
(36%) in those who replace their contact lenses over 4 week intervals compared to those 
who replace their lenses every day to every 3 weeks with the reported incidence being 
4.5% (Porazinski and Donshik, 1999). GPC symptoms may occur after a matter o f 
weeks o f  using contact lenses or may manifest after several years o f  usage. In virtually 
all (90%) cases o f GPC both eyes are affected (Donshik, 1994).
Figure l.v. Giant papillae observed in the upper tarsal conjunctiva o f  GPC patients
Figure l.v. Clinical illustration of GPC. characterized by the presence of large papillae in the 
tarsal conjunctiva of the upper lid. GPC resembles vernal conjunctivitis, but is almost 
exclusively associated with contact lens wearers, (source: (b) idinchildren.com).
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1.9.5 Atopic Keratoconjunctivitis
AKC is one o f the most serious ocular allergic diseases due to the potential o f loss o f  
vision arising from comeal involvement. The clinical effects o f AKC are shown in 
figure l.vi. AKC usually presents in individuals with a family history o f atopic disease 
such as asthma, hay fever and urticaria (Friedlaender. 1992). There is a relatively large 
risk of the development o f AKC (25-40%) in individuals with atopic dermatitis (Hoang- 
Xuan et al, 1997). AKC has no seasonal, climate or geographic associations. Males are 
more commonly affected with AKC (Allansmith and Ross, 1986), generally occurring 
in adults between the ages o f 30 and 50 (Seamone and Jackson, 1996), and the disease 
may last for decades.
Figure l.vi. Illustration o f the clinical effects o f AKC
Figure l.vi. Illustrates the eye of an AKC patient with inflammation of the cornea, conjunctiva and the 
eyelids causing painful, watering, red eye with blurring of vision (source: (a) www.woridallergy.org/atopic 
(b) allergydinic.co.nz.guides)
1.9.6. Cellular infiltrate involved in CAED pathogenesis
Ocular allergic responses are primarily associated with different levels o f  activity o f 
Th2 lymphocytes, mast cells, eosinophils, fibroblasts, epithelial and endothelial cells 
(Bielory, 2002). In VKC and AKC T cells, eosinophils, and mast cells are all found in 
the conjunctiva and are thought to play a role in disease pathogenesis (Zhan et al, 2003). 
In both these ocular diseases a persistent state o f mast cell, eosinophil and lymphocyte 
activation is evident along with the switching from connective-tissue to mucosal-type 
mast cells, increased comeal pathology, follicular development and fibrosis (Bielory, 
2002).
Recent studies have sought to examine the participation o f neutrophils and eosinophils 
in the inflammatory processes associated with atopic keratoconjunctivitis (AKC) and 
vernal keratoconjunctivitis (VKC) (Trocme et al, 2003). Indirect immunofluorescent
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staining was used to localize neutrophil elastase (NE) and eosinophil granule major 
basic protein in conjuntival sections from AKC, VKC and controls. Results showed that 
specimens from both AKC and VKC patients contianed extracellular deposition of NE 
and major basic protein compared to no or minimal of extracellular NE, with no major 
basic protein from control specimen sections (Trocme et al, 2003). Another study has 
postulated a role for eotaxin-1 and eotaxin-2 (potent eosinophil chemotactic and 
activating peptides) in the pathogenesis of VKC and AKC. It was reported that 
cytokine-stimulated conjunctival fibroblasts may be one source of eotaxin-1 in severely 
allergic tissues (Leonardi et al, 2003).
In the past treatment of acute and more chronic forms of allergic conjunctivitis has 
focused on relief of symptoms, in future it is essential that new and effective therapeutic 
strategies are developed, based on a greater understanding of the roles and interactions 
of the cell populations infiltrating the conjuctiva in these sight-threatening disorders 
(Zhan et al, 2003).
1.10 Thyroid Associated Ophthalmopathy (TAO)
Graves' ophthalmopathy (GO)/ TAO is a heterogeneous disorder involving autoimmune 
and inflammatory processes resulting in glycosaminoglycan production, oedema and 
adipogenesis and subsequently increased volume of the orbital contents with disfiguring 
and potentially sight threatening consequences (Meyer, 1999). It is a disorder in which 
the eves are affected as a consequence of thyroid autoimmunity (Many et ah 1999). 
GO/TAO is characterised by the induction of T cells autoreactive to die thyrotropin 
receptor (TSHR) in mice; and in humans genetically susceptible to autoimmunity 
possibly partly due to the depletion of T reg cells. The complexity of GO highlight the 
importance of careful disease classification to promote further progress in 
understanding (Ludgate and Baker, 2004). It has recently been postulated that the 
immunoenhancing effect of CD4+ CD25+ T cell depletion appears to be attributable to 
an increase in thyroid-stimulating antibody production and/or a decrease in thyroid- 
blocking antibody synthesis. Utilizing an experimental model results have been 
published to indicate that CD4+ CD25+ T cells play a role in disease susceptibility and 
severity in adenovirus-TSHR-induced GO. An overall imbalance between effector and 
regulatory T cells appears to be crucial in the pathogenesis of Graves’ disease has been 
proposed (Saitoh and Nagayama, 2006).
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There is a strong association between TAO and GD, which is characterised by 
hyperthyroidism and 90% o f TAO patients have GD. The remaining 10% have 
Hashimoto’s thyroiditis (HT), characterised by hypothyroidism (Roura-Mir et al, 1997; 
Pappa et al, 1997). Patients with TAO may initially present with complaints o f dry 
eyes, foreign body sensation, photophobia, blurred vision, and possibly eyelid retraction 
(proptosis) as illustrated in figures l.v ., l.vi. and lvii.
As the disease progresses patients suffer from orbital pain, double and reduced vision 
along with decreased colour perception (Sendrowski and Jones, 2001). Other clinical 
features include conjunctival infection, chemosis, diplopia, comeal ulceration and in 
severe cases compression o f  the optic nerve resulting in loss in vision (Ludgate and 
Baker, 2002). Symptoms observed relate to increased volume in the orbit, which arise 
due to oedema, the production o f  hydrophilic glvcosaminoglycans (GAG) and 
hypertrophy o f  the adipose tissue by adipogenesis (Heufelder et al, 2000), the former 
two contributing to the expansion o f  the extra-ocular muscles (EOM).
Figures l.vii., l.viii, l.ix. Illustrations o f  the cliniclal effects o f  TAO 
Figure l .vii.
Figure l.vii. A patient with bilateral TAO, upper lid retraction and exophthalmos along with bilateral 
periorbital oedema. Source (www.. mrcopath.com)
Figure l.viii.
Figure l.viii. Right unilateral thyroid eye disease causing severe restriction of the inferior rectus 
and upgaze. Source: (www..mrcopath.com)
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Figure l.ix.
Figure tix . Right unilateral thyroid eye disease showing the lid lag on down-gaze. Source:
(www..mrcopath.com)
1.10.1 Cellular infiltrate and cytokines involved in TAO
The massive infiltration o f mononuclear cells observed results in the enlargement o f 
extraocular muscles. The activated immunocompetent cells localising in extraocular 
muscle, secrete cytokines that stimulate orbital fibroblast to proliferate and to secrete 
glycosaminoglycans (Smith et al, 1991) in particular hvaluronan, contributing to the 
oedema and consequently limited ocular movements. The orbital fibroblast appears to 
have a major role in the pathogenesis o f TAO (Pappa et al, 1997). Activated fibroblasts 
also secrete an array o f  pro-inflammatory cytokines including IL-1, IL-6, granulocyte 
macrophage-colony stimulating factor (GM-CSF) (Feghali and W right 1997). It is 
probable that the cytokines IFN-y and T G F-p  released from activated T cells and 
macrophages are responsible for the activation o f  fibroblasts (Pappa etal, 1997). T cell 
derived cytokines in TAO may induce the expression o f intercellular adhesion 
molecule-1 (ICAM-1) and HLA-DR on orbital fibroblasts (Forster et al, 1998), though 
not on normal fibroblasts (Heufelder et al, 2000), which could suggest as being related 
to their capacity to present antigen.
1.10.2 Autoantigens associated with TAO
A variety o f  methods have been employed to identify a number o f  potential antigens 
including the screening o f  EOM expression libraries (Elisei et al, 1993) and Western 
blotting (Ahmann et al, 1987). The flavoprotein subunit o f mitochondrial succinate 
dehydrogenase (Gunji et al, 1999) and extracellular matrix proteins (Bednarczuk et al,
1999) have been implicated as potential antigens in TAO. Autoreactive CD4+ T cells 
amongst TAO patients have been found to the thyrotropin receptor (TSHR), expressed 
on thyroid epithelial cells and orbital fibroblasts, thyroid peroxidase and tiiyroglobulin 
(TG). The sequences o f  TG and acetylcholinesterase (ACHE), an autoantigen in HD
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would provide a link between the thyroid and die orbit (Ludgate et al, 1989). Similarly 
TSHR may also be a cross-reactive protein in the orbit and the thyroid. Another 
antigen possibly associated with TAO is a 64kDa thyroid membrane autoantigen, 
alternatively known as ‘D1 ’ or tropomodulin, that is also expressed in eye muscle but 
not in any other skeletal muscle and was isolated from a thyroid expression library 
(Dong et al, 1991). Studies using orbital connective tissue and adipose compartments 
have identified a 23kDa protein present in orbital fibroblasts as a possible thyroid eye 
disease (TED) autoantigen (Bahn et al, 1989).
1.11 Therapeutic options for the treatment of inflammatory eye 
diseases
In both inflammatory allergic eye conditions and TAO there are several options 
available for therapeutic intervention. The forms of treatment available range from the 
application of eye lubricants to relieve discomfort such as in TAO, to alleviate dryness 
or for allergic eye conditions the application of topical antihistamine, mast cell 
stabilizers and Hi antagonists to relieve itching, tearing and to control the ocular 
discharge (Koevary, 1999). In both CAED and TAO there is extensive use of steroids 
to control the infiammatioa Other forms of treatment include immunosuppressive drugs 
such as CsA which have proven to be very effective in difficult-to-treat cases of CAED 
(Hingorani et al, 1999) though in TAO patients little success has been seen (Howlett et 
al, 1984). In the case of CAED treatment with nonsteroidal anti-inflammatory drugs 
(NSAIDs) may be administered as a form of treatment. In ocular allergy patients only 
aspirin, from the NSAIDs, given orally has shown to be effective in the treatment of 
patients with VKC (Tinkleman et al, 1993). Other types of medical treatment options in 
TAO include adrenergic blockers and p blockers. Radiotherapy and orbital 
decompression surgery may be used in severe cases of TAO that present with 
periorbital oedema, chemosis, disfiguring proptosis and decreased visual acuity (Bahn 
etal, 1990).
1.11.1 Corticosteroids
Corticosteroids have been widely used in inflammatory conditions due to their potent 
anti-inflammatory properties, ducocorticosteroids exert anti-inflammatory effects 
through actions on blood vessels, inflammatory cells and inflammatory mediators. 
Some of these effects include decreased vasodilatation thereby reducing the
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accumulation of leukocytes such as monocytes. T cell proliferation is decreased mainly 
due to a reduction in IL-2 production. The generation of several other cytokines is also 
decreased including IL-1, IL-4, IL-5, IL-6, IL-8, TNF-a and GM-CSF whereas IL-10 is 
increased (Tuft et al, 1991). In the control of asthma glucocorticosteroids act to 
suppress Th2-type cytokines such as IL-5 (Barnes, 2001).
Corticosteroids have been shown to be effective in the treatment of the allergic 
conditions VKC, and AKC, discussed earlier in this chapter. It is widely recognised 
there are numerous side effects including elevated intraocular pressure, infections, 
cataracts and delayed wound healing therefore the use of such drugs in nonsight- 
threatening conditions such as SAC and GPC is contraindicated (Reiss et al, 1996). 
They are still used, in the form of topical eyedrops, for short courses in patients with 
severe VKC and or systemically in AKC patients displaying conjunctival inflammation 
or keratitis (Liesegang, 1996).
In TAO systemic steroids may effectively control optic neuropathy and other 
inflammatory changes associated with the conditioa However, to achieve desirable 
effects they must be used at high doses for prolonged periods of time and, have 
significant side effects and are associated with complications such as osteoporosis, 
hyperglycemia, hypertension, gastric ulceration, cushings syndrome, psychosis and as 
mentioned earlier cataracts and infection (Day and Carroll, 1967). The use of the 
steroid, methylprednisolone, intravenously for short durations, has been employed in 
patients with soft tissue involvement effectively (Kendall-Taylor et al, 1988.). The use 
of steroids is mandatory when there is optic nerve involvement, severe proptosis, or 
corneal exposure or visual disturbances. In such cases the benefits outweigh the risks 
(Sendrowski and Jones, 2001).
The combination of steroids with cyclosporine or orbital irradiation appears to have a 
synergistic effect, enhancing the efficacy of individual therapy (Prummel et al, 1989). 
The use of steroid has also been recommended to avert die progression of Graves’ 
ophthalmopathy after radioactive iodine (RAI) treatment for hyperthyroidism (Bartalena 
etal, 1989).
It is widely accepted that glucocorticoids are beneficial in conditions characterized by 
dysregulated peripheral tolerance. The efficacy of glucocorticoids is partly attributed to
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reduced T-cell activation and cytokine production (Schwiebert et al, 1996). However 
until recently there was little known of how glucocorticoid treatment affects the activity 
or frequency of T reg cells. A recent report has shown that corticosteroids induce 
human T cell populations to secrete high amounts of IL-10 which is thought to 
contribute to the clinical efficacy observed in corticosteroid-sensitive asthmatic 
individuals whereas CD4+ T lymphocytes from corticosteroid-resistant patients 
exhibited a defect in corticosteroid induced IL-10 synthesis (Hawrylowicz et al, 2002). 
Another study by Karagiannidis et al (2004) showed that glucocorticoid treatment is not 
only immunosuppressive and anti-inflammatoiy but also promotes or initiates 
differentiation towards type 1 T reg cells via a Foxp3 dependent mechanism 
(Karagiannidis et al, 2004).
Glucocorticoids are die first line of treatment for asthma (Umland et al, 2002). They 
have multiple inhibitory properties, including the inhibition of Th2 cytokine synthesis 
and due to the enhancement of IL-10 production. Human T regs secrete high levels of 
IL-10 when stimulated in the presence of dexamethasone and calcitriol (vitamin D3) 
(Richards, et a/,2000). However there are a proportion of patients with severe asthma 
who fail to respond to glucocorticoid therapy and hence their asthma is characterized as 
glucocorticoid resistant alternatively classified as steroid resistant (SR). In such cases 
treatment with dexamethasone does not enhance the secretion of DL-10 by their CD4+ T 
cells. In contrast the addition of vitamin D3 with dexamethasone to cultures of SR 
CD4+ T cells lead to an increase of IL-10 secretion to levels comparable to those 
observed in cells from gulucocorticoid-sensitive patients cultured with dexamethasone 
alone. Additionally, pretreatment with IL-10 of SR CD4+ T cells fully restored IL-10 
synthesis in these cells in response to dexamethasone. It was also shown that the 
ingestion of vitamin D3 by SR asthmatic patients enhanced subsequent responsiveness 
to dexamethasone. Vitamin D3 appears to overcome the inhibition of the 
glucocorticoid-receptor expression by dexamethasone while IL-10 upregulated the 
glucocorticoid-receptor expression by CD4+ T cells. It has therefore been proposed 
that the administration of vitamin D3 to healthy individuals and SR patients enhanced 
subsequent responsiveness to dexamethasone for die induction of IL-10, revealing the 
potential of vitamin D3 to increase the therapeutic response to glucocorticoids in SR 
patients (Xystrakis et al, 2006).
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The stimulation of naive T cells in the presence of dexamethasone and vitamin D3 has 
resulted in the generation of both mouse and human T cells that produce IL-10 but not 
Thl or Th2 cytokines. These in v/Tro-derived EL-10 secreting T reg cells are capable of 
blocking EAE in an IL-10 dependent manner (Barrat et al, 2002). Subsequently it was 
shown by Xystrakis and colleagues (2006) that short term culture, for 7 days, of CD4+ T 
cells with anti-CD3, APCs, IL-2 and IL-4 in the presence of dexamethasone and vitamin 
D3 resulted in an EL-10 expressing phenotype with a reduction in Thl and Th2 
cytokines. Additionally these IL-10 secreting T reg cells were observed to express low 
levels of Foxp3 and no TGF-p so are distinct from naturally occurring CD4+ CD25+ T 
reg cells, expressing higher levels of Foxp3, and from Th3 (Xystrakis et al, 2006), 
known to secrete TGF-p.
1.11.2 Cyclosporin A (CsA)
CsA is a fungal peptide with potent immunosuppressive actions that selectively blocks 
the activation T cells, affecting the early states of T cell proliferation (Rang et al, 1995). 
As CsA has such a profound effect on T cells this inadvertently has a knock-on effect 
on other cells of the immune system. CsA is a very effective drug in CMI responses. 
However it does also have a marked suppressive action on some antibody-mediated 
responses particularly those involving CD4+ T cells. The main effect of CsA is die 
inhibition of the transduction pathway for the synthesis of cytokines, in particular EL-2. 
CsA also has an inhibitory effect on the expression of IL-2 receptors on T cells. CTL 
induction is also inhibited by the actions of CsA though has no action on already 
formed CTL’s. CsA also has inhibitory effects on the release of histamine from mast 
cells and blocks the transcription of genes for EL-3, EL-4 and LTC4  (Rang et al, 1995). 
Normally the interaction of antigen/MHC complex with its corresponding TCR causes 
an increase in intracellular Ca2+ through the inositol (l,4,5)-triphosphate (InsPs) 
pathway. Ca (with calmodulin) stimulates a phosphatase, calcineurin, this 
subsequently activates various transcription factors such as NF-AT and NF-kB 
(Kingsley et al, 1996) which in turn set into action the transcription of IL-2.
CsA binds to cyclophillins, which belong to a class of cytoplasmic proteins called 
immunophilins. Immunophilins are thought to have a vital role in transducing signals 
from die cell surface to the cells’ nucleus. The cyclosporin-cyclophilin complex targets 
a serine threonine phosphatase called calcineurin.
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Cyclophilins are abundant, ubiquitously distributed intracellular proteins that function 
as receptors for CsA The most copious of the cyclophilins are cyclophilin A (CypA) 
and CypB, both having several effects on the immune system via intracellular 
signalling. It has recently been proposed that CypA and CypB also have extracellular 
roles. Extracellular CypB enhances chemotaxis and adhesion of the memory CD4+ T 
cells, whereas extracellular CypA is involved in the chemotaxis of eosinophils, 
neutrophils and T cells (Bukrinsky, 2002).
CsA administered topically in ocular inflammatory conditions leads to a reduction of 
MHC class II expression and Thl, Thl and eosinophil activity at the ocular surface 
(Zieihut et al, 2002). CsA has been reported to have improved the condition of patients 
with VKC (BenEzra et al, 1988) and AKC (Holland et al, 1993), although as mentioned 
earlier, results using topical CsA eyedrops in TAO have been disappointing, showing no 
improvement in clinical observations.
1.12 Experimental/Novel immunotherapeutic strategies
The successful treatment in allergic and autoimmune diseases often requires altering the 
nature of a detrimental immune response mediated by a particular subset of the CD4+ T 
cells (Thl or Th2). Therefore in recent years several immunomodulatory strategies 
have emerged in the management of allergic and autoimmune disorders. Currently 
there is much focus and research involving cytokines as therapeutic targets. Cytokines 
have been used to promote immunodeviation, thereby redirecting a Th2 type immune 
response towards a Thl type response and vice versa. The blockade of cytokines and 
cytokine receptors using mAbs has also been a popular approach in immunotherapy 
(reviewed by Barnes, 2001). In immunopathological conditions, affecting Thl or Th2, 
the method of oral tolerance with antigen has also proven to be successful in tipping the 
immune balance towards the generation of Th3 type TGF-{3 secreting regulatory cells 
(Weiner, 2001) or regulatory T cells. A similar outcome may be achieved by skewing T 
cell responses with antigen to induce allergen-specific regulatory T cells secreting IL-10 
and TGF-p (Zuany-Amorim et al, 2002). Alternatively several researchers have 
investigated the effects of inhibiting cytokine transcription factors involved in the 
generation of pro-inflammatory cytokines. Selective novel immunomodulatory 
approaches that have had great impact in immunotherapy in skewed immune responses 
and those that are relevant to this study shall be discussed in further detail below.
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1.12.1 Immunotherapeutic approaches in Th2 polarized diseases
Studies of allergen-specific T cell clones in both human as well as in animal models 
have shown that allergic asthma is characterised by a relative deficiency in Thl 
cytokines with an overproduction of Th2 cytokines (Riccio et al, 2002). These findings 
have led to the development of a number of strategies to inhibit Th2 cytokine responses 
such as use of soluble IL-4 receptor and antibodies against both EL-4 and IL-5. 
However, unfortunately, these methods proved to be disappointing. Clinical trials 
employing anti-IL-5 antibodies in a double-blind placebo-controlled randomised 
allergen challenge study patients given antibodies against IL-5 failed to display an 
inhibition of the late phase asthmatic response despite a significant reduction in the 
number of eosinophils in the bronchoalveolar lavage of the patients (Leckie et al, 2000). 
Another study involving the administration of recombinant human (Rh) Rh IL-12, in 
order to tip the balance of polarized Th2 cytokine responses in asthmatics towards a 
more Th-1 like cytokine profile also proved to be ineffective for the late phase response 
to inhaled allergen or its attenuated bronchial hyperresponsiveness. However, like anti- 
IL-5 Rh, IL-12 was shown to induce a marked reduction in the number of eosinophils in 
die blood and in the airway lumen of asthmatics (Bryan et al, 2000). The lack of 
efficacy of both anti-IL-4 and anti IL-5 strategies raises questions about the importance 
of Th2 cytokines in asthma as this had no impact on airway responsiveness. Hence an 
increasing amount of focus is being placed on the failure of adequate generation of 
regulatory T cells to control immune responses in allergic individuals (Djukanovic, 
2002). Another explanation for the failure of these anti-cytokine antibody approaches 
could be that the continuous production of cytokine by the cells is unable to be 
completely blocked by antibody, or that other cytokines, such as IL-13 might be able to 
continue to drive the Th2 response.
It is well established that allergic responses involve both T and B cells and the 
subsequent secretion of cytokines that orchestrate an inflammatory cascade, including 
the immunoglobulin isotype switching to IgE. The knowledge of IgE involvement 
fuelled efforts to develop a mAb to block IgE. Mab E-25 (Xlair) was developed and 
trials injecting the antibody either intravenously or subcutaneously fortnightly or 
monthly showed mAb E-25 produced a precipitous fall in circulating IgE levels which 
was sustained for up to two years and is paralleled by clinical efficacy in treating 
asthma and rhinitis (Holgate, 2001).
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As previously discussed the differentiation of both Thl and Th2 cells involves 
signalling via JAK-STAT pathways. However IL-4 and EL-12 activate distinct receptor 
complexes and, consequently, different transcription factors (Wurster et al, 2000). IL-4 
stimulates JAK1 and JAK3, which in turn activates STAT6 that appears to suppress Thl 
specific pathways (Pemis and Rothman, 2002). The transcription factors associated with 
the generation of Th2 cells can also be considered as bring potential therapeutic targets 
in allergic diseases. A recent study by Macaubas highlighted the selective up- 
regulation of the zinc finger DNA binding protein, GATA-3, during cytokine directed 
differentiation of naive cord blood cells into Th2 cells and also in PBMCs from atopic 
adults during in vitro allergen-specific recall responses (Macaubas et al, 2002). These 
findings suggest this transcription factor has a potentially important role in the induction 
and expression of the allergic phenotype in humans and is supported by results of 
increased GATA expression in bronchial biopsy samples from atopic asthmatics 
(Nakamura et al, 1999).
1.12.2 Immunomodulatory therapies for skewed Thl type diseases
The pro-inflammatory cytokines IL-lp (Bresnihan et al, 1999.) and TNF-a (Bresnihan, 
2002) have been prime therapeutic targets in treating RA for over a decade (Elliott and 
Maini, 1995). Both cytokines share many biological effects and have profound 
consequences in the pathogenesis of inflammatory joint disease. Effects of these 
cytokines include T cell activation and proliferation, leucocyte migration and induction 
of synovitis; activation of osteoclastic bone resorption and cartilage matrix degradation 
through the stimulation of PGE2 and metalloproteinases, as well as the inhibition of 
collagen and proteoglycan synthesis and stimulation of acute phase proteins (Nuki, 
2002).
The most significant advance made recently in the treatment of rheumatoid disease has 
been by inhibiting TNF with anti-TNF mAbs, as well as being the most practical 
application of immunotherapy to date (Feldmann and Maini, 2001). Anti-TNF-a mAbs 
and anti-IL-1 mAbs have been used in die treatment of RA, for example in 
streptococcal-cell-wall arthritis, anti-TNF-a mAb inhibits the inflammatory aspect of 
synovitis, whereas anti-IL-1 mAb has a role in the inhibition of proteoglycan synthesis, 
a surrogate marker for cartilage formation (Kingsley et al, 1996). A reduction in
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disease activity and x-ray progression has been reported when targeting IL-1 using 
recombinant IL-1 receptor antagonist. Another cytokine posing as a potential target in 
RA is IL-6 and preliminary studies using an anti-IL-6 receptor monoclonal antibody 
have demonstrated a beneficial response via the dramatic decrease in acute phase 
proteins (Wilson, 2002).
TNF-a induces IL-8 expression via the activation of the transcription factor NF-kB. 
Humanised monoclonal TNF-a antibodies (infliximab) and soluble TNF-a receptors 
(etanercept) have been shown to be effective in the treatment of the chronic 
inflammatory condition RA (Markham and Lamb, 2000; Jarvis and Faulds, 1999). The 
anti-inflammatory effects of both these drugs are effective at reducing signs and 
symptoms observed in patients, as well as lowering levels of C-reactive proteins, when 
taken regularly. Studies on the mechanism of action of infliximab indicate that TNF-a 
is implicated in a number of pathogenic pathways including cellular recruitment via the 
induction of adhesion molecules and chemokines, down-regulation of the cytokine 
cascade, reduction of angiogenesis and in the turnover of matrix metalloproteinases 
(Feldmann and Maini, 2001).
Despite the overwhelming success with these treatments in RA there are a number of 
potential problems associated with the long-term administration of these agents firstly 
due to the development of blocking antibodies in the host, and secondly because of 
injection site reactions and bacterial infections. Other more serious side-efifects of 
etanercept and infliximab include the possibility of demyelination during therapy 
(Mohan et al, 2001) and, in a small proportion of patients treated with infliximab, there 
are reports of cases of tuberculosis (Keane et al, 2001). TNF-a converting enzyme 
(TACE) is required for the release of soluble TNF-a and may be a more attractive 
candidate for target in the treatment of RA. TACE inhibitors are in development and 
some of these are also matrix metalloproteinase (MMP) inhibitors (Barlaam et al, 1999).
1.13. Specific Immunotherapy
It appears that the induction of a tolerant state in peripheral T cells is an essential step in
allergen SIT. Peripheral T-cell tolerance is characterized mainly by suppressed
proliferative and cytokine responses against the major allergens and their T cell-
recognition sites (Akdis. et al.. 1996). The generation of allergen-specific T reg cells
and increased production of their suppressive cytokines IL-10 and TGF-j3 are vital in
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the early events in allergen SIT (Robinson, 2004). The induction o f  peripheral tolerance 
directed to whole antigens in conjunction with increased IL-10 has been reported 
(Oldfield etal, 2002).
SIT treatment is associated with significant increases in specific IgA, IgG l, and IgG4 
levels (Jutek et al, 2003). This increase o f specific IgA and IgG4 levels in serum 
coincides with increased TGF-p and IL-10 levels, respectively (Akdis, 2005). IL-10
acts to suppress both total and allergen specific IgE whereas IgG4 production is 
significantly increased (Akdis, 1998). A recent study conducted to investigate the 
effects o f successful sublingual immunotherapy (SLIT) on in vitro allergen-driven T 
cells responses and cytokine secretion along with serum levels o f chemokines and IgE, 
IgGi and IgG4 antibodies. The study found that SLIT with Dermatophagoides 
pteronyssinus (Dp) monomeric allergoid was shown to down-regulate allergen-specific 
IgE and caused increases in both IFN-y and IL-10 production (Cosmi, et a l 2006).
The immunoregulatory effects o f SIT include the induction o f T cell tolerance (Van 
Neerven et al, 1996), which may involve the generation o f allergen-specific T regi cells, 
clonal anergy or extrathymic deletion o f allergen-reactive memory T cells (Secrist,
1995). More recently it has been recognized that there is a deviation o f Th2 to Thl cells 
(Norman, 2004). The figure below illustrates the mechanisms o f  action o f the T reg 
cells in SIT.
Figure 1.x. Illustratation the mode o f action o f T reg cells in SIT
Figure l.x.The generation of allergen-specific T reg cell response is an essential step in allergen SIT and 
natural allergen exposure of nonallergic individuals. IL-10 and TGF-p secreted from T reg cells directly or 
indirectly suppress Th2 cells, Th1 cells, mast cells, eosinophils, and basophils and regulate antibody 
isotypes in B cells. Red line, Suppression; black line, stimulation. Figure adapted from Akdis et al, 2005.
e p i l h t M
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The systemic side-effects must be considered with SIT therapy and there is much 
evidence to suggest that immunotherapy is effective at reducing symptoms and 
modifying the course of die disease with a predicted rate of one fatality per 2.5 million 
injections. The main setbacks with immunotherapy appear to be the costs, limited 
trained personnel and concerns regarding safety, clarification of what constitutes a 
reasonable risk needs to be addressed (Frew, 2006).
1.13.1 Skewing of T cell responses with antigen
It is clear that the nature of human-specific immune responses against offending agents 
is determined by the cytokine profiles secreted. It is therefore important to understand 
the fine balance of events occurring in the generation of immune responses when 
considerations are made to control infectious diseases and in order to manipulate 
immunopathological reactions. One viable option is the use of selected peptides as 
vaccines targeting infectious diseases. Epitopes present on peptides (8-12 amino add 
slong) bound into MHC I and II molecules, recognised by CD8+ and CD4+ T cells, can 
be mimicked by synthetic peptides. The peptides when delivered with an appropriate 
adjuvant can bind to empty cell surface-expressed MHC determinants and consequently 
trigger an immune response (Romagnani, 1996).
Selected peptides may be obtained from antigens that induce preferential Thl responses. 
Examples include recombinant 403 amino acid protein from L. braziliensis homologous 
to ribosomal protein eBF-4A (Hosken et al, 1995) and the promastigote surface antigen 
2 from L. major (Handman et al, 1995). Peptides may also be altered with changes in 
amino acid residues (Racioppi et al, 1993) along with selection of ligand with various 
class binding affinity, (Kumar et al, 1995) acting to deviate the ability of the T cell 
epitopes to induce different cytokine profiles.
There are currently several antigens and adjuvants that may be employed to promote 
Thl responses and consequently the induction of CMI responses. Antigens may be 
manipulated in many ways, in order to obtain the desired T cell cytokine response, 
including polymerisation (Gieni et al, 1993), incorporation into immune complexes 
(Villacres-Eriksson, 1995), coupling to oxidized mannan (Apostolopoulos et al, 1995) 
or its injection together with components of the mycobacterial cell wall, in view of their 
ability to stimulate the production of IL-12 from macrophages and DCs. Recombinant
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M Bovis (BCG) strains have been proposed as being suitable adjuvants for the 
induction of Thl responses against L. Major (Abdelhak et al, 1995), M. tuberculosis 
(Murray et al, 1996) and the measles virus (Fennelly et al, 1995). Recombinant 
Salmonella administered orally also elicits a dominant antigen-specific Thl type 
response in both mucosal and systemic tissues, in the absence of Th2 cytokines, IL-4 
and IL-5 (VanCott etal, 1996).
IL-12 has an adjuvant effect when used in a vaccine against L. major and effectively 
shifts cytokine profiles from a Th2 type immune response towards a Thl type response 
(Wang et al, 1994). Fibrosis induced by schistosome infection is prevented by the 
coadministration of IL-12 with eggs from S. mansoni (Wynn et al, 1995), whereas 
protection to S. mansoni is conferred by the administration of IL-12 as an adjuvant in 
conjunction with a soluble lung-stage S. mansoni larval antigen preparation (Mountford 
etal, 1996).
Disease states involving Th2 type immune responses can also be switched towards a 
more Thl like cytokine profile. Again one must stress cytokine skewing is an option 
for therapy for chronic inflammatory diseases where disease association correlates with 
an inappropriate elevated Th2 type cytokine responses. One successful approach for 
upregulating Thl responses via the use of recombinant Mycobacteria or other 
adjuvants, APCs that select for Thl cells or plasmid DNA (allergen epitope plus 
cytokine) gene therapy (Romagnani, 1996). A recent study using a mouse model of 
allergic asthma found that mice treated with SRP299, a killed Mycobacteria vaccae- 
suspension, gives rise to allergen-specific CD4+CD45RB’° regulatory cells, which as 
discussed earlier confer protection against inflammation through the secretion of IL-10 
and TGF-p (Erb et al, 1998 ).
1.14. Cytokine switching using anti-DL-4 mAh in combination with Rh 
IL-12 or anti-DL-12 mAh administered with Rh IL-4
Successful treatment in allergic, autoimmune and infectious diseases would, potentially, 
benefit from altering the nature of a detrimental immune response mediated by a 
particular CD4+ Th cell subset. In this context one may postulate the beneficial effects 
of cytokine therapy to treat either Thl or Th2 polarized diseases. It is well established 
that many inflammatory conditions exist due to an imbalance of Thl and Th2 cytokines
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and therefore would be potential candidates for T cell cytokine-directed modulation. It 
has been reported that the administration of exogenous IFN-y or EL-12 seems to inhibit 
allergic asthma responses associated with IL-4/EL-5, in patients and allergic animal 
models (Shibata et al, 2000). It has been reported that the administration of exogenous 
IL-4 in vivo and in vitro, enhances the generation of TGF-{3 (Prud’homme and 
Piccirillo, 2000).
A study carried out to investigate whether autoreactive T cells in patients with MS are 
polarized and commited in their differentiation to a stable cytokine phenotype or 
whether the cytokine secretion pattern can be altered (Windhagen et al, 1998). Results 
highlighted the ability to alter cytokine secretion of autoreactive T cell lines in culture 
conditions promoting the growth of Thl or Th2 type responses. Short term T cell lines 
were established to MBP or TT in the presence of growth conditions promoting Thl 
(IL-12 with a-EL-4 mAb) or Th2 (EL-4 with a-IL-12 mAb) cytokine secretion. The 
study concluded that the cytokine secretion of autoreactive T cell lines even in 
longstanding autoimmune disease might be altered under specific culture conditions 
(Windhagen et al, 1998).
As discussed in previous sections, L. major infections develop as a consequence of poor 
CMI along with the production of Th2- type cytokines both in susceptible mice models 
(Heinzel et al, 1989), as well as in humans with non-healing forms of 
leishmanaisis,(Caceres-Dittmar et al, 1993). Various immunological manipulations can 
be used to render normally susceptible mice resistant, including B-cell depletion (Sacks 
et al, 1984), treatment with anti-IL-4 (Chatelain et al, 1992), anti-IL-2 (Heinzel et al 
1993) and more recently with recombinant IL-12 (Sypek et al, 1993) in combination 
with pentavalent antimony compounds (used in the treatment of leishmaniasis) such as 
pentostam, induces healing in L. major infected mice. Treatment with RhIL-12 in 
conjunction with pentostam are only effective if administered at or near the time of 
parasite inoculation, suggesting that they influence the initial development of Thl cells 
from naive cells, rather than reverse an established Th2 response (Nabors, 1997).
It has been demonstrated in vitro that T cells from human allergen-induced late 
asthmatic responses respond to the addition of IL-12. This study suggested that the 
ability of allergen-specific T cells to produce Th2-type or Thl-type cytokines can be 
regulated by exposure to cytokines such as EL-12, IFN-y and IL-4. It was observed that
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the addition of IL-12 to freshly isolated peripheral blood T cells obtained from atopic 
subjects skews the cytokine profiles from a Th2 response towards a Thl-type response 
(Marshall et al, 1995). Conversely, the addition of IL-4 causes a shift from Thl to T in­
type cytokine production in vitro, (Maggi et al, 1992).
1.15. Current controversies faced studying immunology of the eye
There are some dilemmas for designing improved treatment for chronic inflammatory 
eye diseases such as the ocular conditions studied within this thesis, CAED and TAO, 
which present with multi-faceted clinical features. Firstly although steroids are 
effective in dampening the immune responses, they have unwanted side-effects, 
particularly in the eye and therefore are not ideal. In the clinic, combination therapy of 
CSA and steroids or other drugs will be given to minimise the side-effects and to 
provide the necessary anti-inflammatory effects. Improved therapy regimes need to be 
identified, preferably topically applied (as eye drops) to avoid systemic 
immunosuppression. Secondly due to the chronicity of inflammation, ocular resident 
cells, become activated over time, resulting in secretion of cytokines, which in later 
stages of the disease may become mixed cytokine profiles, and collagen deposition and 
remodelling. Ideally therapy should be localised and target the disease-inducing T cells 
as early as possible in the disease process before the involvement of tissue-resident 
cells. From a clinical perspective, it is still not known at which point in the disease 
process tissue-resident cells play a more important role than the T cells. Further studies 
are required to help elucidate the cellular processes involved longitudinally.
1.16. Hypothesis and objectives of this thesis
Current treatments for TAO and CAED are inadequate due to side-effects and their non­
specific mode of action and an improved therapy to target the T cells causing disease 
needs to be identified. The hypothesis of this study is that immune-mediated conditions 
skewed towards Thl or Th2 pathways may benefit therapeutically from redirecting 
pathological cytokine profiles towards a more balanced cytokine milieu. We propose 
that the application of Thl- and Th2-directing conditions (anti-cytokine antibodies and 
cytokines) could modulate the detrimental Th2 and Thl cytokine-driven diseases, so 
returning to a “normal” environment.
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In order to test this hypothesis I will firstly investigate whether the peripheral blood T 
cell cytokine responses display a skewing similar to those previously observed in T 
cells derived from localised tissues affected during TAO and CAED, Thl and Th2 
respectively. The recognition of such a correlation in peripheral blood would provide 
an invaluable, easily accessible, indicator of immune-deviated diseases. Such findings 
would then enable the utilization of peripheral blood to investigate and explore the in 
vitro effects of immunomodulatory mechanisms, such as cytokine immunomodulation 
and blockade of molecular pathways involved in the generation of inflammatory 
cytokines. Findings from such investigations could potentially lead to development of 
novel immunotherapeutic applications aimed at diverting the immune system from a 
pathological skewed response towards a more balanced response, which may in future 
be applied to localised disease.
The overall objective of this study was to identify skewed Th2 and Thl cytokine 
profiles from peripheral blood of CAED and TAO patents and to manipulate, in vitro, 
the T cell cytokine profiles, towards a less detrimental and more balanced cytokine 
profile. The specific objectives of this thesis are outlined below:-
1. To optimise several parameters of the intracellular cytokine staining technique. 
This method was the main experimental technique of choice, because of its 
sensitivity and its ability to distinguish cytokine expression among mixed 
populations of CD4+ and CD8+ T cells.
2. Utilizing the intracellular cytokine staining technique, the objective was to 
characterise the cytokine expression of PB-derived T cell lines in immune-mediated 
eye diseases CAED and TAO in parallel with controls, in terms of Thl and Th2 
cytokine profiles. The focus was to identify polarised Thl and Th2 PB T cell lines 
as representative of localised skewed T cells in CAED and TAO.
3. To assess the effects of the in vitro application of cytokine immunomodulation via 
the application of exogenous cytokines and mAbs to cytokines in conditions 
favouring the development of Thl and Th2-like profiles. Additionally, the effects 
of immunsuppressive drugs dexamethasone and CsA alone cultured in Thl and Th2 
cytokine favouring conditions, in terms of IL-4 and IFN-y expression were 
investigated. The effects of Till and Th2 polarised culture conditions and
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immunosuppressive drug CsA on T cell phenotypes were also examined. The 
ability to repolarise cytokine profiles of already committed Thl and Th2 cell lines, 
from CAED and TAO T cells lines, was also investigated.
4. To assess the effects on proinflammatory cytokine expression by inhibiting the 
transcription factor NF-kB. using adenoviral transfection and overexpression of 
IkBol C)1okine expression was monitored by ELISA and PCR for IL-4 and IFN-y. 
and the c\1okines EFN-y and IL-10 were quantitated for mRNA expression by real 
time PCR.
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2.1 Tissue culture medium
2.1.1 Heat Inactivation of serum
Heat-inactivation of serum was achieved by placing thawed AB+ human serum (Sigma- 
Aldrich) or foetal calf serum (FCS) (Lab Tech International, Lewes, Sussex) in a water 
bath at 56°C for 45 mins, then aliquoted into working volumes and refrozen at -20°C 
until required.
2.1.2 TCeU Medium
Prepared as required for die culturing of T cell lines. Culture medium was made using 
Hepes-buffered RPMI1640 (Dutch modified), supplemented with L-glutamine [2mM], 
sodium pyruvate [2mM], nonessential amino acids [2mM] and gentamycin [50pg/ml], 
(all from Invitrogen, Paisley, UK), 2-mercaptoethanol [2xlO_5M3 and 10% heat 
inactivated human AB+ serum (Sigma-Aldrich, Poole, UK), pre-screened for optimum 
ability to support T cell growth.
2 .U  J-Y cell Medium
Complete tissue culture medium for the culture of J-Y cells, (a B cell hybridoma, used 
as a source of feeder cells following irradiation), was prepared using Hepes-buffered 
RPMI 1640 (Dutch modified), supplemented with L-glutamine [2mmol/L], gentamycin 
[50pg/ml] (all from Invitrogen, Paisley, UK) and 10% FCS.
2.1.4 Anti-CD3 (OKT3) -  producing hybridoma medium
The anti-CD3 antibody-producing B cell hybridoma line cells (OKT3: EC ACC No. 860 
22706) were maintained in Iscove’s Modified Dulbecco’s Medium (Sigma-Aldrich) 
supplemented with 10% FCS and gentamycin [50pg/ml] at a concentration of 2 x 10s 
cells per ml.
2.2. Tissue Culture
2.2.1 Isolation of peripheral blood mononuclear cells
Venous blood samples were taken into lithium heparin tubes (Becton-Dickinson; B-D, 
Oxford, UK) and diluted 1:1 in 50ml tubes (Falcon) with RPMI 1640 (Dutch modified) 
medium, supplemented with L-glutamine [2mM] and gentamycin [50pg/ml]. Diluted 
blood was layered over Histopaque 1077 (Sigma-Aldrich) and centrifuged at 2400rpm 
for 20 mins with the brake off. Following centrifugation, the mononuclear cell layer 
was extracted from between the yellow plasma and clear Histopaque layers using sterile
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pastettes (Alpha Laboratories Ltd., Eastleigh, Hampshire, UK). This procedure was 
performed immediately after centrifugation to avoid the layer diffusing; careful 
extraction of the cells was necessary to avoid contamination with red blood cells and 
granulocytes. PBMC’s were washed twice with medium, supplemented with 10% FCS, 
L-glutamine [2mM] and gentamycin [50fig/ml], and centrifuged at 1200rpm for 10 
mins. After the second wash the cells were resuspended in T cell medium, counted and 
set up in culture (see below) or labelled as PBMCs and cryopreserved.
2.2.2 Cell counts and cell viability
All cells freshly isolated, for tissue culture or cryopreservation were counted and 
assessed for viability, based on dye exclusion. A small volume (lOp.1) of the sample 
was transferred to a well of a round bottom 96 well plate (Nunc) and diluted 1:1 with 
0.4% (volivol) trypan blue (Sigma-Aldrich). The cells were then counted using a 
haemocytometer (Neubauer) to enable a viability count under a light microscope 
(Olympus, Japan) using the x40 objective. Cells were adjusted to either 2 x 10s/ml for 
culturing or to at least 1 x 106/ml for storage (cryopreservation) in the appropriate tissue 
culture medium Cells with a phase bright appearance under the microscope were 
viable cells whereas cells staining densely with trypan blue were dead cells which, due 
to disrupted cell membranes, take up the tiypan blue. The percentage viability was 
calculated by counting numbers of live and dead cells. Cells were regularly counted 
and adjusted to a concentration of 2 x loVml.
2.2.3. Cryopreservation of cells
Cells surplus to requirement were cryopreserved for future use as feeder cells, or 
PBMCs for T cell line generation, in 1.8ml round bottom cryotubes (Nunc). Cells for 
cryopreservation were adjusted to at least lx 106 in lml volumes in each tube, placed on 
ice and dimethyl sulphoxide (DMSO; Sigma-Aldrich) added dropwise to a final 
concentration of 10%. The cryotubes were then immediately stored in an insulated box 
at -70 °C. 3-4 days later the vials were transferred into liquid nitrogen tanks for long 
term storage.
2.2.3.1. Thawing of cryopreserved cells
Cells that had been cryopreserved and were required for experimental use were taken
out of liquid nitrogen and rapidly thawed by placing in a water bath at 37°C. Cells were
then immediately transferred dropwise to a 25ml tube (Greiner Labortechnik)
containing lOmls of pre-warmed serum-containing medium. Cells were then
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centrifuged at 1200rpm for 10 mins in order to remove die DMSO. Pelleted cells were 
re-suspended and placed into the appropriate culture medium.
2.2.4. Generation and maintenance of T cell lines
PHA or tetanus toxoid peptide (ttp) expanded human T cell lines from donors were 
established from heparinized PBMCs (Sallusto and Lanzavecchia, 2000). All ttp T cell 
lines previously set up were obtained from donors that had previously been vaccinated 
with tetanus and had received a booster immunization within the previous 2 years. 
Cells were maintained in T cell medium supplemented with 10% volrvol human IL-2 
(Lymphocult-T, Biotest, Dreieich, Germany) replaced every 3 - 4  days. The optimal 
concentration of IL-2 for maintaining T cells was determined from a IL-2 bioassy (data 
not shown). Cells were restimulated every 7-10 days with ttp [lpg/ml] (Sigma- 
Genosys, Cambridge, UK) or PHA-P [lpg/ml] (Sigma-Aldrich) and irradiated 
autologous PBMC’s or irradiated J-Y cells (see below). T cell lines were classified as 
such and used for experiments, following at least three cycles of respective 
restimulation. Cell viability counts were performed each week to monitor cell growth 
and adjusted to 2 x 105/ml in fresh T cell medium. Any excess numbers of T-cells 
surplus to experimental requirement were cryopreserved as described above.
2.2.4.1 Classification of donor T- cells
T cells and PBMCs in this thesis were derived from blood from volunteer healthy 
controls, patients with active CAED and patients identified as having TAO. The CAED 
T cell lines were expanded from die PB of patients as described by Calder et al (1999). 
Four AKC patients, two VKC patients and one GPC patient T cell lines from each 
clinical group were used that were not on systemic steroids or immunosuppressive 
therapy at the time of the study (AKC patients data not previously published). 
Treatment of all patients in the study had been stopped 7 days prior PB being drawn. In 
this study the PB T cell lines were expanded from untreated GPC, VKC and AKC 
patients’. The remainder of the AKC patients’ PB T cell lines (two) used in this study 
had been previously treated with steroids. The table below 2a and 2b provides details of 
previously established immunological data, length and duration of specific disease of 
donor and the treatment they had received prior to this study. All cell lines utilized in 
this study were peripheral blood derived lines and had previously been through 4 - 6  
passages. In this study the cell lines were further put through 5 - 8  rounds of
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stimulation with PHA and feeder cells. Clinical data and immunological data 
previously generated are provided in tables 2c and 2d
Table 2a Clinical data for donor CAED patients
CAEDT 
cell line 
No.
Previous 
Tcell 
line No.
Donor
age
Sex Race Associated
systemic
Disease
Treatment Other
medical
conditions
1 AKC 7 47 M C Asth, AD Dex, NS None
2 AKC 8 48 M C Asth Dex, NS Hypertension
3 AKC 9 33 M C Asth, AD, 
HF
FML, SG None
4 AKC 10 26 M c AD FML, SG None
5 VKC 3 13 M c None lodoxamide none
6 VKC 4 18 M c None none none
7 GPC 4 41 M c None NS none
Abbreviations; C; Caucasian; Asth: asthma; AD; Atopic Dermatitis; HF; Hayfever; Dex; Dexamethasone; 
NS; Nedocromil Sodium; FML fiuorometholone; SG; Sodium Cromogtycate 
All donors had disease symptoms for a minimum of 5 year, with the exception of the GPC donor whose 
symptoms were onset with prolonged contact lens usage (6yr).
Table 2b Results from previous ELISA and Immunoflourescenee studies of CAED T 
cell lines
CAED T cell 
Line No.
Previous 
cell line No.
%]Expression ELISA fpg/mll
CD4 CD8 CD3 IL-4 EL-13 IL-10 IFN-y
1 AKC 7 24 43 100 44 851 996.4 3495
2 AKC 8 52 52 100 >4000 >10,000 4246 1317
3 AKC 9 34 62 100 2 707 97 1086
4 AKC 10 44 55 100 4 790 119 1545
5 VKC 3 40 32 99 243 10247 334 478
6 VKC 4 37 34 99 85 6516 65 333
7 GPC 4 56 44 99 35 982 44 55
TAO PB T cell lines were expanded from patients’ with moderately severe TAO by 
Pappa et al (1997; 2000). This study was conducted using PB T cell lines from four 
patients with late stage disease and one with early stage of TAO. These TAO patients 
were not receiving systemic steroids or other immunosuppressive therapy at the time of 
venepuncture. T cell lines’ were expanded from untreated patients. The table below 4b 
provides details of previously established immunological data, length and duration of 
specific disease of donor and the treatment they had received prior to this study. All 
cell lines utilized in this study were peripheral blood derived lines and had previously 
been through 3 - 5  passages with PHA and feeder cells. In this study the cell lines were 
further put through 4 - 7  rounds of stimulation.
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Table 2c. Donor clinical details for TAO patients
T cell 
Line No.
Donor
age
Sex T4 Class
ofTAO*
Duration of 
TAO
Treatment
1 70 F Yes 4(4b) 14 years None
2 58 M No 4(4b,2b) 2 years 10m R
3 58 M No 6(6a,4b) 5 months None
4 60 F No 4(4b,2b) 21 years S® (prior to biopsy
5 38 F No 4(4b) 3 years None
Abbreviations; R' Radiotherapy; S: Steroids
* Class of TAO is according to modified NO SPECS classification described by Grubeck-Loebenstein et a/, 
1994.
00 At time of biopsy receiving 5mg/day prednisalone.
Table 2d. PB T cell phenotypes and ELISA results from previous study (adapted from 
Pappa et al, 1997)
T cell 
Line No.
% Expression pg/ml
CD4 CD8 CD3 IL-4 IFN-y EL-10
1 23 57 100 783 1164 109
2 98 1 99 <31.3 778 <7.8
3 97 2 99 106 1026 <7.8
4 89 3 99 43 270 36
5 ND ND ND ND ND ND
ND = Not done
PBMC-derived T cell lines and PBMCs from volunteer non-atopic healthy controls 
were used for this study for comparison with CAED and TAO.
Control T cell lines generated for the purpose of this study were taken from healthy 
volunteer donors. PBMCs were obtained from 6 donors, accordingly labelled 1 - 6  and 
expanded with PHA and feeder cells. PBMCs from donors 1 and 2 were expanded as 
both ttp and PHA T cell lines, according to the procedure described in 2.2.4 of this 
chapter.
2.2.4.2 Irradiation of feeder cells
Autologous (human) PBMCs for use as feeder cells were irradiated at 3000 Rad, and, J- 
Y cells were irradiated at 6000 Rad (137Cs used as the source of y-rays, LSHTM, UCL). 
Feeder cells were used at a ratio of 2:1 feeder cdls:T cells.
2.2.43. Incubation of cells
All cells were incubated in 25cm2 or 75cm2 tissue culture flasks (Nunc) at 37°C, 5% 
CO2  and humidified. The 25cm2 flasks were placed upright, containing 5 -lOmls. 10 -
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25ml volume of cells in 75cm2 flasks were placed upright whereas 25-50ml cells in 
75cm2 flasks were placed horizontally in die incubator for optimum cell density.
2.2.5. J-Y cell culture
These cells were cultured in medium as described above (2.1.3). Cells were pelleted by 
centrifugation (1200rpm for 10 mins) every 3 - 4  days and resuspended in fresh 
medium along with weekly viability counts. The rapid expansion of these cells enabled 
cryopreservation and plentiful frozen stocks of these cells to be built up.
2.2.6. Culture harvesting of anti-CD3 (OKT3) producing hybrldoma.
Cells were cultured in Iscove’s Modified Dulbecco’s Medium as described above 
(2.1.iv). Anti-CD3 mAb -  (OKT3) produced from the B cell hybridoma line was 
purified by firstly centrifugation of die cells at 1200rpm for 10 mins. The cells were 
then counted and adjusted to the concentration of 4 x 105/ml and placed into medium 
RPMI1640 with glutamine, gentamycin and Nutridoma -  SP (Stock solution was 100X, 
Bo ehringer-Mannheim), a serum-free medium, lml of the serum-free medium (100X) 
was added to 99ml of RPMI 1640 (supplemented with glutamine and gentamycin). 
Cells were then incubated at 37°C, 5% CO2 for 48 hours during which time die cells 
secreted the anti-CD3 (OKT3) antibody into the medium.
After 48 hrs of culturing, the cells were centrifuged for 15 mins at 2000rpm. The 
supernatant containing anti-CD3 mAb was harvested by filtering using double 
interconnected filters (Millipore). A 50 ml syringe (Nalgene) filled with the supernatant 
was connected to a 1.2pM (Millex) filter which was attached to a 0.22 pM (Millex) filter 
and the supernatant was aliquotted in 5ml volumes into several 5ml bijoux and stored at 
-20°C until required. The protein content of the anti-CD3 mAb was measured from a 
BSA standard curve.
2.2.6.1. Coating 24 well plate with anti-CD3 mAb
The 24-well plates were coated with anti-CD3 MAb [10 pg/ml], in PBS with 0.2%
bovine serum albumn (BSA) following a 24h incubation at 4°C to allow the antibody to
adhere to the surface of the wells. After the incubation period the wells were washed
with T cell medium, to remove any non-adhered antibody. The optimum concentration
of anti-CD3mAb for use was determined by comparing a range of concentrations (0 -
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50pg/ml) of the anti-CD3mAb for T cell stimulation by measuring intracellular cytokine 
staining at 24 hrs. In this way, [lOpg/ml] was found to optimally stimulate T cells.
2.2.7 Intracellular cytokine staining
Each intracellular cytokine staining experiment was performed using of 2 x 105/ml T 
cells. Samples usually consisted of an unstimulated negative control with feeder cells, 
positive controls consisting of cells stimulated with either specific antigen (ttp) or non­
specific T cell stimulators, PHA, phorbol-12-myristate-13 -acetate (PMA) with 
ionomycin, (all Sigma-Aldrich) or with plastic-bound anti-CD3 antibodies in 
combination with anti-CD28 mAb (see section 2.2.6.1).
22.7.1. Modes of T cell stimulation
The staining procedure involved placing 2 x 105 T cells with the addition of feeder cells, 
in 1ml volume of T cell medium, into appropriately labelled 1.5ml microfuge tubes. 
Next PHA [lpg/ml], ttp [5pg/ml] or PMA [50ng/ml] with ionomycin [lpg/ml] were 
added to appropriate tubes. In experiments using anti-CD3 with anti-CD28 [2.5pg/ml] 
to stimulate the T cells, pre-coated 24 well plates were used. All samples were then 
incubated at 37°C, 5% CO2 for either 6, 18, 24 or 48 hrs. Brefeldin A (BFA, Sigma- 
Aldrich) was added to each sample at a concentration of lOpg/ml for the last 33% of the 
incubation period, due to it having a time-dependent cytotoxic effect on cells (Ferric et 
al, 1995). BFA blocks the intracellular transport processes resulting in the accumulation 
of cytokines in the golgi apparatus (Jung et al, 1993; Openshaw et al, 1995).
2J2,7J2 Staining
Following incubation die tubes were centrifuged for lOOOrpm for 3 mins then 
supernatants were poured off carefully, not disturbing the pellet The pellets were then 
resuspended in the residual volume by flicking. 5pi of anti-cell surface molecule 
antibody (anti-CD3, anti-CD4, anti-CD8 all conjugated with peridinin chlorophyll 
protein (PerCP) or anti-CD69 (PE conjugated), used as a marker of cellular activation 
(see Table 2.a) (all Becton Dickinson (BD), Oxford, UK) were added to the tubes, 
followed by a 30 mins incubation period on ice (in the dark). Next the cells were 
washed to remove unbound antibody by adding lml of Facsflow (BD) and after 
centrifuging the tubes for 3 mins at lOOOrpm, supernatants were discarded and cells 
resuspended. The next stage involved the addition of lOOpl Cytofix/Cytoperm 
(Pharmingen) to each tube, which were then left for 20 mins at 4°C to allow the cells to
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be fixed and the permeabilization of the cell membranes to occur, thus allowing the 
entry of the anti-cytokine antibodies. The cells were then washed with lx  Permwash 
(Pharmingen) followed by centrifugation as previously described, before adding one or 
two 50pl of pre-diluted anti-cytokine antibodies (all BD), conjugated with different 
fluorescent labels (see Table 2.b). The anti-cytokine antibodies were IL-4- 
phycoerythrin (PE), IFN-y fluorescein isothiocyanate (FITC) or IL-10 (PE), with 
dilutions made using xl Permwash Combinations of three fluorescent cytokine/cell 
surface mAbs were used, permitting each one of the three only to be used once. 
Intracellular staining was carried out by incubating the cells for 30 mins on ice. This 
was followed by a final washing stage after the addition of 1ml xl Permwash then 
centrifuging as previously described. After the final wash, the pellet of cells was 
resuspended in 500pi Facsflow.
Table 2e. T cell flourescent cell surface markers used
Cell surface marker Conjugate Quantity pi Company
Anti-CD3 PerCP 5 pi BD
Anti-CD4 PerCP 5 pi BD
Anti-CD8 PerCP 5 pi BD
Anti-CD69 PE 5pl BD
Anti-CCR3 None 2 pi A kind gift from Dr P. Ponafh*
Table 2.e. Cell surface anffoocfes utilised in staining experiments. *LeukoSite Inc. USA
Table 2f. Intracellular cytokine conjugated antibodies used
Intracellular Cytokine marker Conjugate Quantity pl/Dilution Company
IFN-y FITC 50pl/l:50 Pharmingen
IL-4 PE 50pl/l :250 Pharmingen
IL-10 PE 50pl/l:100 Pharmingen
Table 2.f. Intracellular cytokine antibodies utilised in staining experiments.
23. .13 . Flow cytometry analysis
Following the intracellular cytokine staining, cells were acquired on the Facscan (BD), 
equipped with an argon laser emitting at 488nm immediately or stored at 4°C until 
acquisition (between 1 and 4 days later). Analysis, using Cellquest software, for forward 
scatter (FSC) and side scatter (SSC) was used to establish a live cell gate, ensuring that 
die majority of events were CD3+, as a positive control for stimulation, excluding dead 
cells and debris observed in the bottom left hand comer of the analysis plots. Based on a 
positive control mAb staining for each of the flourescent markers used die flow
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cytometer settings for voltage and compensation were set. Quadrants for the aquisiton 
screen were set based on, isotype matched controls (IgGi) as shown in the table below, 
or using unstained cells. Samples were then acquired and die percentages of single and 
double-positive cytokine-stained cells were then calculated from the CD3+, CD4+ or 
CD8+ cells acquired in the region. Experiments were repeated at least three times and 
the mean percentage expression ± S.D were calculated.
Antibody Isotype Isotype matched controls
a-CD3-PerCP Mouse IgGi algGi PerCP*
a -  CD4-PerCP Mouse IgGi algGi PerCP*
a -  CD8-PerCP Mouse IgGi a  IgGi PerCP*
a -  DL-4 - PE Mouse IgGi a  IgGi PE*
a-IFN-y FITC Mouse IgGi algGi FITC*
* Antibodies are IgGi kappa; done MOPC-21. Al antibodies purchased from 8D.
Compensations settings were adjusted each time intracellular cytokine staining 
experiments were conducted, using single-fluorochromes. Compensation adjustments 
allowed fine tuning to accommodate cell populations in the appropriate quadrants and is 
essential due to die spectral overlap between certain fluorochromes. For example, when 
the combination of FITC and PE were used, then two additional tubes, one for FITC 
alone and another with PE only were set up along with a negative control (unstained 
sample) to set up the instrument. FITC, (fluorescein fluorescence is primarily green) is 
measured in die FL1 channel However, as fluorescein also has a significant yellow 
component to the fluorescence, which appears in the FL2 (PE) channel. Therefore it is 
necessary to subtract this from the FL2 channel before acquiring samples with FITC and 
PE staining. PerCP is measured in the FL3 channel.
Parameter settings were input each time acquisition was carried out to provide details of 
the samples being analysed. Such as FL settings according to the fluorochromes 
conjugated to staining antibodies. Parameter settings were also set to count a minimum 
o f5000 cells in each sample.
2.2.8 In vitro cytokine switching/blocking mAb’s
PBMCs isolated from three donors were set up in different culturing conditions and 
incubated for seven days at 37°C, 5% CO2. For each donor 1 x 106 PBMCs were 
incubated (2 x 105/ml) with either PHA (lpg/ml) and irradiated (J-Y) feeder cells alone, 
PHA in addition to anti-IL-12 [0.02fig/ml] with recombinant human (Rh) Rh IL-4
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[0.2ng/ml] and feeder cells or with PHA in combination with anti-IL-4 [0.4ng/ml] and 
Rh IL-12 [O.lng/ml] and feeder cells (all cytokines and blocking antibodies purchased 
from PEPROTECH EC Ltd, London, UK). On day 7 the T cells were washed, counted 
and adjusted to 2 x 105/ml and re-stimulated with feeders 2:1 (irradiated J-Y feeder 
cells:T cells) and PHA, followed by the same cytokine and antibody conditions as 
before. Then every 3 days until day 14, Rh IL-2 was added at a concentration of 
lOU/ml (Boehringer Mannheim, Germany). Intracellular cytokine staining experiments 
were conducted at day 0, day 7 and day 14.
2.2.8.1 Staining for chemokine Receptor 3 (CCR3)
Cells from switching experiments were additionally stained for CCR3, a cell surface 
marker staining many cell types including Th2 cells but not Thl cells (Bonecchi, 1998). 
Staining was conducted in two stages. The first stage involved the addition of lOpl of 
anti-CCR3mAb diluted 1:200 in PBS (primary antibody), and cells were incubated on 
ice for 30 mins then washed twice with PBS. Next 2pi of the secondary, FITC (goat 
anti-mouse IgGi -FITC mAb) (BD) was added to each sample and left for 30 min on 
ice. Following this stage the cells were washed twice, permeabilized and stained for 
intracellular cytokines as described above. Secondary antibody alone was used as a 
negative control.
2.2.8.2 Incorporation of immunosuppressive drugs in Thl and Th2 cytokine 
favouring conditions.
CsA (Sandoz) and dexamethasone (Sigma-Aldrich) were added to cell cultures in 
cytokine switching experiments. CsA was added at a concentration of 25ng/ml to 
negative control tubes and samples in Thl and Th2 favouring conditions. CsA (lOOmg) 
was dissolved in 1.2ml of premixed solvent of lml pure ethanol and 0.2ml Tween 80 
(both Sigma-Aldrich) then further diluted in T cell medium to a final volume of 100ml 
to give lpg/ml. The optimal concentration of CsA (25ng/ml) was established 
conducting a proliferation assay to determine die optimal level of T cell suppression. 
The range of CsA used was 0 -  200ng/ml (data not shown). Likewise dexamethasone 
[10'7M] was added to Thl, Th2 and to negative control tubes. The concentration used 
was based on findings by Caulfield et al, (2002). Both immunosuppressive drugs were 
added at the same time as the switching/blocking antibodies (days 0,7 and 14).
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2.2.9 Mixed Lymphocyte Response (MLR)
2.2.9.I. One-way MLR
One-way MLRs involve responder cells recognising irradiated allogeneic target 
(stimulator) cells, to which they respond (due to allo-MHC incompatibilities) by 
proliferating. The intense proliferative response observed in mixed lymphocyte cultures 
between cells from unrelated individuals is largely due to the result of CD4 T cell 
recognition of MHC class II polymorphisms. The CD8 T cells respond due to 
recognition of stimulator cells MHC class I polymorphisms (Janeway and Travers,
1996). This method was utilised to test three batches of human AB+ serum with donor 
responder and irradiated allogeneic responder cells from another donor to determine the 
optimal batch and concentration of AB+ serum to use throughout this study, in terms of 
the ability of the serum to support T cell proliferative responses.
The MLRs were performed in 96-well round bottom plates. Cells or medium were 
added per well to a total volume of 200pi. Wells were pulsed with lOpl containing 
0.5pCi methyl-3H-thymidine (Amersham) for the last 18 hrs of a 5-day culture prior to 
harvesting on a cell harvester (Dynatech), and counted on a liquid scintillation counter. 
Lymphocyte proliferation was calculated as mean cpm ± SD from triplicate wells of 3H- 
thymidine incorporation having subtracted background counts from “cells alone”. 
Controls were responder, stimulator and modulator cells alone and stimulated with the 
mitogen PHA (lpg/ml).
2J2J9JL Two-way MLR - MLR with “modulator cdls”
This assay was an extension of a one-way MLR set up utilising responder cells along 
with modulator cells (responder cells treated in different culture conditions). The 
“modulator” cells were classified into three groups of cells made up of (a) PHA T cell 
line, (b) PHA T cells following two weeks treatment with anti-IL-4 and IL-12 whereas 
(c) PHA T cells that had been treated for two weeks with anti-IL-4 and IL-12 in 
combination with CsA [25ng/ml], The assay also incorporated irradiated stimulator 
cells using another donor’s PBMCs. The experiment was set up as shown in table 5 
using 1 x 10s responder or (irradiated) stimulator cells alone or in combination with 1 x 
10s modulator (a, b or c) cells in 96-well plate with stimulator cells, responder cells and 
modulator cells -  alone or in the combinations below in Table 2.h.
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Table 2.h. Protocol for two-way MLR
Wells Responder Stimulator Modulator (a, b or c)
Al-3* - - -
A4-6** - - -
A7-9 V - -
A10-A12 V + PHA - -
Bl-3 - - a
B4-6 - - a + PHA
B7-9 - - b
BIO-12 - - b + PHA
Cl-3 - - c
C4-6 - - c + PHA
C7-9 - -
CIO-12 - V + PHA -
Dl-3 V - V a
D4-6 V - V b
D7-9 V - V c
DIO-12 - V V a
El-3 - V V b
E4-6 - >/ V c
E7-9 V V a
E10-12 V V V b
F1-F3 1 V V c
Table 2h. Two-way proliferation assay using 1 x 10s responder cels, 1 x 10s stimulator cells and 
modulator (a, b or c) cells made up to a volume of 200pi per wel. All samples set up in triplicate wells. 
Wells marked with * represent triplicate wells containing medium alone or ** medium plus PHA.
2.2.10 Enzyme linked immunosorbent assay (ELISA)
ELISAs were performed using commercially available, highly sensitive cytokine- 
specific kits (OptEIA sets, Pharmingen). Cytokine production from T cells and feeders 
was analysed following die harvesting of supernatants at 24 hrs. The kits contained 
anti-cytokine antibody, anti-detection antibody and a standard recombinant human 
cytokine (baculovirus expressed), which was lyophilised. They also provided an 
enzyme reagent, avidin-horseradish peroxidase (HRP) conjugate. A separate cytokine- 
specific kit was used for each cytokine tested. Minimum and maximum levels of 
detection depended on die cytokine used, with levels of detection as follows: IL-2, 25- 
1200pg/ml; IL-4,15-850 pg/ml; IFN-y 25-1000pg/ml.
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2.2.10.1 Preparation of ELISA Standards
The lyophilised standard, from die ELISA kit, was warmed to room temperature (RT) 
and the vial reconstituted with 1ml of dP^O. This was left for 15 mins to allow the 
standard to equilibriate, the vial was then vortexed gently to mix and aliquoted in 50pl 
volumes into sterile 0.5ml microtubes, labelled and stored at -70°C until required.
2.2.10.2 Collection of supernatant samples
Samples were collected following 24 hrs stimulation of the T cells. In most instances 
ELISA tubes were set up in parallel to intracellular cytokine staining tubes and 
stimulated with PHA [lpg/ml] or PMA [50ng/ml] with ionomycin [lpg/ml]. However 
for ELISA BFA was not added to the samples. Following the incubation period the 
cells were pelleted by centrifugation and the supernatants removed and stored at -70°C 
until adequate sample numbers were obtained to perform a 96 well plate ELISA.
2.2.10.3 ELISA procedure and plate reading
Briefly, the procedure for running the ELIS As was as follows: 96 well ELISA plates 
were incubated overnight at 4°C with coating buffer containing capture antibody 
(lOOpl/well). Standards were prepared from serial dilutions, made with assay diluent 
(PBS with 10% FBS), of the stock standard provided for each cytokine. lOOpl of each 
standard concentration along with samples (neat) were added to wells in duplicate. The 
plates were then sealed and incubated for 2 hrs at RT. Plates were then aspirated and 
washed with wash buffer. Next lOOpl of the working detector, containing detection 
antibody with avidin-HRP reagent, was added to each well for 1 hr at RT followed by 
washing the plate. 100pi of substrate solution was then added to each well and the plate 
incubated in the dark at room temperature for 30 mins resulting in reactivity depend ait 
colour change. This reaction was stopped by the addition of 50pl sodium hydroxide to 
stop the reaction. The plates were then read in an ELISA plate reader measuring 
absorbance at 450nm, within 30 mins.
The mean absorbance for the duplicate standards and samples was calculated, 
subtracting background absorbance readings from medium alone and irradiated feeders 
alone. Standard curves were plotted and used to determine the cytokine concentrations 
of the samples. Cytokine concentrations were measured in pg/ml, for samples were 
quantitated by extrapolating from the standard curve.
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2.2.11 Cytometric Bead Assay
Human Thl/Th2 cytokine Cytometric Bead Arrays (CBA; BD) were used to 
quantitate the cytokines IL-2, IL-4, IL-5, IL-10, TNFa and IFN-y in 24-hrs culture 
supernatants following stimulation with PHA and feeders, as described above (section 
2.6.2). This technique enables the detection of different particles on the basis of size 
and intensity of colour. The CBA assay is a simultaneous assay of many analytes in a 
single sample, combined with flow cytometry to create a powerful multiplexed assay. 
The cytokine capture beads have distinct fluorescence intensities and which are coated 
with capture antibodies specific for each of the above, distinguished from brightest to 
dimmest (Thl/Th2) cytokines as shown in table 2.i.
Table 2.i. Cytokine bead fluorescence intensities
Bead Specificity
(Brightest) Al IL-2
A2 IL-4
A3 IL-5
A4 IL-10
A5 TNF-a
(Dimmest) A6 IFN-y
The CBA procedure is highlighted in section 2.2.11.1 with cytokine standards or test 
samples, including controls of unstimulated T cells and unstimulated cells with feeder 
cells.
2.2.11.1 CBA Assay procedure
Reconstitute human Thl/Th2 cytokine standards in assay diluent
1
Dilute standards by serial dilutions using assay diluent (20-5000pg/ml)
Mix lOpl of each human cytokine capture bead suspension (n=6)
Transfer 50pi of mixed beads to each assay tube- containing 50pl test 
Add PE detection antibodies (50|il/test) (anti-c\1okine)
Incubate in darl^for 18 hrs at RT*
Wash tubes with 1ml \*jash Buffer and centrifuge 
Add 300pi of Wash Buffer to each assay tube and analyze samples
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♦Cytometer Setup Bead Procedure
30 min
incubatior
RT- 
in dark
3. Add 400|d of Wash Buffer 
to tubes B and C.
4. Add 450pl of Wash to tube B
5. Use tubes A. B and C for 
c\1ometer setup.
1. Add CMometer Setup Beads 
to setup tubes A.B and C.
2. Add 50pi of FITC+ control to tube 
and 50pl of PE+ control to tube B & C
Tube A contains FL3 startup bead
Standards and samples were analyzed using flow cytometry (BDFACScan), as 
described previously. Five parameters were evaluated simultaneously: FSC, SSC, 
FL1, FL2 and FL3. The R1 gate was adjusted to select and contain the singlet bead 
populatioa FL2 and FL3 settings were adjusted to locate the bead populations with 
distinct fluorescence intensities. A total of 3000 events were counted. The minimum 
levels of detection were 8 pg/ml for IFN-y and 3 pg/ml for the others.
2.2.12. Polymerase chain reaction (PCR)
2.2.12.1 RNA extraction.
Stimulated T cells were pelleted at 6 hrs and the total RNA extracted using an RNeasy 
extraction kit according to manufacturers recommendations (Qiagen Ltd, Crawley, 
UK). Samples were resuspended in 100 pi of buffer containing TRIS-HC1 [90mM], pH
7.5, MgCh [lOmM], NaCl [50mM], and treated with RNA-ffee DNAase [10U] for 15 
mins at 37°C. RNA was extracted twice with phenol:chloroform [1:10], once with 
chloroform, precipitated in ethanol and resuspended in 30pl diethylpyrocarbonate- 
treated distilled water (DEPC-H2O). RNA was quantified by placing lpl RNA 
(extracted) into 69 pi RNAse free cUUO to estimate protein (RNA) content in samples 
with UV spectrophotemeter settings 260nm (excitation) and 280nm (emmision). An 
example of the calculations involved in RNA quantification is shown below: Volume 
of RNA sample =100pl
Dilution = lOpl of RNA sample + 490pi dH20 (1/50 dilution)
Absorbance reading (260nm) of diluted sample = 0.23
When measured in water the absorbance value of 1 is equal to 40 pg/ml of RNA; 
therefore, die concentration of the original RNA sample =40 x Abs x dilution factor;
Hence = 40 x 0.23 x 50 = 460pg/ml 
Total yield = concentration x volume of sample (ml) = 460pg/ml x 0.1 ml = 46pg.
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2.2.12.2 First strand cDNA synthesis
Then 1 - 5pg RNA was converted using a kit (Invitrogen Superscript preamplification 
system) for 1st strand cDNA synthesis to cDNA following the manufacturers’ 
protocol. In each experiment a positive control RNA tube was set up (50 ng/pl, 
provided with die kit) alongside RNA from samples and a reverse transcriptase-free 
negative control. Briefly, RNA/primer mixtures were made up in sterile RNAse-free 
0.5ml tubes containing n.\i\ sample RNA (one as the negative control) or lpl control 
RNA to which lpl oligo dT (0.5pg/pl) was added to each tube and made up to a total 
volume of 12pl with DEPC- treated water. Tubes were then incubated for 10 min at 
70°C (to denature) followed by at least 1 min incubation on ice. Next the reaction 
mixture was prepared for samples n + 3. For each reaction 2pl 10X PCR buffer, 2pl 
MgCh [25mM], 2pl DTT [0.1 M] and lpl dNTP [10 mM] mix was made up, mixed 
and 7pl of the reaction mixture was added to each tube (samples and controls) then 
incubated at 42°C for 5 mins. Next lp l of SUPERSCRIPT II reverse transcriptase 
was added to each tube except for the negative control and tubes incubated for 50 
mins at 42°C. This reaction was terminated by placing the tubes at 70°C for 15 mins 
then placed on ice to chill. Contents of the tubes were next centrifuged and incubated 
for 20 mins at 37°C in the presence of RNase H. Extreme care was taken to prevent 
RNA contamination and all work was carried out with RNAse-free products. Each 
cDNA was then amplified as outlined in the procedure in 2.2.12.3.
2.2.123. Amplification of Target cDNA
cDNA (2pl) samples were made up to a final volume of 50pl containing lUnit Taq 
DNA polymerase [5units/pl], 10X PCR buffer, MgCb [50mM], dNTP mix [lOmM] 
and primers A and B (provided in the kit for cDNA control only to be expressed by 
the control RNA, to check that the conversion had worked) and for {3-actin primers 
and then cytokine primers (A and B for 3’ and 5’ ends) and the remaining volume 
made up with dH20. A list of die primer sequences used in this study is shown in 
Table 2.j. below. The PCR mix was made up for n+1 tubes, with a negative control 
tube excluding 2pi cDNA. The Taq DNA polymerase was added as the last 
component of the mix. The cDNA (2pl) samples were placed into 0.2 ml thin walled 
PCR tubes to which 48 pi of die PCR mix was added. Prior to placing the tubes into 
the PCR machine 1 drop of mineral oil was added to each tube.
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Table2jjPCRj>™
Primers
Predicted 
length of 
PCR product 
(BP)
Sequence
IL-2 5 s 
IL-2 3’
429 ATGTACAGGATGCAACTCCTG
TC AAGTT AGTGTTGAGATGCTTTGACAAAA
IL-4 5’ 
IL-4 35
350 TTCCCCCTCTGTTCTTCCTGCTAG
ACGTACTCTGGTTGGCTTCCTTCAC
IFN-y 5’ 
IFN-y 3’
378 ATATCTTGCTTTTCAGCTCTG 
CT GACTCCTTTTTCGCTTCC
p-actin 5 s 620 GAGC AC AGAGCCTCGCCTTT GC 
GGATCTTCATGAGGTAGTCAGTCAGG
Table 2.j. Primer sequences used in the PCR
All the above primer sequences (shown in Table 2.j.) have been used successfully 
before (Calder et al, 1999)
2.2.12.4 Optimal PCR conditions.
Tubes for PCR were placed in the Thermocycler. Different denaturing and annealing 
temperatures were used for the different primers as shown in Table 2. k. below. As 
well as differing the annealling temperatures, die volumes of MgCl2 required varied 
depending on the primers.
Table 2.k PCR conditions for p-actin and cytokines
Gene
Expression
Denaturing 
Temp. Time
Programme 
Temp. Time
MgCl2 No. of 
cycles
P-actin 96°C 3 min 94°C 1 min 
60°C 1 min 
72°C 1 min
3pl 30
IL-4 94°C 3 min 94°C 1 min 
60°C 30 sec 
72°C 30 sec*
5pl 40
IFN-y 94°C 3 min 94°C 1 min 
55°C 30 sec 
72°C 30 sec*
5pl 40
Table 2k. Shows the primers used to detect mRNA expression from T cells and the different denaturing, 
annealing and elongation conditions, with different concentrations of MgCI2 and the number of PCR 
cycles.
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2.2.12.5. Preparation of 2% polyacrylamide gel
2g of Electrophoresis grade polyacrylamide powder was dissolved in 100ml of 0.5 x 
electrophoresis buffer and solubilized by heating in the microwave. Once dissolved, 
the solution was left to cool and then 10p.l of ethidium bromide [lOmg/ml] was added 
per 100ml. The solution was poured into the gel cartridge with a comb and autoclave 
tape to seal. The gel was then allowed to set for 10 -  15 mins after which time the 
comb and the autoclave tape were carefully removed. The gel was then placed into 
the electrophoresis tank, filling the tank to 0.5cm above the gel with 0.5 x 
electrophoresis buffer.
2.2.12.6. Loading of the polyacrylamide gel with samples
A lOObp weight ladder (Invitrogen) was added to run on the outer wells at each side 
of the gels. 10p.l loading buffer and 10pi of diluted molecular weight ladder (lOObp) 
(lpl ladder and 9pl dPfcO) were mixed prior to adding to the gel. To each of the 
samples in PCR tubes, 50pl of chloroform (ChCfe) was added, resulting in the 
formation of an upper aqueous phase. lOpl of each aqueous phase was mixed with 
lOpl loading buffer and pipetted into the gel. The electrophoresis tank was covered 
and switched on with the gel running towards the red electrode at 77mA ± 20 and left 
for 30 - 60 mins. The identity of the amplified product was confirmed by agarose gel 
electrophoresis, followed by ethidium bromide staining under UV illumination.
2.2.12.7 Confirmation of cDNA
To confirm that the amplification had produced die correct products, bands were 
excised from gels and pooled for sequencing (Calder et al, 1999). All amplicons 
were of the size predicted from the cDNA sequence. In addition, PCR products from 
each amplification protocol were isolated and cycle-sequenced on an ABI PRISM 
automated DNA sequencer and die amplicon was confirmed for each cytokine.
2.2.12.8 TaqMan -  Real time PCR to quantitate cytokine expression
Pre-developed TaqMan® Assay Reagent target kits were used (Applied Biosystems). 
The ABI PRISM® 7700 Sequence Detection System integrates a PCR-based assay with 
laser scanning technology to excite fluorescent dyes present in the specially designed 
TaqMan® probes. It is a fully integrated system for real-time detection of PCR. The
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system includes a built-in thermal cycler, a laser to induce fluorescence, CCD (charge- 
coupled device) detector, real-time sequence detection software, and TaqMan® reagents 
for the fluorogenic 5' nuclease assay. The cycle-by-cycle detection of the increase in 
the amount of PCR product is quantified in real time as the special probes, "reporter 
dye", fluoresces when the "quencher" is removed from the fragment during the PCR 
extension cycle.
The kit contained target primers and probe reagent along with TaqMan universal PCR 
Master Mix for Real Time, in vitro quantitative evaluation of gene expression from 
cDNA samples. First, a housekeeping gene GAPDH was run as a standard curve to 
optimise the PCR, using a cDNA positive control (PHA-stimulated T cells at 24 hrs). 
Then the PCR conditions for the cytokine primer pairs were established for IFN-y and 
EL-10 used in parallel with GAPDH as the positive control. The total amount of PCR 
reaction mix required for all die samples was made up to a final volume of 25 pi for each 
sample, mixed in the following proportions: 10-Xpl RNase-free water, 1.25 pi target 
primers and probe X 2, 12.5pl 20X TaqMan ® universal PCR mix and xpl of cDNA. 
The preparation of the reaction mix is crucial for the accurate calculation if relative 
quantification values. The 25 pi volume for each sample was added to the Micro Amp® 
optical 96 well reaction plate. The plate was sealed and placed in ABI Prism 7700 
thermal cycler on hold for 2 mins at 50°C then for 10 mins at 95°C and then 40 cycles at 
95°C for 15 secs and at 60°C for 1 minute. The reactions were then analysed to produce 
standard curves.
To induce fluorescence during PCR, laser light is distributed to the 96 sample wells via 
a multiplexed array of optical fibers. The resulting fluorescent emission returns via the 
fibers and is directed to a spectrograph with a charge-coupled device (CCD) camera 
The sophisticated precision optics provides highly reproducible and quantitative results. 
The continuous wavelength detection from 500-660 nm allows the use of multiple 
fluorophores in a single reaction (we used two -  FAM and VIC) hence, the ability to 
perform multiple target quantitation in a single tube.
2.2.13 Adenoviral vectors to block NFkB in human T cells
Recombinant replication-deficient adenoviral vector encoding Escherichia coli 13- 
gal actsidase (ADVpGal) or having no insert (AdvO) were provided by Drs A. Byrnes 
and M. Wood (Oxford, UK). The adenoviral vector encoding porcine IkBcx with a
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cytomegalovirus promotor and a nuclear localizaton sequence (AdvIicBa) was provided 
by Dr R. de Martin (Vienna, Austria; Wrighton et al, 1996). Porcine IicBa has >95% 
homology with the human molecule. All viruses contained a deletion in the El and E3 
regions. The viruses were propagated in the 293 human embryonic kidney cell line and 
purified by ultra centrifugation through two cesium chloride gradients (Graham and 
Prevec, 1995; Bondeson et al, 1999). All viruses used were plaque-purified from a 
master stock to prevent contamination with wild-type adenovirus.
2.2.13.1 Adenoviral Infectivity of T cells
T cell lines were plated in a 24-well flat-bottom plate at a density of 4 x 106 cells/well 
and were either left uninfected or infected for 2 hrs with a multiplicity of infection 
(mo.i.) of 100:1 to 3000:1 of AdvO, or AdvpGal in serum-free RPMI-1640. Cells were 
then washed, to remove unincorporated virus and placed in T cell medium containing 
IL-2. The cells were used 48 hrs post infection either in cytokine assay or for 
0-galactosidase staining, as described below.
Cells were spun down after infection and washed in PBS staining solution and 
incubated at 37°C for 10 mins before 45pi of a 2mM solution of Fluorescein-di-(p-D)- 
galactopyranoside (Sigma) was added for 1 min (Clarke et al, 1995). Addition of 
excess (lOx) ice-cold PBS was used to stop the reaction, and cell fluorescence was 
analysed by FACS. This was done by producing the negative control isotype curve 
then superimposing the positive control FITC, comparing different dilutions.
2.2.14 Statistics
All analyses for statistical significance were performed using the Minitab™ statistics 
programme. Non-parametric comparison of means of data was performed using Mann- 
Whitney tests, giving p values < 0.05 as significant, for two independent sample groups 
of patients or data obtained for different cytokines. The Students’ t-test was used when 
comparing means of parametric data in proliferation assays and MLRs. For 
simplification in this thesis statistical significances have been described as being highly 
significant with p values < 0.001, significant p values as < 0.01 or slightly significant 
with p values of <0.05.
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3.1 Introduction
Cytokines function at a micro environmental level to regulate intercellular immune 
interactions. They are produced in the cytoplasm of mononuclear cells, providing a 
network controlling both innate and specific immune responses, including 
inflammation, defence against viruses, proliferation of specific T and B cell clones and 
the regulation of their function. The particular cytokines produced during an immune 
response determine the types of other immune cells recruited. The Thl subset of T cells 
secretes IL-2 and IFN-y which function to activate macrophages and promote cytotoxic 
responses whereas the Th2 subset of cells secrete cytokines such as IL-4 and IL-5 
resulting in the activation of B cells to promote Ab dependent responses. There is 
plenty of evidence suggesting skewed populations of human Thl and Th2 CD4+ T cells 
which, along with their counterparts Tel and Tc2 CD8+ T cells, both participate in 
pathological and immunological processes in disease (Chipeta et al, 1998).
Several reports have demonstrated a gross imbalance in T cell subsets’ cytokine 
production profiles during various human disease states. Commonly described diseases 
such asthma (Bames, 2001) and Graves’ disease (Hiromatsu et al, 2000) are associated 
with a predominance of Th2 and Thl cytokine profiles respectively. Hence techniques 
to determine cytokine expression are useful in understanding the basic mechanisms 
involved in many pathological conditions.
Several methods have been developed to analyse cytokines in biological fluids and in 
tissue culture samples. Some of these include bioassays, ELISA, ribonuclease 
protection assay (RPA), PCR and more recently intracellular cytokine staining and 
multiplex bead arrays. The identification of anti-cytokine mAbs has proved to be a 
useful tool to determine intracellular cytokines for cells in suspension allowing the 
analyses of individual cytokine-producing cells within unseparated cell populations 
(Jung et al, 1993). This technique is valuable to identify the phototype and frequency 
of cell types defined by membrane antigens and intracellular cytokines. Staining for an 
individual cell surface antigen and two cytoplasmic cytokines has been used to identify 
and enumerate cell types such as Thl and Th2-like cells that mainly express cytokines 
in a restricted manner (Prussin and Metcalf 1995). The intracellular cytokine staining 
technique detects cytokine production within cells though does not reflect the levels of 
export of cytokines into tissues. A definitive publication using a panel of monoclonal 
antibodies to bind to intracellular cytokines in their fixed form, initially with mouse T
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cells was described by Openshaw et al (1995) and subsequently for human T cell 
subpopulations. Flow c\1ometry in many instances serves to complement ELISA and 
ELISPOT assays. A prerequisite for studying cytokine expression is that the cells must 
be stimulated, as unstimulated cells only express nominal levels of cytokines. Also in 
order to accumulate the cytokines within the cells, protein secretion must be inhibited, 
by the addition of reagents such as BFA to inhibit cytokine secretion during stimulation. 
BFA inhibits protein transport between the endoplasmic reticulum and the Golgi 
(Nylanderefa/, 1999).
The intracellular cytokine staining technique in this study was the main method of 
choice, because of its sensitivity and ability to distinguish CD4+ and CD8+ T cells. At 
die time of starting this PhD a major objective was to establish die intracellular cytokine 
staining technique in our laboratory for human T cell lines. Established PB T cell lines 
cytokine profiles derived from patients with either active TAO or active CAED, used in 
this study, had already been characterised by ELISA and PCR by Pappa et al (1997) and 
Calder et al (1999) respectively for each disease. Prior to the use of these precious, 
clinically-defined PB-derived T cell lines which were available cyropreserved in limited 
numbers, the intracellular cytokine staining technique was optimised using more 
established readily available PHA or tetanus toxoid peptide (ttp)-specific human T-cell 
lines, stimulated with either PHA, ttp, PMA/ionomycin or anti-CD3+ (OKT3) with anti- 
CD28 mAb.
Although the intracellular cytokine staining technique is standard in most laboratories 
today, at the start of this study, intracellular cytokine staining was new to the lab, 
therefore the aim of this chapter was to optimise several parameters of the method. 
Firstly the choice of feeder cells was made, comparing autologous feeder cells, as had 
been previously used as a source of feeder cells, with an alternative, immortalized 
human B cell line (J-Y) (Palmer and van Seventer, 1997). This was necessary due to 
limited stocks of autologous PB feeder cells from patients with TAO and CAED. 
Secondly, several different methods for stimulation for the T cells were assessed in 
terms of cytokine expression, using specific antigen (ttp), T cell mitogen (PHA), a non­
specific method of stimulation using PMA and ionomycin and the use of an anti-CD3 
antibody (OKT3) co-administered with anti-CD28. It was also necessary to investigate 
the time course of stimulation to optimise each cytokine expressed. The effects of 
stimulating the T cells were quantified with respect to IFN-y, IL-4 cytokine expression
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and one early activation marker of T cells, CD69. The T cells were also examined in 
terms of cell surface markers CD3 , CD4+ and CD8+.
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3.2 Results
32.1 Comparison of the use of irradiated autologous feeder cells with irradiated 
J-Y (B cell line) cells for cytokine stimulation.
The aim of these experiments was to identify an alternative source of feeder cells for 
maintaining the T cell lines, since the stocks of autologous PBLs were limited.
The levels of intracellular expression of IL-4 and IFN-y from T cells when stimulated in 
combination with different irradiated feeder cells (J-Y and autologous feeder) are shown 
(Table 3a.). Results in Table 3a. suggest that when using J-Y cells as feeders, the levels 
of cytokine expression (EL-4 and IFN-y) were comparable, if not slightly greater, than 
levels of expression observed when using autologuous feeder cells. Ttp-specific T cell 
line (1) stimulated with ttp using either autologous cells or J-Y cells as a source of 
feeder cells resulted in higher levels of IFN-y than IL-4 expression. A similar response 
was observed when the same T cell line was stimulated with PHA, with greater levels of 
IFN-y and IL-4, in conjunction with either irradiated J-Y cells or autologous feeder 
cells, than were expressed in unstimulated controls.
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Table 3a Comparison of two sources of feeder cells.
Conditions of T cell cultures % Cytokine positive cells
IFN-y IL-4
Unstimulated T cells (T cell line 1) 0.5 ± 0.2 N.D.
T cells + ttp + ^autologous feeders 12.3 ± 4.8 1.3 ± 0.8
T cells + ttp + -’J-Y feeder cells 12.7 ± 2.8 1.4 ±0.03
T cells + PHA + ^autologous feeders 21.6 ±4.7 1.8 ±1.3
T cells + PHA + ^ J-Y feeder cells 28.8 ± 5.5 2.1 ±0.8
^ Autologous feeders cells alone N.D. N.D.
ir J-Y feeder cells alone N.D. N.D.
Table 3 a  Comparison of IFN-y a id  IL-4 expression with irradiated autologous PBMCs with J-Y 
feeder cells, following 6-hrs incubation stimulating ttp-specific (cell line 1) T cells with either specific 
antigen ttp or PHA The results shown represent data obtaned from triplicate experiments, all repeated 
under similar conditions. Each experiment consisted of 2 x 105 T cells stimulated with ttp [Spc^ml], or 
PHA [lp,g/ml]. None detected = N.D.
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3.2.2. Co-expression of a T cell activation marker with IL-4 and IFN-y during 
activation with anti-CD3/CD28
The aim of these experiments was to identify a marker for activated T cells that is 
unaffected by the stimulation protocol used, since it was known that the expression of 
CD3+ cell subsets (CD47CD8*) are affected.
Results in Figure 3.i. illustrate the cytokine expression from triplicate experiments with 
ttp-specific T cell line (1) in response to stimulation with anti-CD3mAb [lOng/ml] co­
administered with anti-CD28 Ab [2.5pg] or with PMA [50ng/ml] in combination with 
ionomycin [1 pg/ml]. Following a 6 hrs stimulation of cells with PMA/ionomycin, 
significant numbers of cells expressed the early activation lymphocyte marker CD69, 
with a significant increase in CD3+ EFN-y positive cells (40%) and low but detectable 
levels of CD3+ IL-4 positive cells. For cells stimulated with PMA/ionomycin were 
significantly greater than levels of IFN-y observed in response to stimulation with anti- 
CD3/CD28, co-expression of CD69. Nominal levels of EL-4 were detected when the T 
cells were stimulated with either PMA/ionomycin or anti-CD3/CD28.
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Figure 3i. Co-expression of a T cell activation marker with IL-4 and IFN-y during 
activation with anti-CD3/CD28
CD69 IFN IL-4
Figure 3i. 2 x 105 ttp specific T cell line (1) stimulated with anti-CD3 mAb [10ng/ml], costimulated with 
anti-CD28 [2.5pg] or PMA [50ng/ml] with ionomycin [lpg/ml] for 6 hrs. Open bars represent T cells 
stimulated with anti-CD3 with anti-CD28. The filled bars represent T oells stimulated with 
PMA/ionomydn. Results are means ± S.D. from three experiments using the ttp T cell line (1), carried out 
in three separate experiments. Statistically significant levels of CD69 and IFN^were detected, 
comparing the two different methods of stimulation *p£ 0.01 and *p£ 0.001.
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32.3 Expression of T cell marker of activation, CD69 and cytokines IL-4 and 
IFN-y in response to anti-CD3/CD28 or PMA/ionomycin
Die aim of these experiments was to investigate the expression of CD69 as a marker for 
activated T cells when stimulated with anti-CD3/CD28 compared to PMA with 
ionomycia
Dot plots from a CAED T cell line (6) stimulated for 6 hrs with either anti-CD3/CD28 
or with PMA/ionomycin are shown (Figures 3.ii.b - 3.ii.i). Experiments utilizing this 
CAED T cell line (6) were conducted, under similar conditions, on three separate 
occasions. T cells were stained for the cell surface markers CD69 and CD3+, and also 
for cytokines IL-4 and IFN-y. The lymphocyte region gated for analysis of T cell 
surface markers and cytokine expression by cells within the gate are illustrated (Figure
3.11.a). Cells within the gated region, stained with isotype-matched control antibodies 
(PE and PerCP) shown in figure 3.ii.b cells stained with CD3PerCP were virtually all 
positive for CD3+ with a negligible number of cells staining positively for both IL-4 and 
CD3+ (Figure 3.ii.c). Cells stained in identical conditions analysed for CD69 expression 
showed that, a significant proportion were double positive for both CD3+ and CD69+ 
(Figure 3.ii.d).
The same CAED cell line (6) cells were stimulated with PMA/ionomycin under the 
same conditions on a different occasion and stained with isotype-matched control 
antibodies (PE and FITC), as shown in figure 3.ii.e and with anti-CD69 and anti-IL-4 
antibodies (Figure 3.ii.f). Of the cells gated, the majority expressed CD69, whereas 
only 1% of the cells were double positive for CD69 and IL-4. The same cell line cells 
stained for CD69 and IFN-y, had a high proportion of CD69 positive cells, with two 
thirds of these cells also staining positively for IFN-y (Figure 3.ii.g). The same cell line 
was stimulated with anti-CD3/CD28 (Figures 3.ii.h, 3.ii.i) and stained for CD69, IL-4 
and IFN-y expression. The analysis of the T cells revealed a lower level of CD69 
positive cells than with PMA/ionomycin with negligible expression of IFN-y (Figure
3.11.h). In contrast to PMA/ionomycin, when T cells were stimulated with anti- 
CD 3/CD28 and stained for CD69 and IL-4 only a few were CD69 positive and, of 
those, no CD69/IL-4 double positive cells were detected (Figure 3.ii.i).
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Figure 3.ii. CD69, IL-4 and IFN-y expression in response to anti-CD3/CD28 or 
PMA/ionomycin
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Figure 3.ii(a) gated lymphocyte region. 3.ii(b and e) represent isotype-matched controls for CAED (6) T cells 2 x 105 
stimulated with PMA [50ng/ml] with ionomycin [1 pg/ml] (c, d and f, g respectively). Figures 3.ii h and i show VKC 
(5) cells stimulated with anti-CD3 mAntibody [10ng/ml] and anti-CD28 [2.5ng]. Figures b, c and d results from one 
experiment and e - i from another (one of three) experiments performed under identical concfitions utilising the same 
cell line.
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3.2.4 Differential Cytokine Responses
The aim of the experiments conducted, with the results provided below was to 
investigate of differential CD4+ and CD8+ T cell surface marker expression in response 
to different methods of stimulation.
The lymphocyte region was gated for analysis of T cell surface markers and the 
cytokine expression by cells within the gate is illustrated in Figure 3.iii.a For 
background staining to set quadrants, isotype-matched control antibodies were added to 
cells (data not shown) and compensation settings were obtained using single positive 
control samples for each stain. The dot plot illustrated in figure 3.iii.b represents 
unstimulated CAED (1) T cells, with negligible levels of IFN-y expression from both 
CD4+ and CD4' (CD8*) T cells. Similarly, a lack of IL-4 expression was observed in 
unstimulated T cells stained for CD4+ and CD4‘ (CD8+) (data not shown). The CAED 
(1) T cell line examined showed clearly defined CD4+ and CD8+ populations. Dot plots 
in Figures 3.iii.c. and 3.iii.d illustrate the cytokine expression from the same AKC-PB 
derived T cell line, stimulated for 6 hrs with PHA and irradiated J-Y feeder cells, again 
showing the proportions of IL-4 and IFN-y cytokines expressed in terms of clearly 
defined CD4+ and CD4‘ (CD8*) T cells. Similar levels of cytokines were expressed by 
the CD4' and CD4+ T cells for both IFN-y and DL-4 (Figures 3.iii.c and 3.iii.d). 
Cytokine expression from the same CAED (1) T cell line in response to stimulation 
with PMA/ionomycin showed that the majority of T cells, stained with anti-CD4 mAb, 
were CD4' suggesting all were CD8+ T cells (Figures 3.iii.e and 3.iii.f) and a 
downregulation of surface CD4 (experiment repeated on 3 separate occasions). 
Subsequent experiments in similar conditions were conducted in triplicate, staining the 
same cell line as used in Figures 3.iii.a -  3.iii.f, using CD8+ as a T cell marker, as 
several researchers had reported a down-regulation of CD4+ expression following 
stimulation with PMA/ionomycin. This method of analysing CD8‘/CD8+cells revealed a 
slightly higher proportion of the T cells being CD8+ with almost half of the cells being 
IFN-y7CD8+ double positive (Figure 3.iii.g). Similarly, of the CD8‘ cells, 
approximately half were IFN-y7CD8‘ double positive T cells (Figure 3.iii.g). Lower 
though similar levels of IL-4 were detected on both CD8‘ and CD8+ T cells (Figure 
3.iii.h).
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Figure 3.iii. Differential Cytokine Responses
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Figure 3.iii.Represent dot plots generated from CAED (1) T cell line with 3.iii.a showing the gated 
lymphocyte region. 3.iii.b -  3ii.h  represent 2 x 105 CAED (1) T cells. 3.iii.b unstimulated cells. 3.iii.c-3.iii.d 
show cells stimulated with PHA [lpg/ml], 3.iii.e-3.iii.f cells stimulated with PMA [50ng/ml]/ionomydn 
[1 pg/ml] all stained with CD4+ T cell ma’ker. 3.iii.g-3.iii.h illustrate T cells stimulated with PMA/ionomycin 
utilising CD8* T cell surface marker. Each dot plot figure is representative of triplicate experiments 
showing similar results.
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Figure 3.iii. Differential Cytokine Responses
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Figure 3.iii.Represent dot plots generated from CAED (1) T cell line with 3.iii.a showing the gated 
lymphocyte region. 3.iii.b -  3.iii.h represent 2 x 105 CAED (1) T cells. 3.iii.b unstimulated cells. 3.iii.c-3.iii.d 
show cells stimulated with PHA [lpg/ml], 3.iii.e-3.iii.f cells stimulated with PMA [50ng/ml]/ionomydn 
[lpg/ml] all stained with CD4+ T cell marker. 3.iii.g-3.iii.h illustrate T cells stimulated with PMA/ionomydn 
utilising CD8+ T cell surface marker. Each dot plot figure is representative of triplicate experiments 
showing similar results.
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3.2.5 Time course and mode of T cell stimulation
The aim of these experiments was to optimise the length of stimulation of T cell lines 
with relation to the expression of cytokines IL-4 and IFN-y, in response to various 
stimuli, over two different time points, as shown in figure 3.iv.
Results in Figure 3.iv. show the mean percentages of IL-4 and IFN-y expression at 6 hrs 
post stimulation as compared to 24 hrs, comparing each of the three forms of T cell 
stimulation using ttp-specific T cell line (2) conducted on three separate occasions. 
There were higher numbers of cytokine expressing cells at 6 hrs with each form of 
stimulatioa Levels of expression of both IFN-y and IL-4 were significantly greater at 
die 6 hrs time-point as compared to the 24 hrs time-point following stimulatioa Results 
comparing the cytokine response to both ttp and PHA did not differ significantly for 
expression of either IFN-y or EL-4 at either timepoint.
The purpose of these experiments was to optimise the method of stimulation for T cell 
lines with relation to the expression of cytokines IL-4 and IFN-y, comparing stimulaton 
with ttp, PHA and PMA/ionomycin, as shown in figure 3.iv.
Cytokine expression overall was at its maximum when cells were stimulated with 
PMA/ionomycin, lower levels of expression were detected following stimulation with 
PHA and the lowest observed cytokine expression was observ ed in the ttp-specific T 
cell line (1) when stimulated with ttp, as illustrated in dot plots (Figure 3.v.) at 6hrs post 
stimulatioa Irradiated J-Y feeder cells were utilised in experiments where T cells were 
stimulated with PHA or ttp. Subsequent intracellular cytokine staining experiments 
were therefore carried out using PMA/ionomycin to stimulate the cells for 6 hrs.
The expression of cytokines by T cells stimulated for 18, 20, and 44 hrs was also 
examined (data not shown). There was no upregulation of cytokine expression at these 
later time-points in comparison to those achieved at 6 hrs.
127
N. Akhtar PhD Thesis
Figure 3.iv. Time course and mode of T cell stimulation
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Figure 3.iv. Chart showing the mean v^ues (± SD) cytokine expression from ttp specific T cell line (2) in 
response to various stimuli. 2 x 105 ttp specific T cells with 4 x 105 J-Y feeder cells in the samples were 
stimulated with ttp [5pg/ml], PHA [1ng/ml]. The T cell line (ttp 2) cells were also stimulated with PMA 
[50ng/ml]/ionomycin [1pg/mi]. Open bars, filled bars and hatched bars represent cells stimulated with ttp, 
PHA and PMA/ionomycin respectively. Error bars represent means from triplicate experiments ± S.D. 
Results shown are % expression of cytokines having subtracted background staning (unstimulated cells). 
Statistical significances comparing the cytokine expression between the 6 hrs and 24 hrs time points 
denoted* 0.01.
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Figure 3.v. Dot plots representing modes o f T cell stimulation 
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Figure 3.v. Dot plots representing the expression of IL-4 and IFN-y from ttp cell line (1) stimulated with 
specific antigen ttp [5jag/ml], PHA [1p^ml] and PMA/ionomycin [50ng/ml/1jj.<yml] and cell surface marker 
CD8PerCP. Dot plots shown are representative of one of three experiments conduced.
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3.3 Discussion
The assessment of intracellular cytokines at the single-cell level by flow cytometry has 
become a potent tool in many areas of cell biology and in defining the role of cytokines 
in various human diseases (Baran et al, 2001). The application of the intracellular 
staining technique was employed for much of die research included in this thesis. This 
was the main method chosen to analyse the phenotype of T cells (CD4+/CD8+) on die 
basis of intracellular cytokines expressed, following the methods first described by Jung 
et al (1993) as well as in conjunction with other T cell surface characteristics. This 
technique was adopted to monitor the levels of cytokine synthesized within the cell in 
contrast to cytokines secreted as had previously been investigated by ELISA in CAED 
and TAO (Calder et al, 1999; Pappa et al, 1997 for CAED and TAO respectively). 
However, both of these studies had assayed cytokine production from bulk cultures 
rather than at a single cell level. The assessment of multiple c>1okines being expressed 
by individual cells, in conjunction with other cell surface markers is valuable in 
investigations of human diseases such as CAED and TAO, where the source of the 
cytokine is important to determine.
Prior to employing this technique routinely several parameters had to be optimised, and 
the purpose of this chapter was to describe the various strategies adopted to optimise the 
intracellular staining technique. For each experiment conducted throughout this chapter 
the level of background staining was determined using isotype-matched control 
antibodies which were added to cells and compensation settings were obtained with 
single positive control samples for each fluorescent marker. In most experiments 
isotype-matched controls were not shown due to having multiple dot plots in each 
figure, and displaying all would have impacted on the size of the dot plots hence the 
quality/legibility of the figures. However the isotype-matched controls were shown in 
figure 3ii. to clarify why the gates are different between histograms 3iic versus 3iid.
Experiments carried out early in the study analysed the expression of CD69, as an 
indicator of cellular activation. It was observed that there was a positive correlation 
between cellular activation and expression of intracellular cytokines. Hence, as the 
purpose of the study was to identify T cell cytokine profiles in CAED and TAO T cell 
lines, cells were stimulated with PMA in further experiments, stained and analysed for 
intracellular expression of IFN-y and EL-4 along with a T cell surface marker to identify
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T cell populations. This technique enabled us to identify the cytokine response of the 
stimulated T cells and their subsets.
The first issue addressed was the feasibility of using J-Y feeder cells (Palmer and van 
Seventer, 1997) as an alternative to autologous feeder cells due to the limited 
availability of autologous PBMCs for the established T cell lines. The use of irradiated 
autologous feeder cells when stimulating cells with ttp and PHA showed no significant 
differences (see section 3.2.1 table 3a) in levels of IL-4 and IFN-y being expressed in 
comparison with J-Y feeder cells, hence, were used in the remainder of experiments 
when feeder cells were required. Irradiation of murine A20-HL B cell lymphoma cells 
was shown to up-regulate CD80 (B7-1) expression, a costimulatory molecule (antigen- 
non-specific) required for optimal T cell responses. The expression of CD80 is 
enhanced by the induction of TNF-a expression and CD 154 (CD40L), resulting in 
enhanced antigen-presenting ability. This phenomenon of irradiation induced CD80 is 
not exclusive to the A20-HL lymphoma cells and has been reported to occur in other 
tumour cell lines that have been maintained in vitro, such as the MOPC315 
plasmacytoma and P815 mastocytoma lines (Torihata et al, 2004), and is likely to occur 
in J-Y cells too. The autologous PBMCs were only used to generate polyclonal T cell 
lines (PHA-driven) to establish PHA T cell lines following at least 3 passages rather 
than using these cells as a source of feeder cells.
Different methods of stimulating T cells were compared to ascertain which would be the 
best in terms of optimising the levels of cytokine expressioa Initial experiments in 
which the T cells were stimulated with anti-CD3/anti-CD28 were carried out as an 
alternative mode of T cell stimulation which lacked the need for feeder cells. T cell 
cytokine expression generated in response to stimulation with anti-CD3/anti-CD28 
compared to stimulation with PMA/ionomycin was investigated to assess cytokine 
levels generated, since both modes of stimulation lacked the requirement of feeder cells. 
However, T cells stimulated with anti-CD3 in combination with anti-CD28 generated 
lower levels of intracellular cytokines and lower expression of die cellular activation 
marker CD69 in comparison to levels generated in response to stimulation with 
PMA/ionomycin. Importantly, the phenotype of the T cells in terms of cytokines 
expressed remained the same (Thl) comparing the two forms of stimuli. The IFN-y.IL- 
4 ratio differed using the differential modes of stimulatioa It was 2:1 in response to 
stimulation with anti-CD3 mAb whereas with PMA/ionomycin the ratio was 5:1. This
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suggests that IFN-y is preferentially upregulated compared to IL-4 in response to 
PMA/ionomycin, though this finding does not pose a problem as the Thl or Th2 
phenotype of the cell lines is retained whichever mode of stimulation is employed.
Anti-CD3mAb was initially used to identify T cells. However as it was desirable to 
compare cytokine expression in terms of CD4+ and CD8+ T cell subsets the T cell 
surface markers anti-CD4 or anti-CD8 mAbs were used. Experiments in which T cells 
were stimulated with PMA/ionomycin used the anti-CD8mAb due to the down- 
regulation of CD4 expression during stimulation (Neudorf et al, 1991). Another study 
by Baran et al (1991) reported that stimulation with PMA/ionomycin caused prominent 
alteration to cell morphology and membrane expression of CD4 as well as CD 14. This 
study also compared the expression of several intracellular cytokines in PBMCs of 
healthy donors in response to stimulation with PHA and PMA/ionomycin. They found 
that the frequency of PBMCs stained for TNF-a and IFN-y after 6 hrs of activation was 
higher when PMA/ionomycin was used, whilst the frequencies of cells positive for IL-4 
were similar in both.
Finally following many experiments using different T cell lines stimulated at different 
time points and with different modes of stimulation it was deduced that the optimal time 
point for stimulating T cells was 6 hrs and the optimal method of stimulation was with 
PMA/ionomycin. Regardless of the method of stimulation of T cell lines it was 
observed that there was no alteration in the phenotype, in relation to cytokine profiles. 
This can be seen in Figure 3.v. whereby the T cell line displays a Thl phenotype, with 
an expression of IFN-y when stimulated with either ttp, PHA or PMA/ionomycin and 
negligible expression of IL-4. What may be observed is that stimulation with 
PMA/ionomycin enhances the levels of cytokine expression whether the T cells are of a 
ThO, Thl or a Th2 phenotype. Many other groups using the intracellular cytokine 
staining technique have utilized PMA/ionomycin stimulation of T cells for 6 hrs 
(Bladon et al, 2003).
As one of the aims of this thesis was to identify T cells in terms of Thl and Th2 cells in 
relation to cytokine profiles expressed: classification into ThO, Thl and Th2 was done 
using the criteria as outlined in section 1.6 (chapter 1). Within this chapter I only 
looked at IFN-y and IL-4 as a means of Th cell classificaton. This may be seen as a 
weakness, and if more cells had been available. I would have checked for a wider range
132
N. Akhtar PhD Thesis
of cytokines including IL-10. Nevertheless, since IFN-y and IL-4 were used as markers 
for Thl and TTi2 cells, the main focus, of experiments included in this chapter, was on 
optimising experimental techniques, such as feeder cells, mode and time of T cell 
stimulation, for the expression of these cytokines.
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4.1 Introduction
The extra-ocular diseases chronic allergic eye disease (CAED) and thyroid associated 
ophthalmopathy (TAO) have several common immunopathological features. Both TAO 
and CAED are associated with a localised CD4+ T cell infiltration (Pappa et al, 1997; 
Calder et al, 1999) and a high risk of visual impairment is linked with TAO, AKC and 
VKC, along with systemic immune abnormalities (Hoang-Xuan et al, 1997; Leonardi, 
et al, 1999). Hence both TAO and CAED may be classified as immune-mediated 
inflammatory diseases.
CAED describes a group of immune-mediated inflammatory conjunctival conditions 
having several shared characteristics and symptoms. Individuals with AKC and VKC 
have an increased prevalence of atopy and suffer from itching, a stringy discharge and 
the formation of giant papillae in the tarsal (upper eye-lid) conjunctiva in VKC. 
Immunohistologically there are increased levels of CD25+ CD4+ T cells, HLA-DR 
expression, eosinophils and neutrophils in the sub-epithelial layers of conjunctival 
tissues. The term CAED, in this thesis, is the collective term used to describe patients 
with AKC, VKC and GPC, all involving CD4+ T cells (Ehlers and Donshik 1992). Of 
the CAED conditions GPC is not associated with atopy but is clinically and 
histologically similar to VKC, it is benign, reversible with no comeal involvement 
(Calder etal, 1999).
AKC is related to both type I and type IV hypersensitivity reactions (Power et al, 1998). 
IgE levels have been shown to be elevated in both serum (Power et al, 1998) and tears 
(Tauber et al, 1998) in patients with AKC. Conjunctival biopsy results reveal several 
abnormalities such as mast cell and eosinophil infiltration of the epithelium, an increase 
in number of goblet cells, mononuclear cell infiltrates, macrophages, Langerhans cells 
with increased MHC class II molecules on die epithelium along with an enhanced 
number of activated T cells (Power et al, 1998) and inflammatory cytokines. It is the 
most severe and chronic form of CAED and is always associated with atopy. AKC is 
more autoimmune with Thl-like locally, in the eye, and is always associated with 
asthma or atopic dermatitis, thus having a Th2 component, whereas VKC is not.
The pathophysiology of VKC is linked with chronic or recurrent type I hypersensitivity 
responses along with type IV DTH reactions (Bleik and Tabbara, 1991). 
Histopathological studies have revealed the presence of T cells, mast cells, eosinophils 
and basophils in the conjunctiva (Allansmith et al, 1979; Abelson et al, 1980).
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Elevated levels of eosinophils and IgE have also been detected in peripheral blood and 
tears of VKC patients implying systemic involvement, associated with atopy and not 
due to the eye involvement (Bonini et al, 1997). Clinical manifestations in VKC 
include itching, redness, tearing, papillae, and plaque formation (Caldwell et al, 1992). 
The white plaques, seen in severe cases, result from an accumulation of eosinophils and 
epithelial cells (Smolin and O’Conner, 1986). Other symptoms include pain or foreign 
body sensation, photophobia, blurred vision and stringy mucus discharge. Th2 cells 
also play a role in VKC and increased levels have been observed in tears from these 
patients (Avunduk et al, 1998) and in conjunctival tissue (Allansmith and Ross, 1988). 
The giant papillae found on die upper tarsal conjunctiva in VKC consist of dense 
fibrous tissue (connective tissue hyperplasia) along with eosinophils, mast cells, 
basophils, polymorphonuclear leukocytes, lymphocytes and macrophages (Friedlander, 
1992).
GPC is not associated with atopy but is associated with contact lens and prosthetics 
usage. Clinically and histologically it is similar to AKC and VKC, but lacks comeal 
involvement and the risk of visual impaiment GPC is thought to occur due to multiple 
factors such as mechanical trauma and an immune response to the antigen coating the 
contact lens, in genetically predisposed individuals (Donshik, 1994) and DIH responses 
(Allansmith, 1990). The antigen coating of the lens mechanically aggravates the tarsal 
conjunctiva with each blinking action which has been suggested to lead to die release of 
mediators such as neutrophil and eosinophil chemotactic factors and the subsequent 
accumulation of inflammatory cells (T cells, neutrophils, basophils, mast cells, 
eosinophils). It is thought that the immunological recognition of antigen results in the 
increase of IgE, IgG and the anaphylatoxin C3 in the tears that then interact with their 
appropriate receptors on the inflammatory cells causing the release of vasoactive amines 
and cytokines contributing to the localised oedema and cellular infiltration (Ehlers,and 
Donshik, 1992). The perpetuation of the chronic inflammation observed in CAED is 
predominantly mediated by CD4+ T cell activation. The immunopathology in AKC 
and VKC is not treatable with mast cell inhibitors alone and generally requires the use 
of CsA and steroids which strongly implicates the disease association with T cells.
In TAO the eye muscle and retroorbital (RO) fatty tissue are two major sites of 
lymphocytic infiltrate (Hiromatsu et al, 2000). Histological examination of RO tissues 
from TAO patients demonstrate mononuclear cell infiltration consisting mainly of 
activated T cells along with a few B cells, macrophages and mast cells (Forster et al,
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1998). Common to both the EOMs and orbital fat/connective tissue is the orbital 
fibroblast, which when activated results in the activation of GAGs causing oedema and 
the subsequent the enlargement of EOMs (Pappa et al, 2000). Expanded tissue volume 
within the orbit of TAO may be measured in computed tomography (CT) scans taken of 
patients’ orbits. Some patients appear to have enlarged extraocular muscles as the 
predominant anatomical change. Others display little eye muscle involvement but show 
greatly increased orbital adipose tissue volume (Prabhakar et al, 2003).
The phenotypes of T cells infiltrating EOM and establishing T cell lines from EOM 
biopsy and peripheral blood T cell lines were studied to determine the cytokine profiles 
of TAO patients (Pappa et al, 1997). Most of the cells were characterised as CD4+, 
CD45RO+, all of which expressed activation markers HLA-DR and CD25. T cell 
cytokine profiles, following antigenic stimulation, were determined by ELISA and RT- 
PCR. A range of cytokines were investigated using specific oligonucleotide probes, for 
IL-la, ILl-p, IL-2, IL-4, IL-6, EL-8, IL-10, IL-12, IL-13 and EL-15. Results using 
tissue-reactive (EOM and a TSH receptor preparation) T cells in EOM suggested that 
when stimulated, the T cells produced a mixture of cytokines including IL-4 in the 
majority of T cells (60% biopsy and 75% from PBMCs) IFN-y (100%) from all lines, 
IL-10 in most T cells (100% in biopsy with 50% in PBMCs) and TNF-p was also 
commonly found (56% biopsy and 75% of PBMC lines). Overall these results indicated 
a heterogeneous T cell population (Pappa et al, 1997), perhaps reflecting that these were 
polyclonal T cell lines that had not been cloned.
Another study analysing 117 T cell clones established from orbital adipose/connective 
tissue, indicated a relationship between disease duration and the predominant Th subset. 
They postulated that Thl responses predominate in recent onset TAO whereas in the 
later stages Th2 subsets predominate (Aniszewski et al. 2000). Recently a review on 
the immunological mechanisms of orbital inflammation in TAO, by Ludgate and Baker 
(2002) reported that the clinical presentation of TAO is varied. These authors claimed 
that a large proportion of patients have increased orbital fatty connective tissue without 
muscle enlargement and further hypothesised that increased fatty tissue occurs among 
the most extreme cases with a Th2 response. Ludgate and Baker’s findings were based 
solely on T cells derived from orbital fat whereas our studies have focussed on T cells 
derived from EOM from which we have observed a heavy infiltration of T cells, hence 
has been a focal part of our studies. It has been reported that muscle enlargement and 
swelling is foUowed by Thl associated fibrosis. Other studies attempting to
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characterise the cytokine profiles secreted by orbital-fat-infiltrating T helper (CD4+) 
cells in TAO have reported a mixture of cytokine responses which include some 
reporting Thl-type responses (Hiromatsu et al, 2000) others observing Th2-tvpe 
response (McLachlan et al, 1994) and a ThO-like response has been reported (Grubeck- 
Loebenstein, 1994). It must be noted that many studies investigating TAO analyse 
orbital fat cellular infiltrate as the muscle is less accessible.
Other groups have found a significant increase of macrophages and infiltration of T 
cells in the early stages of TAO compared to later stages of the disease and when 
compared to control EOM (Pappa et al, 2000). A central role for T cells in TAO has 
been implied by several studies identifying a restricted TCR V region gene expansion in 
orbital connective fatty tissues and pretibial tissue of patients with active TAO (Davies 
et al, 1991). The activation of T cells and the local release of cytokines such as EFN- 
y are thought to be crucial to the disease process and hence their downregulation is 
likely to be helpful in the early stages of die disease (Pappa et al, 2000).
Despite the disparate clinical features and etiologies, both CAED and TAO involve 
extensive fibrosis, collagen deposition and tissue remodeling as part of their late-stage 
chronic inflammatory processes. During clinically active TAO, fibroblast activation 
occurs probably due to the presence of proinflammatoiy cytokines (Koumas et al, 
2002) resulting in secretion of an array of cytokines including IL-1, IL-6 and 
granulocyte macrophage-colony stimulating factor (GM-CSF). Thus stimulated 
orbital fibroblasts proliferate and secrete GAGs (Smith et al, 1991) in particular 
hyaluronan, which contributes to the oedema and, consequently, fibrosis of the 
extraocular muscles, leading to limited ocular movements (Bednarczuk et al, 2002). In 
CAED, fibroblast activation results in collagen deposition and tissue remodeling 
within the conjunctival tissues. In addition, it has recently been found that it is the 
conjunctival fibroblasts, as opposed to epithelial cells, that secrete eotaxin following 
cytokine activation, suggesting their role in recruitment of eosinophils and other 
inflammatory cells (Leonardi et al, 2003).
The basic immunopathogenic mechanisms involved in CAED and TAO remain unclear 
but in both, T cells are known to play important immunopathogenic roles. This chapter 
aims to investigate the cytokine profiles from PB T cells in both the immune-mediated 
eye diseases studied in parallel with controls, with a view to identifying skewed Thl 
and Th2 cytokine responses among these PB T cell lines as representatives of localised
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cytokine-expressing T cells. The methods utilized to determine cytokine profiles 
include the intracellular cytokine staining technique compared with ELISA to detect 
cytokine productioa
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4 .2  R esults
4.2.1. IL-4 and IFN-y expression from PB T cell lines
The aim of these experiments was to compare IL-4 and IFN-y expression in different 
groups of T cell lines.
Following the expansion of TAO, (T cell lines 1 -  5), CAED (CAED 1, CAED 2, 
CAED 3, CAED 4, CAED 5, CAED 6 and CAED 7) and control T cell lines (1 -  6), to 
sufficient numbers for the intracellular cytokine staining technique, cells were 
stimulated with PMA/ionomycin prior to staining. Results are expressed as the mean % 
cytokine staining ± S.E.M. of 5 TAO and CAED T cell lines and 6 control T cell lines 
as illustrated in Figure 4.i. Comparing CAED to control and TAO there were 
significant (p ^0.01) and highly significant (p< 0.001) decreases in the levels of 
expression of IFN-y+ CD4+ cells, respectively. When comparing the TAO and control 
T-cell lines for IFN-y expression by CD4+ cells there was no significant difference. 
These results suggest that the TAO T-cell lines are more Thl-like than the CAED.
The percentages of IL-4 expression were determined with the same cell lines, as shown 
in Figure 4.i. with CAED CD4+ T cells expressing significantly greater levels of IL-4 
than both TAO and control CD4+ T cells (p<0.01). There was no significant difference 
between TAO and control T cell CD4+ IL-4 expression. The CAED CD4+ T cell lines 
displayed a more a Th2-type cytokine response.
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Figure 4.i.
80 n
CAED TAO Controls
Figure 4.i. Mean IFN-y and IL-4 expression from CAED (n=5:CAED T cell lines: CAED 1, 2, 3, 4 and 5), 
TAO (n=5: cell lines TAO 1, 2, 3, 4, 5) and control T cell lines (cell lines 1-6) following 6 hrs stimulation 
with PMA [50n<^ml]/ionomycin [lpg/ml]. Mean % for cytokine expression from triplicate experiments 
shown with ±  SEM following the subtraction of cytokine levels (nominal 0 - 0.8%) observed in unstimulated 
controls. IFN-y open bars, IL-4 filled bars, significant values denoted with * p< 0.01 and • p< 0.001, 
statistical analysis performed using Mann Whitney non-parametric test.
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Results obtained after intracellular cytokine staining for IFN-y and IL-4 expression from 
the individual CD4+ T-cell lines from CAED, TAO and controls are illustrated in Figure
4.ii. From CAED CD4+ T-cell lines, four out of five CD4+ T-cell lines displayed 
significantly greater levels of IL-4 compared to IFN-y expression (p < 0.01). Two of the 
four CAED CD4+ T cell lines expressed IL-4:IFN-y with a ratio of at least 2:1, 
respectively, and we classified them as being Th2-like. Three of the CAED T cell lines 
expressed similar levels of IL-4 and IFN-y. Two out of the three CAED patients from 
whom T cell lines had been expanded displayed mixed heterogeneous cytokine profiles 
with higher expression of IL-4 and IFN-y. The mixed cytokine profiles in these two cell 
lines (CAED 1 and CAED 2) were observed from the cell lines derived from patients 
that had previously been treated with steroids. One ThO line producing low levels of 
both IL-4 and IFN-y was observed from a GPC cell line (CAED 7). The VKC cell line 
(CAED 5) T cell line showed a predominance of IL-4 compared to IFN-y.
Of the TAO CD4+ T-cell lines, shown in Figure 4.ii., all five expressed significantly 
greater (p < 0.01) levels of IFN-y compared with IL-4. Four of the five TAO CD4+ cell 
lines expressed IFN-y:IL-4 at a ratio of at least 2:1, and were classified as Thl -like. One 
TAO line expressed similar levels of IFN-y and EL-4 so was classified as being mixed 
heterogeneous. All five TAO T cell lines were obtained from patients that were 
untreated for the condition at the time of the study. The cell line expressing 99% IFN-y 
with no IL-4 was expanded from a patient that had TAO for a duration of 14 years (the 
longest time the disease had been prevalent, without treatment amongst the T cell lines 
examined in this study).
For CD4+ T-cell lines from control subjects shown in Figure 4.ii., all of the 6 lines 
expressed significantly greater (p < 0.01) levels of EFN-y compared to IL-4. All six T 
cell lines had EFN-y:IL-4 at a ratio of at least 2:1 and, therefore, were characterised as 
having a Thl phenotype.
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Figure 4.ii. IFN-y and IL-4 expression from individual CAED, TAO and control T cell lines.
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Figure 4.ii. Represents IFN-y and IL-4 expression from individual CAED, TAO and Controls CD4+ T-cell 
lines respectively, following a 6 hrs stimulation with PMA [50ng/ml] and ionomydn [lpg/ml]. Cytokine 
expression levels shown above represent values obtained following the subtraction of cytokine expression 
observed from unstimulated controls
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4.2.2. Cytokine expression from CD8+ and CD4+ T cells.
The aim of these experiments were to compare the patterns of cytokine expression from 
CD4+ and CD8+ from CAED, TAO and control groups.
The previous section concentrated on examining cytokine expression in CD4+ T cells. 
Results shown in this section look at cytokine expression from CAED, TAO and control 
CD8+ T cells compared to CD4+ T cell cytokine levels expressed by each of the groups. 
In all 4 of the TAO lines the CD8+ T cells showed significantly greater expression of 
IFN-y (p< 0.05) than IL-4. Of the four TAO T cell lines containing CD8+ T cells, two of 
the cell lines displayed a ratio of at least 2:1 (IFN-y:IL-4) and were categorised as Tcl- 
like. One of the TAO lines lacked the detection of CD8+ subset of T cells, and was 
defined as a Thl-like line from the levels of IFN-y:IL-4 expressed by the CD4+ cells. 
Of the four TAO lines containing CD8+ T cells, 3 expressed significantly greater levels 
of IFN-y than the CD4+ T cells (Thl).
Three out of the five CAED T cell lines consisted of CD4+ T cells expressing greater 
levels of IL-4 than IFN-y (Table 4.a) and of these, two expressed IL-4: IFN-y at a ratio 
of greater than 2:1. Of the CD8+ control T cell lines analysed, five out of six expressed 
significantly greater levels of IFN-y as compared to IL-4 (p< 0.01). Of these, 4 
expressed IFN-y:IL-4 at a ratio of at least 2:1 and therefore were categorised as Tcl- 
like. The other two control lines (2 and 4) had similar levels of IFN-y and IL-4 and so 
were considered as having mixed heterogeneous cytokine profiles (Th)). Five of the 
control cells lines expressed significantly (p^0.05) greater levels of IFN-y from the 
CD8+ T cells compared to the CD4+T cells (Thl).
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Table 4.a. Cytokine expression from CD4+ CD8+T cells
Cell lines % CD4+ % CD4+ % CD8+ % CD8+
IFN-y+ IL-4+ IFN-y+ IL-4+
1 98.7 2.9 - -
5 52.4 11.19 94.7 6.9
O
£
4 35.3 21.2 39.2 15.4
3 56.5 26 93.6 61.7
2 50.7 44.8 86.2 69.0
5 14.9 60.3 12.8 51.6
Q
2 46.5 52.6 46.9 53.2
w
< 1 15.3 31.6 27.5 28.2u 7 16.4 15.1 20.8 7.6
3 29.4 67.5 80.7 49.5
3 62.1 19.1 74.7 23.4
4 66.6 15.4 30 33.0
I 1 87.3 33.7 91.9 14.9
s©
U
2 64.5 41.3 85.5 61.8
5 41.8 10.5 84.9 12.5
6 41.6 9.4 71.6 10.6
Table 4 a  IFN-y aid IL-4 expression from individual PB-derived T cell lines from TAO (n=5), CAED (n=5) 
and controls (n=6). Cytokine expression by CD4+ and CD8+ T cell subsets was expressed as % (cytokine 
positive cells in the subset divided by the total number of cells in each subset), following 6 hrs stimulation 
with PMA [50ng/ml] with ionomydn [1 pgfml].
In figure 4.iii.dot plot ‘a’ represents the gated lymphocyte region with dot plot ‘b \ 
representative of unstimulated T cells showing the CD8 levels. Isotype matched 
controls were used to set quadrants illustrated in dot plots (c -  e). Dot plots of cell line 
TAO 5 (Figure f  and g) highlights a skewing of cytokines towards a Thl-like response 
with cytokines IFN-y: IL-4 ratio on both CD8+ and CD4+ T cells of approximately 5:1, 
respectively. Th2-like dot plots of CAED cell line 1 (.h and i) highlights a skewing of 
cytokines towards a Th2-like response with IL-4:IFN-y ratios from both CD8+ and 
CD4+ T cells being greater than 5:1. Dot plots of a GPC T cell line (GPC 4) 
demonstrated it as non-polarised ThO type, with low levels of both IL-4 and IFN-y, with 
5% double positive cells, as illustrated in dot plot.
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Figure 4.iii. Analysis of T cell lines in terms of Thl/Tcl, Th2/Tc2 and non-polarised 
ThO cells.
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Figure 4.iii. a. Gated lymphocyte regon. b. Cytokine expression from unstimulated T cells. Dotplots c. d. 
and e. represent isotype matched controls used to set quadrants. Dot plots f. and g. represent IFN-y and 
IL-4 expression from a T cell line classified as being Th1 (TAO line 5). Th2 (CAED 1) dot plots shown in 
figures h. and i. Th1 and Th2 classifications were made on the basis of cytokine levels observed on CD& 
T cells. Figure j. (CAED 7) represents non-polarised T cells with low levels of T cells double-positive for 
both IL-4 and IFN^ y. All experiments were conducted following 6 hrs stimulation with PMA 
[50ng/ml]/ionomycin [1 ptg/ml] and each experiment was repeated at least three times.
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4.2.3 Cytokine production from CAED, TAO and control T cell lines
The objective of these experiments was to measure cytokine production by ELISA in 
the CAED, TAO and control T cells line supernatants to assess whether there is a 
skewing of cytokines observed to that observed with the intracellular cytokine staining 
technique.
The T-cell lines examined for intracellular cytokine expression were also assayed by 
ELISA for IL-2, IL-4 and IFN-y cytokine production. Results shown in Figure 4.iv. (A) 
represent the mean levels of IL-2 production from quadruplicate readings from 2 
experiments. Upon stimulation, IL-2 levels were significantly upregulated in all three 
groups, with at least a three-fold increase in IL-2 in all three groups. However basal IL- 
2 levels were high, reflecting the high activation status of these cells pre-stimulation. 
The basal levels of IL-2 production in the CAED group were significantly higher when 
compared to the control and TAO groups (p< 0.05).
For IFN-y production (Figure 4.iv. (B)) IFN-y levels were highest in the CAED group 
from stimulated cells though there was no significant difference when compared with 
basal levels. IFN-y production from the TAO and CAED groups was significantly 
increased when compared with the control group (p< 0.05).
Levels of IL-4 production (Figure 4.iv. (C)) were significantly upregulated following 
stimulation in all three groups. Basal levels of IL-4 were significantly higher in the 
CAED group compared to TAO (p< 0.01) and CAED (p< 0.001) than controls.
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Figure 4.iv.
A
Control TAO CAED
Figure 4.iv. Cytokine production as detected by ELISA in 24 hrs culture supernatants from 
T cells either unstimulated or stimulated with PMA[50ng/ml]/ ionomydn[1 jig/ml]. Results 
are shown as mean cytokine levels [ng/ml or pg/ml] ± SEM, for unstimulated cultures 
(open bars) and stimulated cells (filled bars) for control lines (1-6), TAO lines 1-5 and 
CAED lines: 1,2,3, 4,5. Levels of significance are shown as 0 p< 0.05, * p< 0.01 and 
•  p< 0.001 in comparison with controls.
148
N. Akhtar PhD Thesis
4.3 Discussion
In this chapter, I investigated the cytokines expressed and produced from PB T cell lines 
from two different forms of immune-mediated eye diseases, CAED and TAO compared 
to control T cells. The five CAED T cell lines were made up as follows: 3 AKC, 1 
VKC and 1 GPC. The three AKC T cell lines all displayed a predominance of Th2- like 
cytokine expression with higher levels of IL-4 in comparison with EFN-y, however all 
the AKC lines expressed varying amounts of IFN-y with CAED 2 cell line expressing 
similar levels of both IL-4 and IFN-y. The GPC line (CAED 7) displayed a ThO—like 
phenotype with similar, but low, levels of Thl and Th2 cytokine expression. The VKC 
T cell line (CAED 5) expressed significantly higher levels of Th2 compared to Thl 
cyokines. It is of interest that elevated Th2 cytokines levels were found to be expressed 
from all CAED T cell lines (5/5) derived from patients with atopy and hence not 
surprising that a predominance of Th2 cytokines were detected in PB as the VKC and 
AKC individuals have systemic atopic disease therefore elevated Th2 levels in the 
blood. This association of systemic disease component in AKC and VKC would 
explain the cytokine profiles in the observed in blood. Localised, conjunctival AKC, T 
cell cytokine production has previously been reported to display increased levels of 
IFN-y CD3+ T cells compared to IL-4 (Calder et al, 1999). The patterns of CD4+ and 
CD8+ expression in most of the TAO and CAED T cells displayed a prevalence of Thl 
and Tcl+ and Th2 Tc2+ cells in TAO and CAED T cells respectively. Conjunctival T 
cell cytokine production previously characterised from CAED patients, with Thl, Ih2 
and ThO type cytokines prevalence in AKC, VKC and GPC respectively. The control 
donors’ T cell lines (from non-atopic individuals) predominantly displayed a Thl-like 
response.
Previous work in our laboratory from bulk cultures of conjunctival T cells and EOM 
cells have identified the important role of Thl cells in CAED and TAO. Using 
intracellular cytokine staining the profiles of PB lines we have identified several T cell 
lines that are representative of localised tisuue, cytokine profiles previously reported. 
This correlation of PB T cell lines with localised EOM Thl cells was observed in all 5 
of the TAO donor T cells. Whilst there is not definitive explanation for such findings it 
enabled the utilization of these partially skewed T cell lines as in vitro models for 
cytokine manipulation studies.
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The results within this chapter have clearly demonstrated that there is considerable 
skewing of cytokine responses observed from T cells derived from peripheral blood, a 
non-specific disease site when activated polyclonally with a non-disease related 
stimulus. The aim in this chapter was to identify PB T cells lines with skewed cytokine 
profiles and to utilize them as models for skewed cytokine profiles often observed 
locally in TAO and CAED as well as in various other disease states. Having identified 
the skewed PB lines the next stage will be to test the feasibility of in vitro cytokine 
immunomodulation. It is noteworthy that a correlation appears to exists between PB 
cytokine profiles and localised T cells in both TAO and VKC. However it is not being 
suggested that localised cytokine responses would be reflected in PB T cells. The study 
merely aimed to identify Thl and Th2 T cell lines as models as localised T cells are not 
always readily available and, wherever possible, to obtain localised ocular T cells 
limitations exist with the expansion of these lines to generate adequate numbers for 
multiple experiments. The main advantage of this system is that it avoids the 
requirement of obtaining precious localised cells and a specific antigen that has not been 
identified. It would be of immense value to compare the similarities of other cellular 
markers, apart from cytokines, between localised and PB T cells to ascertain whether 
comparisons may be drawn, and the function of the cells.
Several other researchers have studied, via intracellular cytokine staining, T cell 
cytokine expression in T cells derived from peripheral blood and have reported this 
method could help in providing a crude estimation of any cytokine imbalances (Makino 
et al, 1995). It is important to note that polarized disease states have characteristic 
alterations in subsets of memory CD4+ T cells which can rapidly be identified by flow 
cytometry on fresh blood samples with four-colour flow cytometry measuring CD4, 
CD45RA, CD62L and CDlla, (Mitra et al, 1999). This can be performed without 
stimulation or intracellular cytokine staining and is of potential use to assess changes in 
chronic disease that may lead to pathology or immunosuppression as a result of an 
imbalance of Thl and Th2 responses (Sher and Coffman, 1992).
Other researchers consider a shift of T cell cytokine expression pattern detectable from 
PB as being controversial. A study investigating the Th subset balance in PB of coeliac 
disease patients concluded that the increased shift towards a Thl response is mainly 
restricted to the actual site of inflammation and that circulating T cells do not show the 
same response. They postulated that this is probably due to low numbers of activated T 
cells in PB (Kertula et al, 1999). Also van der Graaf et al (1999) studying IL-4
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producing T cells in synovial fluid and peripheral blood of RA patients found that Thl 
cells preferentially home to inflamed joints and this did not result in an altered Thl/Th2 
ratio in the PB of RA patients.
It was observed that significantly greater levels of IFN-y by all CD4+ and most CD8+ T 
cells were expressed in TAO and control groups as compared to CAED T cells both 
CD4+ and CD8+. A recent review of TAO highlighted several studies demonstrating the 
presence of the Thl cytokine, EFN-y, in the orbit with no IL-4 or IL-5. Other studies 
identified predominantly Th2 cytokines (IL-4 or IL-5), whereas a third group indicated 
the presence of T cell clones secreting IFN-y, IL-4 and IL-10, hence a more ThO type 
response. In contrast another study revealed that Thl-like T cell clones were found to 
predominate with recent onset of disease whereas in the later stage Th2 cytokines may 
play an important role in late-stage fibrosis (Prabhakar et al, 2003). In this thesis it has 
been shown there is a predominance of a Thl-type response, in TAO, though there is 
also the expression of IL-4, at varying levels of expression, in all the PB T cell lines 
examined, with two lines displaying a more ThO like phenotype. This is likely due to 
PMA stimulation probably upregulating IL-4 expression in vitro even if it is not being 
produced in vivo. The expression of Th2 cytokines by localised TAO T cells has been 
reported in later stages of the disease by Prabhaker et al (2003). The TAO T cell lines 
in this study were all established from patients with active disease, but at a relatively 
earlier stage than in the Prabhaker et al study.
IFN-y is frequently detected in control T cells in response to stimulation with PMA/ 
ionomycin. A recent study to determine whether there is an association between 
intracellular cytokine profiles and the expression of surface antigens, was conducted 
utilising flow cytometry in 11 healthy volunteers. PB lymphocytes were stained for 
CD4+ or CD8+, as well as CD1 la, CD25, CD26, CD29 and CD45RA or the chemokine 
receptors CCR3, CCR4, CCR5 or CXCR3 and stimulated with PMA and ionomycin, 
and assessed for intracellular IFN-y and IL-4. It was concluded that CD4+CD29hi helper 
T cells and CD4+CXCR3+ cells were involved in the induction of IFN-y and TNF-a 
production, indicating both these CD4+ subsets consist mainly of Thl cells (Matsui et 
al, 2003). It may be of value to assess the Thl -type cytokines in future experiments and 
to assess whether there is any difference in the cellular markers, in terms of CD29W or 
CXCR3+ T cells at the site of disease compared with PB T cells and control localised 
and PB T cells.
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In contrast to TAO and controls, most CAED T cells (both CD4+ and CD8+ T cell 
subsets) expressed higher percentages of IL-4 expression. Although there was not a 
total skewing ie. 100% IL-4, this is to be expected as it is rare to get high IL-4, which 
would only be observed in cloned Th2 cells. Localised cytokine profiles in CAED have 
been studied by several researchers. A study analysing cytokine levels in tears, in terms 
of IFN-y, IL-2 and IL-4, measured by ELISA, concluded that Th2 cytokines were 
playing an important role in the pathophysiology in AKC and VKC and that the severity 
of atopic dermatitis correlated with tear IL-4 levels (Uchio et al, 2000). GPC, AKC and 
VKC have been reported as having similar cellular infiltrating phenotypes, with 
increased numbers of T cells and eosinophils and an increased level of IL-4 and IL-5, 
despite clinical differences (Trocme and Sra, 2002). However, in that study the source 
of the increased IL-4 was not investigated, and could have been mast cell-derived. In 
this study we have detected CD4+ and CD8+ T cell IL-4 cytokine expression, which 
might be representative of the localised events in CAED.
Another study utilized the method of in situ hybridization to identify cytokine 
messenger RNA (mRNA), and two-colour immunohistochemical analysis to investigate 
the immunoreactive cytokines localizing to T cells in the conjunctiva. Results showed 
greater expression of IL-2 and IFN-y in AKC tissues compared to VKC, whereas IL-5 
was found to be present more in VKC tissues. The study concluded that VKC and GPC 
cells displayed Th2-like cytokine profiles, whereas in the more chronic AKC there was 
a shift towards a more Thl-like cytokine profile which was accounted for by the 
different ways in which the diseases manifest, since VKC is chronic but has seasonal 
exacerbations (Metz et al, 1997). In this study it was observed that two CAED T cell 
lines had mixed cytokine profiles and these cells expressed both Thl and Th2-type 
cytokines to give a mixed heterogeneous profiles.
The advantage of using the intracellular cytokine method is that one may examine 
cytokine profiles in the context of CD4+ and CD8+ T-cell subsets. In most of the T cell 
fines there were both CD4+ and CD8+ T cells present and die polarization of cytokine 
expression was conserved on both CD4+ and CD8+ cells for most of the cell fines. This 
would suggest either that in vivo both T-cdl subsets are likely to be involved during 
disease or that the cytokine microenvironment favors a skewing of both T cell subsets. 
It can therefore be proposed that in CAED and TAO, Th2/Tc2 and Thl/Tcl cytokines 
respectively are elevated. Several investigators have observed a similar phenomenon in 
other pathological conditions (Austin et al, 1999).
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The intracellular cytokine expression following PMA stimulation highlighted the 
different disease-specific cytokine polarizations. In contrast, the cytokine levels as 
detected by ELISA demonstrated no overall difference between control, TAO and 
CAED following PMA/ionomycin stimulation. There were some differences in the 
baseline levels of cytokine production between the groups, indicative of the activation 
status of the cell lines prior to stimulation, but there was very little difference between 
the stimulated levels of IL-2, IFN-y and IL-4 produced from control, TAO and CAED 
T-cell cultures. This is probably due to the potent stimulatory capacity of 
PMA/ionomycin, which would have maximally stimulated the cells before 24 hrs 
when the supernatants were harvested. It is well known that different modes of 
stimulation exert differential effects on cytokine production in CD4+T cells as well as 
other cytokine producing cells (Ebtekar et al, 1996). Staphylococal enterotoxin B 
(SEB) has been shown to exert a strong effect on cytokine profiles switching towards 
a Thl-like profile (Bright et al, 1999) whereas purified protein derivatives -  PPD2 
(H37Ra non virulent) from a strain of mycobacterium tuberculosis resulted in 
increased production of IL-5 (Ebtekar et al, 1996). Therefore revealing a ThO-type 
cytokine bias by ELISA in all groups was unexpected and again might reflect the non­
specific stimulation of the cells prior to analysis of supernatants collected. 
Furthermore one would rarely expect to obtain 100% DL-4+ with 0% IFN-y. So any 
low levels of IFN-y-positive cells might have been stimulated by PMA to dominate 
the cultures.
In some T cell populations, the CD4+ T cells were Th2 and the CD8+ cells were Thl. 
A similar phenomenon was observed in mixed connective tissue disease (MCTD) 
patients with active disease, where the percentage of CD8+/IFN-y+ Tel cells was 
significantly increased compared to inactive disease or to non-inflammatoiy controls. 
Whereas IL-4 expression of CD4+ T cells was scarcely detectable in MCTD, a 
subpopulation of CD8+ Tc2 cells produced IL-4 in active disease (Bodolay et al, 
2002). The results we observed in a VKC cell line may relate to die disease activity 
state in the individual. It is also possible that as die cells were already activated in 
vivo, and might not have responded as well to PMA stimulation. Additionally, the 
effects of long-term in vitro culturing may not be representative of how the cells 
behave in vivo. One study investigating cytokine expression from freshly isolated 
localised T cells from tears and PB T cells from VKC patients, using the intracellular 
cytokine staining technique, after a short stimulation, may better reflect the
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physiologic situation of already activated lymphocytes within the target organ. It was 
observed that T cells infiltrating the inflamed conjunctiva in VKC, whether stimulated 
by specific or non-specific stimuli may result in a preferential Th2 response in a 
genetically predisposed host (Leonardi et al, 1999).
A recent study of allergen challenge model of SAC aimed to determine the role of IFN-y 
in the pathogenesis. They found that IFN-y knock-out (KO) mice and normal mice 
treated with anti-EFN-y antibody displayed milder clinical symptoms of allergic 
conjunctivitis along with a 70% reduction of neutrophils infiltrating the conjunctiva 
(Stem et al, 2005). These results were unexpected along with findings that the elevated 
production of Th2 cytokines did not inhibit the increase of IFN-y from CD4+ T cells 
from sensitised mice. The researchers suggested that despite an expansion of Th2 
allergen specific cells and increased Th2 cytokines the polarization of Th2 responses is 
incomplete thereby enabling the production of significant amounts of IFN-y (Stem et al, 
2005). There is an increased acknowledgement that Thl and Th2 interactions may not 
solely be antagonistic but to the contrary may effect the immune system in a complex 
manner (Gor, et al 2003). Studies of a mouse model of allergic asthma have shown that 
Thl cells are involved in the production of eosinophil infiltration in the lungs and 
adoptive transfer of allergen specific Thl T cells exacerbated allergic disease (Dahl, et 
al 2004).
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5.1 Introduction
Chapter four of this thesis outlined the Thl and Th2 skewed cytokine profiles in T cells 
derived from patients with TAO and CAED respectively. One potential therapeutic 
strategy for the treatment of Thl and Th2 biased conditions (autoimmune and allergic 
diseases) has focussed on altering die cytokine environment of T cells in attempt to 
redirect their cytokine profiles thus neutralising deleterious cytokine environment by the 
administration of specific cytokines to skew the T cells alternatively by targeting 
specific cytokines to such as TNF-a with a-TNF-a therapy (Bloebaum et al, 2004). In 
this context one may postulate the beneficial effects of blockade or neutralising cytokine 
therapy to treat either Thl or Th2 types of polarized diseases (Adorini, 2003). The data 
presented in this chapter focuses on in vitro attempts to switch cytokine profiles of T 
cells, thus indirectly neutralising the effects of the effector cytokines based on the fact 
that IL-4 is antagonistic for IFN-y, and vice versa Several researchers have employed 
die strategy of cytokine immune deviation to alter detrimental cytokine effects in animal 
models and human allergic and autoimmune diseases. However this approach is novel 
and has not yet been applied to die immune-mediated ocular diseases investigated in 
this thesis. Given that within the conjunctiva there are several proinflammatory 
cytokines present during CAED, one potential therapy would be to attempt to redress 
the balance of the T cell subpopulations by cytokines. Hence within this chapter the aim 
was to attempt to skew existing effector T cell populations away from their original 
cytokine profiles using anti-cytokine antibodies and recombinant cytokines.
The activation of T cells results in different effector functions, dependent on their 
cytokine profiles (Mosmann et al, 1986; Mosmann and Coffman, 1989). IL-12 and IL- 
4 are essential components of the immune system that direct the differentiation of Thl 
and Th2 cells, respectively (Abbas et al, 1996) and these subpopulations of Thl and 
Th2 cells reciprocally regulate one another, so that any given immune response exists in 
a state of balance between the two compartments (Mosmann and Coffman, 1989). An 
imbalance in the cytokine network plays an important role in the initiation and 
perpetuation of autoimmune diseases (Kuchroo et al, 2002) and in allergic diseases such 
as in acute asthma where an increased production of IL-4 and IL-5 with a decreased 
production of IFN-y by CD4+ T cells has been implicated in the immunopathogenesis 
(Cho et al, 2002).
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It has been reported that the administration of exogenous IFN-y or IL-12 seems to 
inhibit allergic asthma responses associated with IL-4/DL-5, in patients and allergic 
animal models (Shibata et al, 2000). IL-12 suppresses pro-allergic Th2 cytokine
production and induces Thl- type cytokine production from PB T cells from subjects 
with allergic disease (Varga et al, 2000). In vitro studies suggest the possibility of 
switching allergen-specific T cells to produce Thl-type from Th2-type cytokines. 
Mocd and Coffman, had suggested that differentiated Th response could be reverted 
and had demonstrated that polarized CD4+ Thl cells, isolated from Leishmania major- 
infected mice could be switched to a Th2-like phenotype when cultured for one week in 
die presence of APC, together with the antigen, L. major Ag, and IL-4. In a follow up 
study they sought to investigate the cellular basis for this population switch and 
separated CD4+ lymph node cells from Thl-polarized L. /wayor-infected mice into two 
subsets based on the level of expression of L-selectin (Mel-14 low or high). 
Subsequently each subset was stimulated with APC and IL-2 for one week in the 
presence or the absence of IL-4. It was observed that Mel-14iow T cells contained all of 
the initial Thl activity and these cells retained their Thl phenotype following culture 
with IL-4. In contrast, Mel-1 4 ^  T cells did not produce cytokines upon challenge with 
L. major Ag, and following culture with IL-4 gave rise to a Th2-like population (Mocci 
and Coffman, 1997).
The main aim of the chapter was to investigate, using human PBLs, the ability of T cells 
to switch from Thl to Th2 and vice versa then to address the effects of 
immunotherapeutic drugs CsA and dexamethasone in conjunction with cells being 
cultured in cytokine switching conditions favouring Thl and Th2 expressioa Both CsA 
and dexamethasone are well known immunosuppressive drugs which exert their effects 
on T cells, and are both frequently used in the treatment of severe CAED. CsA is 
probably the most thoroughly studied of the immunosuppressive agents acting on T cell 
cytokine production (House, 1999). The immunosuppressive activity of CsA results in 
the inhibition of Thl, Th2, Tel and Tc2 cells. It selectively blocks several pro- 
inflammatory functions of activated T-cells and to-date inhibits the release of the 
following cytokines IL-2, IL-3, IL-4, IL-5, IFN-y, GM-CSF and TNF-a.
The in vivo effects of CsA on the production of EL-10 in mice, were studied by Durez 
and collegues (1993). Two different stimuli were used to induce IL-10 production: the 
145-2C11 anti-mouse CD3 mAb as a polyclonal T cell activator, and bacterial LPS as an 
activating agent for B cells and macrophages. In both instances, increased levels of
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serum IL-10, in addition to IL-10 mRNA accumulation in spleen were observed. Their 
main findings related to the differential effects of CsA on the production of IL-10 
induced by anti-CD3 mAb or LPS. Previous reports had suggested that the transcription 
of several cytokine genes in mouse T cells including IL-2, IFNy and IL-4 genes was 
inhibited in vitro and in vivo by CsA (Flamand et al, 1990; Granelli-Pipemo, 1990; 
Sigal and Dumont, 1992), also that the drug does not affect the production of IL-10 by a 
TH2 clone (Wang et al, 1991). This study demonstrated that CsA blocks the systemic 
release of IL-10, as well as IL-10 gene expression induced by anti-CD3 mAb in vivo. In 
contrast, pretreatment with CsA in the LPS model resulted in die super-induction of IL- 
10 gene expression and a significant enhancement of IL-10 released systemically 
(Durez et al, 1993). The super-induction of TGF-p by human T cells (Li, et al, 1991) 
and IL-6 (Walz, et al, 1990), by human PBMCs has been associated with CsA 
treatment This effect of CsA-mediated cytokine gene super-induction may be 
explained by the inhibition of the production of nuclear factors binding to negative 
regulatory sequences of the corresponding gene alternatively due to the lack of 
inhibition of regulatory proteins that promote cytokine gene expression (Li, et al, 1991; 
Altmeyer, et al, 1991).
CsA exerts its effects by inhibiting certain lymphocyte-specific DNA-binding 
transcription factors involved in controlling the expression of many genes encoding 
cytokines, by binding to regulatory sequences contained in their promoter regions. CsA 
completely inhibits the activation of IL-2 gene transcription, modulated by the 
transcription factors NF-AT, NF-IL2A and NF-EL2B. Cyclosporin also partially 
inhibits transcriptional activation mediated by NFkB (Ibelgauft, 2002).
Dexamethasone is a glucocorticoid analogue with potent immunosuppressive and anti­
inflammatory effects which is used in the treatment of both Thl and Th2 associated 
inflammatory diseases (Barrat et al, 2002) including rheumatoid arthritis and asthma 
(Wilckens De Rijk, 1997). Glucocorticoids are renowned for their anti-inflammatory 
properties. They function by reducing cellular recruitment to sites of inflammation via 
the effects on adhesion molecule expression and cytokine production (Amano et al, 
1993). Important Thl and Th2 cytokine gene regulation transcription factors such as 
NFAT, AP-1 and NFkB are inhibited by dexamethasone (Chen et al, 2000). It has been 
reported that dexamethasone induces human T cell populations to secrete large amounts
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of IL-10 (Hawrylowicz et al, 2002), in addition to reducing levels of IL-4, IL-5 and IL- 
13 produced by human CD4+ and CD8+ T cells (Richards et al, 2000).
We have therefore examined the cytokine profiles during switching conditions alone 
and in the presence of CsA, to investigate whether the cytokine profiles are altered. The 
switching conditions which were used were standardised, chosen based on previous 
studies with human T cells conducted to polarise T cells during their expansion into T 
cell lines (Windhagen et al. 1998), and modified for use in our laboratory.
It has been reported that chemokines play specific roles in AKC and VKC, and these 
molecules are thought to have key roles in recruitment and activation of leukocytes 
(Miyazaki, et al, 2004). Eotaxin-1, also called CCL11, was first described in 1994, as a 
highly specific eosinophil chemokine. Several other cell types including lymphocytes, 
macrophages, bronchial smooth muscle cells, endothelial cells and eosinophils, are able 
to produce this chemokine, predominantly after cytokine stimulatioa Eotaxin-1 also 
regulates the chemotaxis and, in some conditions, activation of basophils, mast cells and 
T lymphocytes. CCL11 binds to the CCR3 receptor (Amerio, etal, 2003).
CCR3 selectively recruits eosinophils into tissues at allergic sites it is also expressed on 
eosinophils, basophils, mast cell subpopulations, activated Th2 cells, macrophages and 
airway epithelial cells (Erin, et al, 2002). Thus, chemokines that target CCR3 in 
concert with Th2 cytokines appear to play a pathogenic role in allergy. In contrast, 
chemokines that target CXCR3 in concert with Thl cytokine appear to play a beneficial 
role. Accordingly, inhibiting CCR3/Th2 pathway using CCR3 antagonists is viewed as 
a potentially useful strategy for anti-allergy drug development (Gangur et al, 2003). It 
was our aim to establish if there is any upregulafion of CCR3 under Th2 favouring 
conditions as opposed to Thl culturing conditions, and to explore the effect of CsA 
upon CCR3 expression.
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5.2 Results
The aim of this experiments was to optimise the cytokine switching protocol with a 
view to in vitro manipulation of skewed Th cell lines that had been identified in CAED 
and TAO T cell lines examined in chapter 4.
In order to optimise the cytokine switching conditions, 3 healthy donor source of PB 
cells were used to compare 3 different culture conditions in triplicate experiments. The 
cytokine expression was initially monitored at different timepoints to assess the 
magnitude of cytokine expression and extent of the effects of the cytokine switching 
conditions and to ascertain the optimal conditions for expression.
5.2.1 Optimising the cytokine switching protocol.
Levels of intracellular expression of IL-4 and IFN-y were monitored in response to the 
different culturing conditions at three timepoints from 3 pooled experiments, as shown 
in fig 5 .i.
Levels of IL-4 expressed from cells cultured with PHA alone were similar at days 0, 7 
and 14. At day 7 of the experiment expression of IL-4 in Th2 culturing conditions was 
slightly lower than levels expressed in control (PHA alone) T cells. Levels of IL-4 
expressed from the T cells in Thl culturing conditions were similar to control T cells at 
day 7. The levels of IL-4 expression were significantly (p< 0.001) increased at day 14 
of the experiment in response to both Thl and Th2 culturing conditions when compared 
to control T cells at the same timepoint
IFN-y expression in control T cells (PHA alone) was significantly (p<0.05) less at day 0 
when compared to expression at days 7 and 14. The expression of IFN-y at days 7 and 
14 of die experiment were similar. The levels of IFN-y expressed in response to 
culturing cells in Thl (Anti-IL-4 with Rh IL-12) were highly significant (p< 0.001) at 
both 7 and 14 days when compared to PHA alone (control) at the same timepoints. It 
was observed that levels of IFN-y expression in Thl culturing conditions increased
lL
between the 7 and die 14 day of the experiment. IFN-y expression from cells 
cultured in Th2 conditions was significantly (p< 0.05) decreased at day 7 compared to 
controls at the same timepoint whereas at day 14 there was a significant (p<0.01) 
increase in levels expressed compared to day 14 control T cells.
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Figure 5.i. Cytokine expression at different timepoints utilizing the cytokine switching 
protocol.
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Figure 5i. Mean IFN-y and IL-4 expression from 1 x 106 T-cell lines from three different donors. Cells were 
cultured for 14 days in either PHA (l|ig/ml) and irradiated J-Y feeder cells, PHA in addition to anti-IL-12 
[0.02jj.g^ml] with Rh IL-4 [0.2n^ml] and feeder cells or with PHA in combination with anti-IL-4 [0.4ng/ml] 
and Rh IL-12 [0.1ng/ml] and feeder cells. Cytokine profiles of these lines were then determined by 
intracellular cytokine expression following 6 hrs stimulation with PMA [50n^ml] and ionomycin [lpg/ml] on 
day 0, 7 and 14, IFN-y dark blue bars and IL-4 lime bars. Means were calculated from triplicate 
experiments and results shown as ±  SD for the three donors. Levels of significance, using the Studjents’ t- 
test, were as follows:- □ p< 0.01, ■ p< 0.001.
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5.2.2 Dot plot analysis of cytokines IL-4, EL-10 and IFN-y. in Thl or Th2 culture 
conditions.
The following experiments were conducted utilizing die cytokine switching technique, 
as optimised, to monitor the effects of switching conditions on the expression of 
cytokines IL-4, IFN-y and IL-10.
Following culturing of the T cells for 14 days in PHA with anti-IL-4 with Rh IL-12 
(Thl-) or Th2-favouring conditions the T cells were analysed for intracellular cytokine 
expression following stimulation with PMA/ionomycin, as shown in Figure 5.ii. The 
live T cells were gated and, when analysed, all fell within the region of 400-800 
Forward Scatter (FSC) and 20-250 Side Scatter (SSC) (not shown). Using anti-CD3 
mAb staining, all events in the T cell region were 100% CD3+. Therefore we assumed, 
as before, that CD8' cells were CD4+ and vice versa
Non-polarizing conditions:
T cells cultured with PHA alone, demonstrated low levels of IL-4 with greater levels of 
IL-10 (-14%) and IFN-y (28%) from (CDS') CD4+ and CD8+ T cells respectively 
(Figure 5.ii (A)).
Thl-favouring conditions:
Cells cultured in conditions favouring Thl cytokines expressed similar levels of IL-4 to 
that observed in control T cells, cultured in PHA alone. However, the IFN-y levels were 
significantly increased on both CD4+ and CD8+ T cells. Increased levels of IL-10 
expression were also seen on both T cell subsets (Figure 5.ii. (B)).
Th2-favouring conditions:
Cells cultured in conditions favouring Th2 cytokines demonstrated significantly greater 
levels of EL-4 expression on both CD4+ and CD8+ cells compared to levels observed in 
control T cells (PHA alone). Levels of Thl cytokine EFN-y were slightly reduced 
compared to control cells. A slight decrease in levels of IL-10 expressed in comparison 
with those cells in PHA alone was also observed (Figure 5.ii. (C)).
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Figure 5.ii. Dot plots representing cytokine switching experiments on cytokines IL-4 
IFN-y and IL-10.
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Figure 5.i. IFN-y, IL-4 and IL-10 expression (y axis) from 1x10® donor PB T-cell lines. Cells were cultured 
for 14 days in PHA [1 jxg/ml], PHA with anti-IL-12 [0.02pg/ml] and Rh IL-4 [0.2ng/ml] or PHA with anti-IL-4 
[0.4ng/ml] and Rh IL-12 [0.1 ng/ml] all with irrradiated J-Y feeder cells. Identical experiments were set up 
as above in addition to CsA [25ng/ml]. Cytokine profiles were then determined by intracellular cytokine 
expression following 6 hrs stimulation with PMA [50ng/ml] and ionomycin [lpg/mi]. For each fluorescent 
marker used an isotype matched control was used to set quadrants (IgGi PBrcP IgGi0X0 and I g G i -  not 
shown).
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5.2.2.1. IL-10 expression at day 14 of T cell lines cultured in Thl and Th2 
favouring conditions.
The purpose of these experiments was to assess whether there were any effects on IL-10 
expression in either Thl or Th2 culturing conditions.
Due to the more significant cytokine changes obtained at day 14, this timepoint was 
chosen for the subsequent studies. The mean response of three donors PB T cells 
following exposure to different culturing conditions are shown in Figure 5.ii. T cells 
were cultured for 14 days in PHA alone in comparison with PHA and anti-IL-4 mAb 
with Rh IL-12 (Thl favouring conditions) or with anti-IL-12 with Rh IL-4 (Th2- 
favouring conditions).
Levels of intracellular expression of IL-10 were analysed within the cells cultured in the 
three differing conditions. Cells which were cultured in conditions promoting Thl cells 
demonstrated an slight increase in expression of IL-10 compared to T cells cultured in 
PHA alone (p< 0.05). In contrast, the expression of IL-10 in T cells cultured in Th2- 
favouring conditions as compared to T cells cultured in PHA alone showed no 
significant difference. However the increase of IL-10 did not fit with the predicted Th2 
skewing, as it was not increased in Th2 favouring conditions.
The results shown in Figure 5.ii illustrate that the T cells cultured in Thl (anti-IL-4 with 
Rh IL-12) and Th2 (anti-IL-12 with Rh EL-4), conditions showed a skewing of cytokine 
profiles and a shift in die ratio of IFN-y:IL-4 occurred in accordance to the culture 
conditions.
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523 . Multi-cytokine bead detection assay results comparing PB T cells cultured 
in PHA alone with cells cultured in Thl favoring conditions.
The experiments described within this section are presented to validate die enhanced 
Thl cytokine, IFN-y expression, in Thl favouring conditions utilising the multi­
cytokine bead detection assay by an alternative methodology. This technique enables 
the investigation of die effects of Thl culturing conditions, on an array of cytokines.
The effect of cytokine-induced polarization on a range of cytokines was also measured 
using a multi-cytokine bead detection assay (Table 5a.). Results shown are from one 
donor’s T cells following 14 days exposure to PHA alone or in Thl-favouring 
conditions, and a similar effect was found with two other donor cultures. On day 14, 
the cell were restimulated with PHA and feeders and supernatants harvested at 24 hrs. 
The supernatants were tested in triplicate and an increase in the level of IFN-y following 
treatment was detected as well as significant decreases in levels of IL-2 (p< 0.01), IL-4 
(p< 0.05) and IL-5 (p< 0.01). No significant changes in TNFa levels were observed but 
an increase in IL-10 was detected (p< 0.05).
Table 5a
Cytokines T cells + PHA 
fps/ml]
Thl-favouring conditions 
fps/mll
IL-2 558.0 ±63.1 166.9 ±30.7*
IL-4 84.1 ±21.8 27.4 ± 7.8 0
IFN-y 2648.0 ± 1292.0 92676.0 ±73917.0
TNF-a 10.90.0 ± 498.0 1372.0 ± 604.0
DL-5 5660.0 ±1011.0 256.6 ±94.7*
IL-10 21.2 ±9.6 63.7 ±7.10
Table 5 a  CBA for quantitating multiple cytokines in T cell culture supernatants at 24 hrs stimulated either 
with PHA alone or in Th1-favouring conditions. Data shown are meanstSD from triplicate experiments 
with one of three donors assayed, ail three showing similar trends. Statistical significance shown as • p£ 
0.01; 0 p£0.05 vs controls.
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5.2.4 Cytokine expression by T cells cultured in Thl- or Th2- favouring 
conditions with tbe addition of CsA.
The purpose of these experiments was to examine the effects of CsA on cytokines EL-4, 
IFN-y and EL-10, expression from T cells cultured in Thl and Th2 favouring conditions.
Cytokine expression from the PB T cells cultured in the presence of anti-IL-4 mAb with 
Rh IL-12 (Thl-favouring) or in anti-IL-12 with Rh IL-4 (Th2-favouring) in addition to 
CsA for 14 days is also illustrated in figure 5.iii. The concentration of CsA [25ng/ml] 
used in the experiments was based on the optimal concentration used to inhibit T cell 
proliferation (data not shown).
Thl-favouring conditions:
The levels of expression of IFN-y from T cells cultured in Thl-favouring conditions 
along with immunosuppressive drug CsA were greatly reduced when compared to cells 
cultured in Thl-favouring conditions alone (p<0.001). A slight non significant 
reduction in levels of IL-4 was observed in Thl conditions with the addition of CsA. 
Levels of IL-10 were significantly enhanced (p< 0.05) in Thl culture conditions with 
CsA compared to levels observed in Thl culture conditions alone.
Th2-favouring conditions:
The levels of both IL-4 and IFN-y were significantly reduced (p< 0.001) in cells 
cultured in Th2-favouring conditions with the addition of CsA in comparison to similar 
culture conditions without CsA. Highly significant increases in IL-10 expression were 
observed in T cells cultured in Th2-favouring conditions in addition to CsA compared 
to levels expressed in Th2-favouring conditions without the addition of CsA (p< 0.001).
Non-polarizing conditions:
For those cells in PHA alone, in the absence of Thl or Ih2 polarising conditions, the 
levels of cytokines IL-4 and IFN-y expressed were greater than in cells cultured in PHA 
along with CsA. Similar levels of IL-10 were expressed in T cells cultured in PHA 
alone in comparison with T cells cultured in PHA and CsA
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Figure 5iii. Cytokine expression at day 14 from CD4+ T cells cultured in T hl and Th2 
favouring conditions alone and in addition to CsA
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Figure 5.iii. Mean IFN-y, IL-4 and IL-10 expression from 1 x 106 T-cell lines from three different donors. 
Cells were cultured for 14 days in either PHA (lpg/ml) and irradiated J-Y feeder cells, PHA in addition to 
anti-IL-12 [0.02 pg/ml] with RhlL-4 [0.2n^ml] and feeder cells or with PHA in combination with anti-IL-4 
[0.4ng/ml] and Rh IL-12 [0.1ng/ml] and feeder cells. Duplicate T cells were set up in the same culture 
conditions as described above but with the addition of CsA [25ng/ml]. Cytokine profiles of these lines 
were then determined by intracellular cytokine expression following 6hrs stimulation with PMA [50ng/ml] 
and ionomycin [lpg/ml]. Means were calculated from triplicate experiments (with the exception of PHA 
CsA), and results shown as ±  SD from triplicate experiments. IFN-y dark blue bars, IL-4 lime bars and IL- 
10 turquoise bars. 0p<  0.05; *p< 0.01; •  p< 0.001 indicates statistically significant values.
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5.2.5 Expression of cytokines IFN-y, IL-4 and IL-10 from T cells in response to 
the addition of dexamethasone cultured in Thl and Th2 favouring conditions.
The purpose of these experiments was to examine the effects of dexamethasone on 
cytokines IL-4, IFN-y and IL-10, expression from T cells cultured in Thl and Th2 
favouring conditions.
Cytokine expression from the PB T cells cultured in the presence of anti-IL-4 with Rh 
IL-12 (Thl-favouring) or in anti-IL-12 with Rh IL-4 (Th2-favouring) in addition to 
dexamethasone [10'7M] (Caulfield et al, 2002) for 14 days is shown below in table 5.b.
IFN-y expression:
The levels of expression of DFN-y from T cells cultured in Thl-favouring conditions 
along with immunosuppressive drug dexamethasone were greatly reduced when 
compared to cells cultured in Thl-favouring conditions alone (p<0.001). A significant 
reduction in levels of IFN-y was observed in both Thl and Th2 favouring conditions (0 
p< 0.05; *p< 0.01 respectively) with the addition of dexamethasone when compared to 
PHA control.
IL-4 expression:
The levels of IL-4 were significantly reduced (*p< 0.01) in cells cultured in U n ­
favouring conditions with the addition of dexamethasone in comparison to similar 
culture conditions without dexamethasone.
IL-10 expression:
IL-10 expression was significantly increased (*p< 0.01) in both Thl and Th2 favouring 
conditions with the addition of dexamethasone when compared to expression of IL-10 
in respective culturing conditions in the absence of dexamethasone.
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Table 5.b. Cytokine expression in response to PHA, Thl and Th2 favouring conditions, 
alone and in combination with the immunosuppressive drug, dexamethasone.
Culturing
conditions
Mean % Cytokine expression and standard deviations
IL-4 S.D.
i
IFN-y S.D. ± EL-10 S.D.
±
PHA 7 1.3 1 7 - 4 12 3.4
PHA&Dex 2.8 0.9 5 2.1 16 1.4
Anti-IL4 + 
Rh IL-12
5.5 3.3 7 3 + • 8.7 24.9"*
*
4.6
Anti-IL4 +
Rh IL-12+ Dex
3.2 0.6 I 2 j •
0
1.4 40 J 1.7
Anti-IL-12 + 
Rh IL-4
30.6""
*
4.5 8.4 1.9 26 ^
*
3.3
Anti-IL-12 + 
Rh IL-4 + Dex
8.6 J 1.2 1.5 -J * 0.2 45.7-J 4.2
Table 5b. Mean IFN-y, IL-4 and 1L-10 expression from 1 x 106 T-cell lines from three different
Cells were cultured for 14 days in either PHA (lpg/ml) and irradiated J-Y feeder cells, PHA in addition to 
anti-IL-12 [0.02 pg/ml] with RhlL-4 [0.2ng/ml] and feeder cells or with PHA in combination with anti-IL-4 
[0.4ng/ml] and Rh IL-12 [0.1ng/ml] and feeder cells. Duplicate T cells were set up in the same culture 
conditions as described shove but with the addition of dexamethasone [10-7M]. Cytokine profiles of these 
lines were then determined by intracellular cytokine expression following 6hrs stimulation with PMA 
[50ng/ml] and ionomycin [ljrg/ml]. Means were calculated from triplicate experiments, and results shown 
alongside ± SD from triplicate experiments. Statistically significant values denoted: 0p< 0.05; *p< 0.01;
•  p< 0.001.
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52.6. Cytokine expression of Thl and Th2 cell lines cultured in conditions 
favouring opposing cytokine conditions.
Following the establishment of a successful cytokine switching protocol the aims of 
these experiments were to assess the effects of culturing skewed CAED (1, 2, 3 and 5) 
and TAO (TAO 1, 3, 4 and 5) and T cell lines in opposing Thl and Th2 favouring 
conditions.
The T-cell lines, as listed above, had been previously been shown as having skewed 
cytokine profiles towards Thl or Th2 in TAO and CAED, respectively (chapter 4) and 
were placed in cytokine-defined culture conditions in an attempt to skew existing 
cytokine profiles towards a more balanced cytokine environment
Eight T-cell lines, 4 CAED and 4 TAO, were placed into culture, in Thl- or U n ­
favouring conditions, respectively. The majority of the T cell lines (n=7) failed to 
thrive and after 14 days in culture all stained densely with trypan blue, indicating the 
absence of any viable cells. One of the CAED T-cell lines had enough viable cells to 
perform an intracellular cytokine staining experiment, as illustrated in figure 5.iv. This 
Th2 cell (AKC 1) line when cultured in PHA alone resulted in a large percentage of IL- 
4 positive cells with significantly lower amounts of IFN-y expressing cells. These cells, 
exhibiting a strong Th2-like response, were cultured in parallel in Thl-promoting 
conditions, resulting in increased levels of IFN-y positive cells, than when cultured with 
PHA alone. There was also a considerable decrease in levels of IL-4 expression when 
cultured in Thl-favouring conditions. Dot plot inserts (A & B) represent the shift in 
cytokine expression from Th2-like to Thl-like as a result of culturing the cells in Thl 
favouring conditions. It was only possible to present results from one of three 
experiments, hence no error bars, and only cultured in PHA alone and in Thl-favouring 
conditions, due to cells failing to thrive.
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Figure 5.iv. Cytokine expression o f a  Th2 cell line cultured in Thl favouring conditions.
B:p; R3
PH A Thl - favouring culture 
conditions
Figure 5.iv. Intracellular cytokine expression of CAED 1 T-cell line following 14 days culture either in PHA 
[1 pg/ml] and feeder cells alone or in Th1-favouring conditions (anti-IL-4 mAb [0.4ng/ml] and IL-12 
[0.1ng/ml]). Mean ± S.D. percentages of IFN-y (blue bars) and IL-4 (lime bars) expression of the cell line 
were determined by flow cytometric analysis of triplicate experiments. Insert illustrates IL-4 and IFN-y 
expression in dot-plots (A) cells with PHA alone and (B) cells with PHA dnd anti-IL-4 mAb and Rh IL-12 
(Th1-favouring conditions).
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52.7. Expression of CCR3 in differing culture conditions
The experiments described in this section were conducted with the aim of identifying 
whether there were any changes in the expression of CCR3 in Thl or Th2 favouring 
conditions.
CCR3 was described for T cells as a marker for human Th2 cells (Bertrand and Ponath, 
2000; Wang et al,2003) and was used in this study to determine whether the CCR3 
expression correlated with the effects of IL-10, as a Th2 cytokine, or as a regulatory 
cytokine, independently of Th2 (TL-4) cytokines. The purpose of this series of 
experiments was to explore whether skewed Thl or Th2 cytokine conditions had any 
affect on the Th2 T cell marker CCR3.
The expression of CCR3 was monitored following culturing of the donor T cells for 14 
days in PHA with anti-IL-4 with Rh DL-12 (Thl-) or anti-IL-12 with Rh IL-4 (Th2-) 
favouring conditions alone or in the presence of CsA. The T cells were then analysed 
for the surface expression of CCR3 following stimulation with PMA and ionomycin, as 
shown in Figure 5.vi. Cells cultured in non-polarised, PHA-stimulated conditions were 
found to express low levels of CCR3. Similar, but slightly lower levels of CCR3 were 
observed in culture conditions favouring Th2 conditions. Significantly increased levels 
of CCR3 were detected in cells that were cultured in Thl-favouring conditions 
compared to PHA alone and Th2 culture conditions (p< 0.05). CCR3 levels were 
significantly enhanced in both Thl- and Th2-favouring conditions in die presence of 
CsA (p£ 0.001; p^ 0.01, respectively) compared to Thl- and Th2-favouring conditions 
alone.
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Figure. 5.vi.
pha a/IL12 a/IL4 a/IL12 a/IL4
CSA CSA
culture conditions
Figure 5.vi. CCR3 expression (y axis) from 1 x 106 donor PB T-cell lines. Cells were cultured for 14 days in 
PHA [lp^mll, PHA with anti-IL-12 [0.02pg/ml] and Rh IL-4 [0.2ng/ml] or PHA with anti-IL-4 [0.4ng/ml] and 
Rh IL-12 [0.1ng/ml] all with irrradiated J-Y feeder cells. Identical experiments were set up as above in 
addition \o 9$A [25ng/ml], Chemokine profiles were then determined by cell surface chemokine 
expression following 6 hrs stimulation with PMA [50ng/ml] and ionomycin [lpg/ml]. Statistically significant 
values denoted as follows:- 0 0.05, * pS 0.01, • p< 0.001.
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5.2.8. Modified One-way MLR
From the results obtained from the cytokine switching experiments, there was a 
significant shift of cytokine expression in response to skewed cytokine (Thl and Th2) 
culturing conditions (figure 5.i.). Additionally it was shown, in figure 5.iii. that there 
was a profound effect of CsA when added to the polarised cytokine conditions, in 
particular in terms of IL-10 expressioa Therefore we sought to further investigate the 
function of these IL-10 cells. Since they were IL-10 positive, the aim of this series of 
experiments was to determine if they were regulatory by testing their ability to 
downregulate proliferation of “normal” T cells in a one-way MLR, and to assess 
whether this increase of IL-10 expression had suppressive actions on IL-4 and IFN- 
y secreting cells. An assay was designed by modifying a previous MLR described by 
O’Garra and colleagues (Viera et al, 2004) using a MLR as a T reg assay. Our assay 
was set up with a responder cell population (R), a stimulator population (S) and cells 
classified as modulator cells (M), which had undergone prior treatment with PHA alone 
(Ml, control T cell line), or that had previously been cultured with anti-IL-12 and Rh 
IL-4 (M2) or with anti-IL-12 and Rh IL-4 in addition to CsA (M3), as shown in figure 
5.iv. The modulator cells were those with a potential to act as regulatory T cells. This 
experiment was designed to examine the proliferative responses of the R cells in 
different combinations to explore the possibility that the modulated, in particular, die 
M3 T cell population was responsible for a reduced proliferative response by the 
effector T cells (R), which would suggest an immunoregulatory role for the IL-10 
positive cells.
Responder cells (R) were obtained from die same donor as the modulator cells to avoid 
any allogeneic responses due to mis-matched HLA. R cells alone showed low levels of 
proliferation during the 5 day culture, the addition of PHA to the assay significandy 
increased the levels of proliferation (p£ 0.01). Comparing R cell proliferation with 
PHA to R cells cultured with allogeneic S cells there was a significant increase in T cell 
proliferation. The wells incorporating responder, stimulator cells in addition to 
modulator cells all showed a highly significant decrease in cell proliferation 
(p^ 0.001). Wells containing modulator (Ml) cells (PHA-stimulated T cells) showed 
greater levels of proliferation compared to both modulator (M2) cells (previously 
cultured with anti-IL-12 and Rh IL-4) and modulator (M3) cells (cultured with anti-IL- 
12 and Rh IL-4 in addition to CsA). The latter (M3) demonstrated the lowest levels of
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proliferation to PHA, but all gave significantly lower levels of proliferation than 
responders with stimulator (S) cells obtained from an allogeneic donor, suggesting the 
modulator cells inhibited allo-T cell responses.
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Figure 5.vi.
5000  -
4500  -
4000  -
3500
3000  -
2500  -
2000  -
M1 M2 M3 
PHA PHA PHA
R + R + S R  + S R  + S R  + S 
PHA +M1 + M 2  +M3
Figure 5.v. 1 x 105 responder (R), stimulator (S) and modulator (M) cells alone or in above combinations. 
Responder and modulator cells from the same donor with stimulator cells using another donor’s  PBMCs 
(irradiated). The 'modulator' cells were classified into three groups of cells made up of (1) PHA T cell line, 
(2) cells include PHA T cells following two weeks treatment with anti-IL-4 and IL-12 whereas (3) consisted 
of T cells that had been treated for 14 dayss with anti-IL-4 and IL-12 in combination with CsA [25ng/ml], 
The assay was performed in 96-well round bottom plates (in triplicate) containing a total volume of 200pJ 
for and cultured for 5 days. Wells were pulsed with 0.5jiCi methyPH-thymidine (37MBq/ml) for the last 18 
hrs of the culture. Statistically significant values denoted * p< 0.01, • p< 0.001
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5,3. Discussion
A previous chapter (4) in this thesis revealed the existence of polarised, Th2 and Thl 
cytokine profiles detected in CAED and TAO T cell lines, respectively. However, it 
must be stressed that despite the detection of skewed T cell cytokine profiles in both 
CAED and TAO lines we did not consider these as being relevant to the ocular diseases 
and appreciate that PB T cell cultures may only provide a crude reflection of the 
localised immune responses. It is also important to consider local, rather than 
peripheral, immune modulation as being preferable for a more selective yet clinically 
successful immunotherapy (Till et al, 2004). Currently, topical immunosuppressives 
such as CsA are effective in treating AKC, and systemic steroids are usually given. 
However the side-effects of systemic steroids, particularly in the eye, mean that 
improved immunosuppressive treatments are needed. Recently a new, more 
hydrophilic, formulation of CsA in the form of eye drops (‘Restasis,’ Allergan), 
underwent clinical trials in patients with severe steroid resistant AKC and was reported 
to improve symptoms greatly when compared to placebo administered AKC patient 
group (Akpek et al, 2004). Our aim is to investigate other approaches that could, in 
the future, be applied as local treatment, in the form of eye-drops, in immune-mediated 
eye disease, administered either alone or in conjunction with steroids or CsA Several 
studies have been conducted using the approach of switching cytokine responses from 
Thl-like to Th2-like and vice versa (described in Chapter 4; Somasse et al 1996; Nabors, 
1997; Windhagen et al, 1998). The technique of cytokine switching, employed within 
this chapter, utilised PBMC-derived T cells as an in vitro model for investigating a 
potential therapy for CAED and TAO.
It has been demonstrated in vitro that T cells from human allergen-induced late 
asthmatic responses respond to the addition of IL-12 (Bryan et al, 2000). The study 
suggested that the ability of allergen-specific T cells to produce Th2 or Thl cytokines 
can be regulated by exposure to cytokines such as IL-12, IFN-y and EL-4. It was 
observed that the addition of IL-12 to freshly isolated PB T cells obtained from atopic 
subjects skews the cytokine profiles from a Th2 response towards a Thl-type response 
(Marshall et al, 1995). Conversely, the addition of IL-4 causes a shift from Thl to Tin­
type cytokine production in vitro (Maggi et al, 1992).
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Within this chapter the effects of blocking antibodies with the addition of exogenous 
Thl or Th2 cytokines, IL-12 or IL-4, have been comprehensively studied and have 
demonstrated a predictable shift in cytokine expression dependent upon culturing 
conditions using control, freshly isolated PB T cells. Experiments conducted using 
TAO and CAED PB T cells however, did not show the same degree of success. Only 
one of the eight PB T cell lines from CAED and TAO patients’ displaying polarized 
cytokine responses were successfully manipulated. Exogenous Thl cytokines and Th2 
blocking antibodies enabled the shift of a Th2-like skewed cytokine response towards a 
Thl-like response. An explanation as to why the majority of the skewed PB T cell 
lines, when cultured in opposing cytokine culture conditions, failed to be switched 
could be that the T cells were already highly committed in terms of their cytokine 
profiles. Most of the T cell lines used had undergone at least six passages. It has been 
reported that Thl and Th2 cells that are repeatedly stimulated become irreversibly 
committed to their cytokine profile phenotype (Perez et al, 1995; Muiphy et al, 1996). 
In RA a large proportion of T cells infiltrating the RA synovium have the phenotype of 
memory Thl (Buchan et al, 1988). It has been postulated that a shift in the cytokine 
balance in RA could have a beneficial effect However, Thl cells seem to be difficult to 
shift and retain their EFN-y- secreting capacity despite manipulation with Th2 promoting 
cytokines whereas human Th2 cells appear to be less stable and can switch into ThO 
types (Aarvak et al, 1999). This finding coincides with the preliminary results we 
observed with the 8 T cell lines used in this research. The study by Mocci and 
Coffinan, (1997) concluded that undifferentiated Th precursors could be induced to 
develop into either Thl or Th2 cells and were not recent thymic emigrants as they were 
present in mice thymectomized before infection. That study highlighted also that a 
chronically stimulated and highly polarized Thl population consisted of both precursor 
T cells able to differentiate into Di2 cells and cells fully differentiated into Thl cells 
that could not be induced to switch their pattern of cytokine productioa
Results from experiments that had been conducted repeatedly (at least three times) but 
failed to generate data on at least two occasions have been shown as single experiments, 
with no error bars or p values, within this chapter. The difficulties encountered which 
caused the failure to generate results stemmed from at least one of the following 
reasons: cells unable to thrive, cultures becoming contaminated, insufficient cell 
numbers to conduct an intracellular cytokine staining experiment.
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The control of polarized Thl and Th2 cell populations may also be regulated by ‘anti­
inflammatory’ cytokines such as IL-10 (Adorini, 2003). IL-10 is known to inhibit the 
production of DL-12 from APCs and blocks the synthesis of IFN-y by differentiated Thl 
cells (Moore et al, 2001). IL-10 also has the ability to induce regulatory cells (Trl) 
capable of inhibiting autoimmune diseases (Groux et al, 1996) as well as numerous 
anti-allergic properties, including suppression of mast cell, eosinophil and T cell 
responses (Till et al, 2004). Hence we sought to establish if there was any change in 
expression of IL-10 in response to the switching treatment employed in this chapter. 
Our observations were that IL-10 was significantly increased in Thl-favouring culture 
conditions, as demonstrated by the intracellular cytokine staining technique and 
subsequently confirmed with the multiple cytokine detection assay (shown in table 5.a 
of the results section). Other researchers have reported similar findings in cultures with 
Rh IL-12 (Palmer and van Seventer, 1997; Windhagen et al, 1998). The detection of 
IL-10 from PB T cells following immunotherapy in response to allergen stimulation has 
consistently been reported and it is postulated that immunotherapy might induce IL-10- 
producing regulatory T cells of die CD4+ CD25+ phenotype (Till et al, 2004). A recent 
study by Cosmi et al (2006) reported that the increased production of IL-10 and IFN-y 
in PBMCs was observed in response to allergen-specific immunotherapy. It was noted 
in this study that all patients that experienced clinical benefits with allergen-specific 
immunotherapy showed a significant increase in either IFN-y or IL-10 or both, and 
claimed to be the first study to show the co-expression of both cytokines by allergen- 
specific CD4+ T cells. Since both EL-10 and IFN-y are able to impair Th2 responses, 
this finding provides a biological basis for the clinical effects seen with allergen-specific 
immunotherapy (Cosmi et al 2006).
IL-10 upregulation is partly IL-4-dependent (Bullens et al, 1998; Rafiq et al, 2001) and 
the addition of rhIL-4 to PB T cell cultures enhances the production of IL-10 from both 
control and allergic patients (Bullens et al, 2004). Our research also supports this 
finding since the IL-10 levels expressed were greater in cultures favouring Th2-like 
when compared to PHA control cells although failed to reach statistical significance. In 
our study we also observed a significant increase in IL-10 levels from T cells in Thl 
favouring culture conditions when compared to cells cultured in PHA alone (p < 0.01).
The immunosuppressive drugs CsA and dexamethasone were administered to control 
PB T cell cultures in combination with the cytokine switching conditions. A similar
179
N. Akhtar PhD Thesis
study has been performed adding dexamethasone into cultures (Barrat et al, 2002) and, 
to our knowledge, the use of CsA in this system was a novel approach at the time the 
research was conducted. Both Thl- and Th2-favouring culture conditions have been 
observed to promote the secretion of IL-10 from T cells (Windhagen et al, 1998). In 
both Thl- and Th2-favouring conditions with the addition of CsA and dexamethasone a 
profound effect in cytokine expression, in particular a significant increase of EL-10 was 
observed. It would appear from our data that immunosuppressive drugs CsA and 
dexamethasone have an effect on enhancing the expression/production of IL-10 in Thl- 
and Th2-favouring conditions. Other reports have suggested that CsA blocks the 
production of IL-10 (Rafiq et al, 2001), and the functions and effects of dexamethasone 
and CsA, on IL-10 have been described earlier in this thesis (chapter 1 sections 1.11.1 
and 1.11.2).
The expression of IFN-y and IL-4 was significantly decreased in response to CsA 
treatment in each of the experiments using CsA The level of IFN-y and IL-4 
expression varied in differing culturing conditions. The greatest extent of IL-4 and 
IFN-y decrease was observed in Th2 culturing conditions. A study investigating the 
cytokine mRNA profiles in allogeneic organ transplantation and healthy controls 
revealed variable results of in vitro CsA sensitivity. Whole blood samples of 3 of 11 
healthy individuals demonstrated a marked suppression of EL-2 mRNA expression 
(>50%) and a partial inhibition of IL-4, EFN-y, and TNF-a mRNA expression on 
addition of CsA In contrast, the remaining 8 healthy individuals had cytokine mRNA 
expression levels that were unaffected or even increased when CsA was administered in 
vitro (Hartel et al, 2003) despite a higher concentration being used in their study lpg/ml 
(we used 25ng/ml). In our experiments it was shown that for all the donor T cells, a 
considerable inhibition in response to CsA and dexamethasone was obtained. It would 
appear from our investigation that there is an inverse correlation between the expression 
of IL-4 and IFN-y with IL-10 in both Thl- and Th2-favouring conditions. It has 
recently been reported that dexamethasone decreases IL-12-induced STAT4 
phosphorylation and IFN-y production and enhances IFN-p-induced STAT4 activation 
and IL-10 production. These effects are associated with a down-regulation of IL-12R|31 
expression but an up-regulation of IFN-pR (Fahey et al, 2006).
In view of the findings from the cytokine switching experiments we were keen to 
determine functionally if the IL-10 expressing cells were regulatory. We examined the
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effects of the modulated cells on T cell proliferation and whether this may be associated 
with the detection of increased IL-10 observed in the cytokine switching experiments, 
and whether the modulated cells caused a reduction in effector cell proliferation. Hence, 
we conducted a modified MLR system with the incorporation of the cells that had been 
subjected to in vitro cytokine manipulation -  so called “modulated cells”. The cell 
numbers utilized in the MLR experiments were controlled by the addition of exactly (a 
total of 105 cells) the same number of T cells into each well, whether alone or 
combinations of differing cell populatioa Each well contained either R = 105, R + S = 
105 or R + S + M = 105 cells. These experiments revealed a reduction in T cell 
proliferation with the addition of modulated cells. This finding would correspond with 
the observation of increased IL-10 expression and thus a reduction in T cell 
proliferation in response to the addition of the modulated cells. It is of some surprise to 
detect a reduction in T cell proliferation in response to the modulator (control) cells 
cultured in PHA (Ml) as opposed to Thl (M2) and Thl with CsA (M3) skewed 
cytokine environments. Despite the fact that a marked reduction in proliferation was 
observed with R + S cells in combination with M2 and M3 cells it should be pointed out 
(illustrated in fig 5v.) that extremely low levels of proliferation were observed in Ml 
and M2 cells stimulated with PHA The reason for low levels of proliferation may be 
accounted for by low number of viable modulated cells (1 + 2) at the start of the 
experiment or high levels of proliferation resulting in exhaustion/cell death from 
depletion of growth factors in the medium leading to sub-optimal 3irthymidine uptake 
by day 5 of the experiment It was also not possible to conduct this experiment with 
the inclusion of Th2-favouring conditions (anti-IL12 with Rh EL-4) due to insufficient 
numbers of viable cells following the 14th day of culture. Due to limited time I was 
unable to repeat the experiments, increasing the cell numbers at die start of such 
experiments to overcome the problems encountered as a result of insufficient cells. 
Experiments of this nature would be valuable to repeat and it would be useful to 
investigate any increases of TGF-p and of CD4+ CD25+ following cytokine 
immunomodulation. It has recently been reported that treatment with CsA in kidney 
transplant patients results in an upregulation of plasma TGF-p levels (Citterio et al, 
2004). Any future experiments similar to the MLR conducted in these studies would be 
better conducted using CFSE, prelabelling the cells prior to the assay, and propidium 
iodide (PI) assay in order to trade viable proliferating T cell populations. CFSE is 
incorporated into dividing cells, and PI into dead cells. This type of assay would be 
able to detect whether it is in fact the modulated T cell population that is proliferating,
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with a decrease in effector cell proliferation. Also supernatants couls also be collected 
at various timepoints to measure cytokine production in these cultures. If this were to 
be the case this hypothetically could explain the increase in IL-10 observed in the 
cytokine switching experiments and suggest the presence/induction of Treg cells.
A recent study was carried out investigating the effect of the corticosteroid drug, 
fluticasone propionate, on CD4+ CD25+ T regulatory cells and IL-10 using asthmatic 
and control (non-asthmatic) PB T cells (Nguyen and Robinson, 2004). The study 
postulated that increased suppressive activity by CD4+ CD25+ cells may play a role in 
the anti-inflammatory effects of corticosteroids in asthma and allergic disease. They 
showed that human PB CD4+CD25+T cells can inhibit allergen-stimulated proliferation 
and Th2 cytokine production from CD4+ CD25‘ cells from both atopic and non-alopic 
donors (Nguyen and Robinson, 2004). In that study the suppressive activity of the 
regulatory T cells in vitro was less in atopic individuals, especially those with active 
disease compared to non-atopic subjects. Hence increased regulatory activity from T 
cells would be beneficial in controlling asthma and allergic disease. It was observed that 
prior exposure of fluticasone propionate to CD4+ CD25+ cells enhanced IL-10 
production from the cells when stimulated. The addition of anti-IL-10 antibody was 
able to reverse the steroid-induced increase of suppression and levels of IL-10, which 
led to the conclusion that corticosteroids would lead to an increase in suppressive 
activity of CD4+ CD25+ T cells. Alternatively, the addition of vitamin D3 with 
corticosteroids resulted in the generation of IL-10 producing T regulatory cells (Barrat 
et al, 2002). It would be of value to conduct future experiments to compare AKC 
(atopic) with non-atopic GPC conjunctival or PB-derived T cells for their T regulatory 
capacity. We hypothesise that CsA induced a population of T cells with suppressive 
activity and increased expression of IL-10.
The development of Thl and Th2 cell subsets is a major determinant of the outcome of 
physiological, as well as pathological, immune responses including autoimmune, 
allergic and infectious diseases (Romagnani, 1994; Abbas et al, 1996). It is becoming 
increasingly necessary to develop strategies to treat these deleterious conditions. 
Immunomodulation will play an essential role in future therapies for allergic (Bloebaum 
et al, 2004) and autoimmune diseases, as well as reducing the morbidity and mortality 
associated with these conditions.
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Cytokine based immunointervention offers a potential therapeutic approach in 
autoimmune and allergic diseases, with skewed cytokine profiles. However, the 
potency of cytokines along with the complexity of the cytokine network can result in 
severe side-effects (Adorini, 2003). An alternative to this approach could adopt the 
local delivery of anti-inflammatory cytokines by gene therapy (Mathisen and Tuohy, 
1998; Martino et al, 1998) or alternatively with immune-mediated eye diseases in the 
form of eye drops.
The chemokine receptor phenotypes of Thl and Th2 have been investigated following 
manipulation in Th2 and Thl favouring conditions respectively. It was observed that a 
Thl inducing cytokine environment lead to an increase of the expression of CCR5 in 
Thl cells and on Ih2 cells compared to IL-2 cultured controls. In addition it was 
reported that CCR3 could be expressed on both Thl skewed cells, Thl clones and ThO 
cells following culturing conditions favouring Th2 development. An increase in CCR3 
correlated with a reduction in EFN-y secretion, though IL-4 secretion was not induced. 
The induction of CCR3 on terminally differentiated memory Thl cells highlights a 
change in chemokine receptor phenotype in relation to Th2 culturing conditions without 
a change in cytokine profile. The study concluded that the expression of CCR5 and 
CCR3 (Thl and Th2, respectively) is flexible and can easily be changed during culture 
in either Thl or Th2 promoting conditions (Aarvak et al, 2001). In this thesis data has 
also suggested that CCR3 expression may be present on T cells cultured in both Thl 
and Th2 favouring conditions. Similar levels of CCR3 were detected in Th2 promoting 
culture conditions with an increase in expression in Thl favouring culture conditions as 
compared to the control T cells. Our study also highlighted an effect of CsA on CCR3 
expression In both Thl and Th2 favouring conditions there was a significant increase 
in CCR3 expression when CsA was incorporated into the cultures. A study 
investigating the expression of CCR3 in rats with induced pulmonary infection in 
response to CsA resulted in a reduced eosinophil entry into lung tissue and airways 
however no apparent effect on CCR3 was detected suggesting CsA acts to inhibit 
eosinophil recruitment either by an eotaxin-independent mechanism, or by targeting 
factors that synergise with eotaxin, or an event post eotaxin expression (Harrington et 
al, 1999).
In this chapter we also investigated die effects of polarised cytokine conditions on the 
expression of chemokine receptor CCR3. Chemokines are important components of 
polarised Thl and Th2 type responses and have a role in several stages during T cell
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differentiation. DCs, which are responsible for T cell activation and the polarity of 
cytokine secretion, are also affected by chemokines which are involved in directing the 
type of DCs activated and the numbers recruited to the site of inflammation CCR5 is 
involved in driving DCs to secrete IL-12 whereas CCR2 acts to inhibit IL-12 secretion 
thereby having an effect on the resulting type of T cell differentiation Chemokine 
receptors expressed on effector T cells determine where the cells migrate (Matsukawa et 
al, 2000). Polarised Thl and Th2 populations have been shown to display distinct 
chemokine receptor profiles in vitro with Thl cells expressing CXCR3 and CCR5 
enabling them to respond to IFN inducible chemokines, CXCL9, CXCL10 and 
CXCL11 (Sallusto etal, 1998; Shields etal, 1999).
In contrast, die CC chemokines, macrophage derived chemokine (MDC) and thymus 
and activation regulated chemokine (TARC, CCL17) attract polarised Th2 cells that 
express CCR3 and CCR4 (Bonecchi et al, 1998). DL-4 and IL-13 induce the production 
of MDC whereas it is inhibited by IFN-y and IL-12. Several studies have reported 
bilateral evidence of regulation of chemokines that induce and sustain polarised type 1 
and type 2 responses.
Therefore in this chapter we have developed an in vitro cytokine-induced T cell 
switching model with which the effects of the drug, CsA and dexamethasone, which 
currently in use for treating CAED, was investigated. In the future other 
immunosuppressing drugs could be tested using this system.
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6.1 Introduction
Inflammation is an effective component of immune defence against infection, but. if left 
uncontrolled, can cause considerable damage. A chronic inflammatory disease such as 
rheumatoid arthritis is an example of uncontrolled inflammation that would benefit from 
therapy to switch off rather than dampen the inflammatory response. NF-kB regulates 
the expression of pro-inflammatory mediators such as IL-8 along with other 
chemokines. TNF-a and some MMPs. It is known as the master regulator of the innate 
and adaptive immune systems and lias a central role in the onset of inflammation and 
thus has been the focus of much attention as a potential target for immunomodulation 
(Bell, 2002).
In most unstimulated cells NFkB is inactive and complexed to an IkB protein (Baldwin, 
1996). Upon cellular activation IkB undergoes degradation of two N-terminal serine 
residues (Ser32 and Ser36 of IkB). The degradation of IkB results in the release of 
active NFkB dimers, which are free to translocate to the nucleus and initiate the 
transcription of target genes (Roshak et al, 2002). There are two pathways, the classical 
and the alternative, via which NF-kB can be activated with different outcomes which 
are illustrated in Figure 6.1.
Several approaches may be adopted to inhibit NF-kB including gene transfer of IkBoc to 
inhibit NF-kB, inhibition of IkB kinases (IKK) or NF-kB inducing kinase (NIK) and 
IkB ubiquitin ligase, involved in the regulation of NF-kB activity, or drugs to inhibit the 
degradation (Barnes, 2001). Recently published reports have indicated that NFkB 
blockade, through DC’s transfected with an adenoviral vector encoding IkB, in murine 
and human DC’s both in vitro and in vivo has shown to be an effective strategy in 
blocking antigen presentation, thereby inhibiting T cell dependent immune responses 
(Yoshimura et al, 2003; Calder et al, 2003). A drug currently in development is being 
designed to inhibit the degradation of IkB (Delhase et al, 2000).
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Figure 6.i. The various routes and effects NF-kB activation
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Figure 6.i. Illustrates the classical and alternative NF-kB pathway (a) The classical NF-kB pathway is 
activated by a variety of inflammatory signals, resulting in coordinate expression of multiple inflammatory 
and innate immune genes. The proinflammatory cytokines IL-1p and TNF-a activate NF-kB, and their 
expression is induced in response to NF-kB activation, thus forming an amplifying feed forward loop, (b) 
The alternative pathway for NF-kB results in nudear translocation of p52-RelB dimmers, is strictly 
dependent on IKKa homodimers and is activated by LTpR, BAFF, and CD40L, by NIK. Many reports 
strongly suggest that the alternative pathway plays a central role in the expression of genes involved and 
maintenance of secondary lymphoid organs, (c) highlights the interaction of IRAK 1 and 4.
Abbreviations: BAFF-B-cell-activating factor belonging to the TNF family; BLC, B-lymphocyte 
chemoattractant;, CD40L - CD40 ligand, COX-2 -  cydooxygenase 2, ELC, Epstein-Barr virus-induced 
molecule 1 ligand CC chemokine; GM-CSF - granulocyte-monocyte colony-stimulating factor, ICAM-1 - 
intercellular adhesion molecule, IKK -  IkB kinases, iNOS -  indudble nitric oxide synthase, MCP-1 monocyte 
chomotactic protein-1, MIP-1a - macrophage inflammatory protein-1a, NIK - NFkB  indudng kinase, PLA2 - 
phospholipase-2, SDF-1 -  stromal cell-derived factor 1; SLC -  secondary lymphoid tissue chemokine, TLRs 
- Toll-like receptors, TNF-a - tumor necrosis factor-a, VCAM-1 -  vascular cell adhesion molecule-1
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Gene therapy is the term commonly used to describe the technique for introducing 
foreign genetic material into cells with a correction of a dysfunctional gene as its final 
aim (Majhen and Ambriovic-Ristov, 2006). A major impediment to the successful 
application of gene therapy for the treatment of a range of diseases is not due to the lack 
of therapeutic genes, but rather due to the deficiency of an effective non-toxic gene 
delivery system. Having evolved to deliver their genes to target cells, viruses are 
currently the most effective means of gene delivery and can be manipulated to express 
therapeutic genes or to replicate specifically in certain cells (Young et al, 2006).
Rowe and colleagues discovered adenoviruses over 50 years ago when they were trying 
to culture adenoid tissue in the laboratory (Rowe et al, 1953). Since their discovery the 
viruses have been studied intensively, mainly as a model for basic eukaryotic cellular 
processes such as transcription, RNA processing, DNA replication and translation. The 
adenovirus are non-enveloped virions with a double-stranded DNA genome of 26 -  
45kb which replicates in the nucleus after infection of either quiescent or dividing cells 
(Shenke, 2001). The adenovirus genome is arranged in five early (El A, E1B, E2, E3 
and E4) four intermediate (Iva2, IX, VAI and VAH) and one late transcriptional unit. 
The primary receptor responsible for the attachment of most adenoviral serotypes is the 
Coxsackie-adenovirus receptor (CAR-Ad) (Roelvink et al, 1999). There are now 51 
identified human adenovirus serotypes, which mostly cause mild infection of the upper 
respiratory tract, gastrointestinal tract and the eye (Horwitz, 2001). Cell infection 
begins with high affinity binding of Ad to CAR followed by the internalisation of the 
Ad particle which binds with low affinity to Oy integrins on the cell surface for 
internalisation (Young et al, 2006). The virus uptake is mainly mediated by clathrin- 
dependent receptor-mediated endocytosis and once inside the cell cytoplasm the virions 
travel along the microtubules toward the nucleus where they dock with the nuclear pore 
complex (Meier and Greber, 2004) and enter the nucleus.
In order to achieve a therapeutic effect any gene therapy vector should be able to deliver 
genes of interest to the designated target and to ensure their expression for an 
appropriate amount of time. The adenoviral replication depends on the El A region of 
the viral genome, all recombinant adenoviral vectors have this region of its genome 
deleted, and desired genes are cloned into a multi cloning site inserted in place of the 
El A region of the genome, these are then referred to as “replication-deficient”. Such 
vectors are capable of infecting a cell only once, no viral propagation occurs, and the
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infected cell does not die as a result of vector infection (Majhen and Ambriovic-Ristov, 
2006).
Wild type adenovirus types 4 and 7 have been used in vaccines with very few reported 
side effects (Takafuji, 1979), hence contributing to view that Ad is safe to use for 
human gene therapy. Within the past decade, adenovirus vectors (AdV) have been the 
vectors of choice for transferring corrective genes into human cells for transient 
expression. Recombinant adenovirus serotype 5 (rAd5) vectors have proven to be one 
of the most immunogenic vaccine vectors in comparative pre-clinical immunogenicity 
studies using standardized inserts. Additionally the rAd5 vectors can be produced in 
large quantities, although a limitation to die rAd5 vectors is that there is a high 
prevalence of pre-existing immunity against the Ad5 vector itself through Ad5 
neutralizing antibody (Nab). It has been postulated that the delivery of rAd5 vectors via 
mucosal routes rather than systemic routes may help to circumvent the suppressive 
effect of anti-Ad5 immunity though safety issues have been raised with this approach 
alternatively coating the rAd5 particle with polyethylene glycol may mask neutralizing 
Nab on the capsid surface (Barouch, 2006).
There have been as many hundreds of gene therapy clinical protocols and of these 
almost a third used AdV to deliver therapeutic or marker genes (Kamen and Henry, 
2004). Below some examples are highlighted as potential as well as existing 
therapeutic applications utilizing adenovirus. Clinical trials of recombinant adenovirus 
expressing IL-12 in patients with advanced digestive tumours or of a vaccine 
comprising autologous melanoma cells transduced with GM-CSF have shown to be safe 
and have some anti-tumour effects (Sangro et al, 2004). In China adenovirus therapy 
has been safely used to deliver the p53 tumour suppressor gene by direct injection in 
combination with conventional radiotherapy in the treatment of head and neck cancer 
(Peng, 2005).
Adeno-associated virus (AAV) has been implicated as having potential in the delivery 
of the cystic fibrosis gene (CFTR) (Lee et al, 2005/ Phase two clinical trials using 
AAV for cystic fibrosis have been reported to having encouraging results (Moss et al, 
2004). The AAVs are single-stranded DNA viruses that require adenovirus helper 
functions to replicate. AAVs are non-pathogenic and their genome contains only two 
open reading frames (ORFs) flanked by inverted terminal repeats (ITRs). The AAV-
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based vectors have most of their viral DNA deleted leaving onl the ITRs (Young et al, 
2006). A genetic therapy approach has been employed for the treatment of 
cardiovascular disease either to control vascular growth or to protect and repair 
myocardial damage. The local delivery of vascular protective genes for the control of 
hypertension, for example endothelial nitric oxide synthase, or genes to stimulate 
vascular growth to repair or prevent coronary artery disease, such as VEGF, have been 
demonstrated using adenoviruses for transient effects or persisting effects using AAV 
gene expression (Melo etal, 2005).
Several attributes make adenovirus an attractive vector such as the relative ease of 
production of large amounts with high efficiency transduction. Other advantages 
include the ability to produce the virus inexpensively at high titre (1010 -  1013), a low 
particle : infectivity ratio, the capability of containing DNA virus inserts the ability to 
infect both replicating and differentiated cells. Additionally, since they lack integration, 
they do not cause mutagenic effects caused by random integration into the host genome. 
The last generation of adenovirus vectors, also known as helper- dependent or gutless 
adenovirus are particularly attractive for gene therapy due to a greatly reduced in vivo 
immune response compared to first and second generation adenovirus vectors. The 
gutless adenoviruses, as well as having the above attributes, are stable in target cells 
with low immunogenicity and have the potential for inserting full length DNA 
sequences for most genes, up to 36kb, long full length cDNAs, endogenous promoters 
or additional regulatory sequences such as enhancers or insulators can provide a tightly 
regulated expression of the therapeutic gene, similar to physiologic conditions. The 
gutless adenovirus has been the most used vector in clinical trials over the last five years 
(Alba et al, 2005). Disadvantages of the adenoviral system are discussed in the 
discussion section of this chapter.
The aim of this chapter was to investigate an alternative mode for dowregulating T cell 
cytokines, via intracellular signalling blockade. Direct infection with an adenowiral 
vector containing IkB, was carried out to block activation of NF-kB, commonly 
involved in T cell production of pro-inflammatory cytokines. Experiments were 
conducted to investigate whether firstly it was possible to transfect human T cells with 
adenoviral vectors, and secondly if IkB could be overexpressed as a result of this 
transfection. Finally the iKB-overexpressing T cells were investigated for their cytokine 
responses to various stimuli, including specific antigen, ttp (Sallusto and Lanzavecchia,
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2000) or polyclonal stimuli (PHA and PMA). The methods of detection of cytokines, 
following adenoviral infection of T cells with IkB in this chapter include ELISA, PCR 
and real time PCR. Some of the preliminary research presented in this chapter was 
conducted solely by Dr. V. Calder who kindly gave her permission for this data to be 
incorporated into this chapter as background information. Data from real time PCR 
experiments shown in the latter part of tins chapter were conducted in collaboration 
with Dr. V. Calder, and colleagues at the Kennedy Institute of Rheumatology.
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6.2 Results
6.2.1. Adenoviral infection of control T cells
These experiments were conducted to investigate the infectivity o f T cells with AdvO.
Results in Figure 6.ii illustrate freshly isolated T cells from normal donor PB obtained 
by Ficoll then by elutriation, giving > 99% pure T cells. T cells were then infected with 
different concentrations o f  Advpgal (pgal is the FL1 used for optimising the m o.i. o f  
Adv in flow cytometric detection). AdvO was used as a control (infectivity o f T  cells 
described in chapter 2) and stained at 48 hrs. However, even at the highest moi, 3000:1, 
there were very low levels o f  infectivity. This experiment was repeated twice and 
demonstrated that infectivity o f non-activated T  cells with Adv-pgal was very low even 
at the highest concentration o f  virus, whereas w hen chronically activated T cells were 
used, (Figure 6.iii) a much higher infectivity rate was achieved, presumably due to an 
increase in virus receptor expression by activated T cells. There is a lot o f literature on 
Adv receptors on cells although T cells were always thought to be impossible to 
transfect. Colleagues at the Kennedy Institute o f Rheumatology then ran gel shift 
assays to demonstrate IkBcx overexpression in the T cells (data not shown).
Figure 6.ii. Adenoviral infection o f control T cells
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6.2.2. Successful human T cell line transfection with AdvpGal
Following the successful infection o f control T cell with AdvO T the aim o f this 
experiment was to transfect T cells with AdvpGal.
Results obtained and illustrated in figure 6.ii. show at 1000:1 m o.i, there was a greater 
than 90% T cell infectivity with adenovirus. On repeating the titration more extensively 
the optimal m.o.i. for pgal expression was found to be 600:1 (data not shown). The 
cells used in Figure 6.iii were stimulated with PHA prior to infection. Successful 
infectivity was confirmed by electrophoretic mobility shift assays (data not shown).
Figure 6.iii.
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Figure 6.iii. Ranges of m.o.i. investigated with 1000:1 showing greater than 90% of T cells can be infected 
with adenovirus. The T cells were infected with AdvO (shown in purple) or AdvpGal (shown in green) 
followed by flow cytometric analysis staining for pGal.
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6.2.3. Cytokine production from AdvO and IkB infected T cell lines
Having demonstrated by gel shift assays that IkB was overexpressed following infection 
of the T cells, the aim of this study was to investigate whether cytokine production was 
inhibited in iKBa-overexpressing T cells. Results sho^n in figure 6.iv. were obtained 
from three ttp-specific T cell lines which were either uninfected, infected with AdvO or 
with AdvIkB, the latter to induce the overexpression of IkB.
62J.1, Cytokine production from T cell lines treated with IL-2
The three different lines (A, B and C), shown in figure 6.iv. demonstrated considerable 
inter-experimental variation in levels of both IFN-y and IL-4 produced However since 
the cell lines were derived from different donors and on different dates, it is not 
surprising that variable cytokine responses were detected T cell lines B showed a 
reduction in the levels of IFN-y produced when comparing uninfected T cells with those 
overexpressing IkB. T cell line C showed reduced production of both IFN-y and IL-4 in 
response to IL-2, as illustrated in figure 6.iv.
6.2.3.2. Cytokine production from T cell lines stimulated with PHA
The three different lines (A, B and C) showed variable levels of both IFN-y and IL-4 
production on each occasion the experiments were conducted. In T cell line A levels of 
IFN-y were reduced comparing AdvO infected T cells with Adv-hcBa overexpressing T 
cells in response to PHA. Adv-hcBa overexpressing T cells line B showed a reduction 
in IFN- y production compared to uninfected T cells. T cell line C displayed a large 
degree of inhibition of IFN-y and IL-4 production from T cells infected with IkB 
compared with uninfected or AdvO infected T cells as illustrated in figure 6.iv.
Similar experiments were done with PMA, ionomycimand PMA with ionomycin, but no 
consistent differences in cytokine production were observed between uninfected, AdvO 
infected or AdvhcB-infected T cells (data not shown).
194
N. Akhtar PhD Thesis
Figure 6.iv : Production of IFN-y and IL-4 from three T cell lines in response to IL-2 
and PHA
T IL-2 PHA T IL-2 PHA
Figure 6 iv. Three different donor T cells monitored for their production of IFN-Q and IL-4 under different 
conditions. Unstimulated T cells (T), T cells with IL-2 and T cells in response to PHA. Under each 
culturing condition T cells were set up uninfected (open bars), infected with AdvO (speckled bars) and 
A c M k B  infected (filled bars). The upper levels of detection in the assays was 16,000 and 2000pg/ml for 
IFN-y and IL-4 respectively.
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6.2.4. Cytokine production from T cell lines treated with PMA in 
combination with CsA.
The aim of these experiments was to assess the production of IFN-y and IL-4 from T 
cells over-expressing AdvIicB in comparison with control T cells, either uninfected or 
transfected with AdvO (negative control for the virus).
T cells stimulated with PMA in the presence of CsA showed a decrease in levels of 
IFN-y and IL-4 produced in T cells infected with AdvIicB in comparison with those 
cells stimulated with PMA in the absence of CsA Highlighting the finding that CsA 
and PMA/iono causes the inhibiton of IFN-y in IkB infected cells in comparison with 
PMA alone. Infected T cells showed a decrease in levels of cytokines produced 
following treatment with PMA/iono in combination with CsA (Figure 6.v.). However 
there was no effect on IL-4 production, suggesting an NF-KB-independent pathway for 
IL-4 productioa
Figure 6.v.
600 0 2000
T -HL-2 +PMA +CSA +PMA/ +CsA T -HL-2 +PMA +CSA +PMA/ +CsA
10NO IONO
Figure 6.v. ttp specific T cell line uninfected (open bars), infected with AdvO (hatched bars) and AdvIicB 
infected cells were set up unstimulated, stimulated with IL-2 or PMA alone and in combination with CsA 
and PMA/ionomydn alone and with CsA. Graphs represent means of duplicate values for IFN-y and IL-4 
production from one experiment
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6.2.5. Cytokine production from IkB infected T cells stimulated with 
ttp and PHA
The aim of these experiments was to investigate the levels of cytokine production and 
levels of inhibition of IL-2, IL-4 and IFN-y in response to T cells over-expressing IkB 
to examine whether there was a differing response with cells stimulated with specific 
antigen, ttp compared to PHA.
The data shown in this chapter shows that there was little or no change detected in 
cytokine profiles in IkB infected T cells stimulated polyclonally, or through the IL-2R 
therefore antigen-specific stimulation of AdvhdB infected T cells was investigated. The 
ability of these cells to proliferate in response to Ag was tested (Figure 6.v.). The 
concentration of ttp was determined from a proliferation assay in which maximal T cell 
responses were obtained in response to stimulation with lOpg/ml (Calder et al. 2003).
The basal levels of production of IFN-y, IL-4 and IL-2 from unstimulated T cells are 
shown in Figure 6.vi. IFN-y levels were similar in both AdvO (120pg/ml) and 
AdvhcB (121 pg/ml) infected T cells and slightly reduced when compared to uninfected 
T cells (138 pg/ml), suggesting the virus had an effect on IFN-y, but NF-kB was not 
involved. IL-4 production was decreased slightly in IkB overexpressing T cells 
(28 pg/ml) compared to AdvO (41 pg/ml) and uninfected T cells (48 pg/ml). IL-2 levels 
produced from uninfected (173 pg/ml) and AdvO infected T cells (169 pg/ml) were 
similar though reduced in AdvhcBa infected T cells (40pg/ml), suggesting NF-kB is 
involved in IL-2 production by unsitmulated T cells. Clearly by inhibiting NF-kB, 
other signalling pathways could take over from NF-kB so all you can tell from this 
experiment is whether other pathways are involved when NF-kB is inhibited.
IFN-y production levels from T cells stimulated with ttp (353 pg/ml) was significantly 
higher than unstimulated T cells (138 pg/ml), though predictably lower than T cells 
stimulated with PHA (7859 pg/ml). AdvhcBa infected T cells (91 pg/ml) IFN-y 
production was slightly decreased when compared to AdvO infected T cells (153 pg/ml). 
Similar levels of IL-4 and IL-2 (44pg/ml and 169 pg/ml respectively) production was 
observed from cells AdvhdB infected compared to both uninfected (32 pg/ml and 
170 pg/ml) and AdvO T cells (44 pg/ml and 169pg/ml), suggesting NF-kB is not 
involved in IL-2 and IL-4 production by T cells in response to specific antigen. Again.
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all one may deduce from this experiment is whether other signalling pathways are 
involved when NF-kB is inhibited.
Cytokine production from cells stimulated with PHA were monitored for IL-4 and DFN- 
y. The production of IFN-y was decreased in AdvhcBa infected T cells (5631 pg/ml) 
compared to uninfected T cells (7859pg/ml). Levels of IL-4 (40pg/ml) were similar to 
those detected in unstimulated T cells (48 pg/ml) whereas AdvO (82pg/ml) and 
AdvhcBa infected T cells (73pg/ml) showed greater levels of IL-4 being produced than 
uninfected T cells (40 pg/ml).
Due to the variable results obtained from die ELISA assay it was not possible to 
calculate mean levels of cytokine production, of each T cell line assessed. Hence it was 
not possible to compare each of the cell lines statistically, however each data point 
shown for each cell line was conducted in duplicate samples therefore the mean values 
were illustrated.
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Figure 6.vi. Cytokine production from T cell lines stimulated with specific antigen 
compared with PHA
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Figure 6.vi. T cell line assessed  for cytokine production from unstimulated T cells and T cells stimulated 
with ttp [10pg] and PHA. The cytokine production being monitored from uninfected (open bars), AdvO 
(checked bars) and AdvkB (filled bars) infected T cells from one experiment Each data point represents 
mean values of duplicate samples.
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6.2.6. PCR experiments to monitor IFN y^ and IL-4 signal from 
AdvIicB infected T cells.
The aim of these experiments was to assess the mRNA signals of IFN-y and IL-4 from 
AdvIicB infected T cells.
RNA was extracted from 3 T cell lines that had been infected with AdvO or Adv- 
IkB and cDNA synthesised for PCR, to compare the relative levels of signal for IL-4 
and IFN-y mRNA expression with uninfected T cells. The results of one of the 
representative T cell lines is shown in Figure 6.vii. The signal intensities from the gels 
were graded by eye and results shown in Table 6. a. As with the ELISA experiments 
and real time PCR, the uninfected T cells, AdvO and bdBa infected T cells to either 
unstimulated or stimulated with ttp or PHA at 24 hrs were investigated for their 
expression of p-actin (as the housekeeping gene), EFNy and IL-4. All of the stimulated 
T cells showed a reduction in IFN-y in IkB overexpressing T cells. IL-4 expression was 
weakly detectable in two of the three uninfected T cell lines, AdvO infected control T 
cells displayed moderate levels of IL-4. In contrast hcBa infected T cell lines displayed 
increased levels of IL-4 in comparison with uninfected and AdvO infected T cells.
It is interesting that EFN-y was detected, albeit at a low level and only in the PHA- 
stimulated cells, in the three lanes (8, 9, 10) lacking p-actin expression which IkB- 
infected, suggesting the majority of cells were dead, (Figure 6.vii.). IL-4 appeared also 
to be upregulated in all IkB infected T cells, whether stimulated with feeders alone, 
specific antigen or PHA, perhaps suggesting a switch in cytokine responses by these 
cells.
These assays were preliminary and must be repeated, perhaps using larger numbers of T 
cells per condition. The lack of p-actin expression could be due to a decreased viability 
in the AdvhcB infected cells, which was not due to the virus since p-actin signals were 
readily detectable in the AdvO mock-infected cultures (lanes 4-6).
200
N. Akhtar PhD Thesis 
Table 6.& Expression o f  mRNA from T cell lines
Lanes
Expression o f c>tokine transcript
p-actin IFN-y IL-4
1. T + ^ f +/- +
2. T + ^ f + t t n + + +/-
3 T + ^ f + P H A ++ ++
4 T AdvO ++ ++ ++
5 T A d v O + ^ f ++ ++
6. T AdvO+ ^ f + P H A ++ ++ -
7. T Ix B a + +/- +/-
8 T I x B + ^ f - - +
9. T IkB + + ttp - - ++
10. T IkB « + + PHA - + +
Table 6.a. mRNA expression for cytokine transcripts by RT-PCR. Signal intensity was scored by eye as 
negative (-), weak (V-) moderate (+ ) or strong (++). T; T cells, ^f; irracfiated feeder cells; ttp -  tetanus 
toxid peptide from one T cell line.
Figure 6.vii.
p-actin (620bp)
IFN-y (378bp)
IL-4 (350bp)
Figure 6.vii Gel electrophoresis of RT-PCR products, from the cell line to which the above data relates 
(Table 6.a.), demonstrating the relative expression of IFN-y, IL-4 and p-actin.
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6.2.7. Real time PCR
The aims of these experiments were to quantitate IFN-y and IL-10 levels of expression 
from a panel of T cells as previously screened by PCR (section 6.2.6.) using the real 
time PCR technique.
The same cDNA samples tested in the PCR experiments described above were used for 
the real time PCR in an attempt to quantitate the relative levels of expression of IFN-y 
and IL-10. The cDNAs were run for each (2) of the experiments, with results shown in 
figure 6.viii. Results gave large error bars hence no significant differences were 
observed between T cells and feeder cells and cells stimulated in other conditions. 
However there were two lines (A and B) that showed a considerable inhibition of IFN-y 
following IkB overexpression. These were in response to PHA, compared with AdvO 
infected T cells in response to PHA and AdvO infected T cells in response to ttp 
compared to IkB overexpressing T cells in response to ttp. Overall the mean cytokine 
levels of IFN-y and IL-10 were low. Unfortunately. TadvO and ttp responses w ere not 
determined for line A in this study and are important controls for the effect of mock 
virus on responses to antigea This series of experiments needs to be repeated before 
any firm conclusions can be drawn Nevertheless IL-10 expression appeared to be 
unaffected throughout the experiment at this timepoint (24hr).
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Figure 6.viii Real time PCR- a relative quantitative comparison of cytokines IFN-y and 
IL-10 following infection with AdvO AdvIicB.
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Figure 6.viii. Illustrates 2 T cell lines (A-*B) stimulated with autologous feeder cellsdone (T+F), or with ttp 
(T+tt), with PHA (T + PHA) with or without AdvO or AdvIicB. Calculations to find gene of interest done 
using the comparative CT method, as described in Chapter 2. IFN^y gene expression represented by filled 
bars with IL-10 gene expression shown in open bars. Statistical significance levels:- 0 p< 0.05, * p<
0 . 0 1 ,* p < 0 . 0 0 1 .
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6.3 Discussion
The focus within this chapter was to investigate the effects on c>*tokine production and 
CAtokine gene expression in T cells infected to OAer-express IkB in an attempt to block 
NF-kB activation, a crucial step in pro-inflammatory cytokine signalling pathways. 
Several experimental strategies were employed to investigate the effects of IkB over­
expression in this chapter. Initial experiments shown in Figures 6 .ii and 6 .iii address the 
feasibility of T cell infectivity with adenoviral vectors. It is very difficult to infect T 
cells with adenoviral vectors, for various reasons. However results from Figure 6 .iii 
demonstrate a high percentage of T cells taking up the adenoviral vector (Adv-pgal 
control), provided that the T cells were activated. Even comparing freshly isolated PB-T 
cells stimulated with PHA, the infectivity rates are much lower than with chronically 
restimulated T cell line cells. Following transfection it is important to assess if the 
transfection has any effects on cell viablility or the activation status. In order to 
establish whether the transfection procedure effects the T cell viability or activation 
status it is critical to set up parallel control cultures of T cells and conducting regular 
cell counts with PI to monitor cell viability over time and to monitor the effects of 
stimulation of the cells via CAtokine production/expression by ELISA/Aoav CAtometry.
Other researchers haAe shown in vivo activated but not resting human T cells to be 
permissive to adenovirus infection and therefore allow analysis of NF-icB-dependent 
signaling pathways (Conron et al, 2001). Other cell types such as alveolar macrophages 
(Conron et al, 2001), RA synovium macrophages, cell lines such as CV-1 origin SV-40 
(COS), Chinese hamster ovary or Jurkat cells (Bondeson et al, 1999) and human DCs 
(Calder et al, 2003) have been shown to be able to be transfected efficiently. All major 
cell types derived from a pathological site, such as the rheumatoid synovium, appear 
able to be infected with adenovirus with a high frequency. It is probable that the state of 
activation of the cell, such as in T cells, as well as expression of integrins and other 
receptors is important for increasing infectability (Bondeson et al, 1999). In mature 
human DCs it has been reported that antigen presentation is NF-kB dependent. NF-kB 
coordinates MHC expression, costimulatory molecule (CD80/CD86) expression and 
cytokine production (eg IL-12). The expression of molecules regulating the adherence 
of APCs to T cells such as LFA-1, ICAM-1 and ICAM-3 is also regulated by NF-kB as 
is the duration of APC-T cell contact (Yoshimura et al, 2001).
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Having demonstrated our ability to transfect human T cells with Adv-IkB, the aim of 
this study was to investigate whether the IkB overexpression by T cells could inhibit 
NF-kB-mediated cytokine signalling. The cytokine responsiveness to a range of stimuli 
was therefore examined, using different cytokine detection techniques.
The ELISA results gave rise to considerable variability, in terms of levels of cytokine 
production from control T cells, AdvO and hcBa. infected T cells, although it was 
observed that most of the cell lines investigated showed an inhibition of IFN-y when 
IkB was overexpressed whether die cells were stimulated with PHA, ttp, PMA or 
PMA/ionomycia It should be noted that human T cell lines obtained from different 
donors on different days are invariably heterogeneous in their responses, and that many 
more lines and clones need to be examined to reach any firm conclusions as to the 
effects on T cells overexpressing IkB. In contrast the overexpression of IkB had little 
effect on the production of IL-4 and most of die cell lines showed similar or increased 
levels of IL-4 when cells were overexpressing IkB. This may be accounted for by the 
differential regulation of IFN-y and IL-4. It is known that IFN-y is NF-kB dependent 
whereas IL-4 signalling utilizes the NF-AT and AP-1 pathways and is independent of 
NF-kB (Conran et al 2001). It must also be clarified that in figure 6 iv the limits of IFN- 
y and IL-4 detection were 16,000 and 2,000 respectively and may have shown 
considerably enhanced effects if time had permitted for the supernatants to re-titrated in 
further ELISAs. Additionally ELISA results illustrated in figure 6 v are from one 
experiment showing the means of duplicate samples therefore represent preliminary 
data that would need to be repeated. Some doubts on the validity of these results (6 v) 
may be cast, as there is a lack of IFN-y expression upon stimulation. However it is 
noteworthy that for stimulation with PMA and CSA an inhibition of IFN-y is observed 
with AdVhcB and not AdvO. If it was permissible future experiments of this nature 
would be repeated and seek to monitor the levels of IL-10 produced in response to PMA 
and CsA. Similarly results shown in figure 6 vi may be questioned regarding the 
validity of the results, in particular for IFN-y production, which was greatest in 
uninfected cells whether unstimulated, or stimulated with ttp or PHA, suggesting the 
virus itself might have an effect. Results shown in 6 vi for EL-2 and IL-4 also showed 
similar levels of the cytokines in uninfected, AdVO and AdVhcB infected T cells. The 
variability of the ELISA results made it difficult to draw any conclusive results and 
would benefit from being repeated.
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The mRNA from transfected and control cells were extracted and initially assessed for 
cytokine expression via PCR at 24hr post stimulatioa From these experiments it 
appeared to show a downregulation of cytokine expression in the IkBa overexpressing 
cells. It must be noted that despite obtaining a signal for IL-4 in samples 7 - 1 0  and 
both IL-4 and IFN-y in sample 10, there was no signal for p-actin so essentially these 
results may not be interpretable. However, if the signal for IFN-y is considered real for 
sample 1 0  (failure to detect p-actin) there is a considerable decrease in the signal for 
IFN-y with cells overexpressing IkBa following stimulation with PHA in comparison 
to both T cells and T AdvO cells (in combination with feeder cells) stimulated with 
PHA, when a strong IFN-y signal was observed. It is suspected that the cytokines 
detected may be as a result of the irradiated feeder cells in the IkB samples, resulting in 
no p-actin but the detection of cytokines although uninfected T cells and ^feeder cells 
did not expressIL-4 signal. It is also likely that at earlier timepoints after stimulation, a 
more pronounced signal would be detectable and therefore this experiment should be 
repeated looking at an earlier timepoint. Nevertheless these results prompted the 
investigation of cytokine expression by the real time PCR to try to quantitate levels.
It has been reported that NFAT proteins are expressed in most immune system cells and 
are involved in the regulation of critical cytokine genes transcription for the immune 
response. A series of novel immunosuppressive drugs (3,5-bistrifluoromethyl pyrazole 
(BTP) derivatives) block Thl and Th2 cytokine gene transcription. These drugs have 
been shown by electrophoretic mobility shift assays and confocal microscopy block the 
activation-dependent nuclear localization of NFAT and prevent the movement of NFAT 
from the cytosol to the nucleus (Trevillyan et al, 2 0 0 1 ).
Hence it was decided to test the effects of CsA in T cell lines overexpressing IkB as it is 
known to block the NF-AT cytokine pathway. CsA is known to completely inhibit the 
activation of transcription of the IL-2 gene, which is modulated by transcription factors 
NF-AT, NF-IL2A and NF-IL2B. Cyclosporin also partially inhibits transcriptional 
activation mediated by transcription factor NF-kB (Ibelgaufts, 2002). It has been 
suggested that NF-AT2 regulates IL-4 and EL-13 production and the inhibition of IL-4 
and IL-13 correlated with the defective induction of NF-AT2. It was observed that 
defective NF-AT2 induction had no effect on IFN-y productioa Contrary to this, 
stimulation of T cells with anti-CD3/28 mAb in the presence of CsA, which blocks
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nuclear import of NF-AT has also shown to increase in IFN-y secretion (Rafiq et al, 
1998). Another report suggests the defective expression of both NF-AT 1 and NF-AT2 
is responsible for the deficiency of mRNA for EFN-y in SCID patients (Feske et al, 
2000). However results in our study showed a considerable amount of variability in the 
production of cytokines, IFN-y and IL-4, despite IicBa over-expression and treatment 
with CsA. It is noteworthy and encouraging that both IL-2 and PHA-induced 
production of IFN-y and IL-4 were downregulated by IkB (figure 6 .iv. C). Although a 
decrease in IL-4 production was noted, in IkB infected T cell stimulated with 
PMA/ionomycin with CsA compared to PMA/ionomycin alone, it was a nominal 
decrease. It would be of benefit if these experiments were to be repeated to obtain better 
consistency of results.
It has mostly been reported that PMA with ionomycin is a potent stimulator of T cells 
and generally greater levels of cytokines are detected with this mode of stimulation. 
Our ELISA data showed cytokine production in response to PMA and PMA with 
ionomycin be lower than observed in response to PHA, hence it would be valuable to 
repeat these experiments. Due to the discrepancies in results observed in response to 
polyclonal stimulation it was decided to investigate cytokine production in response to a 
more specific ttp response in AdvhcBa infected stimulated T cells. Again experiments 
were conducted and repeated at least four times (data not shown) however still showed 
considerable variability in cytokine responses and degrees of inhibition with IkB. The 
cell line in figure 6 .iii. illustrated some hcB-mediated inhibition of production of IFN-y 
in response to stimulation with PHA and to a greater extent, ttp,. Hence, therapeutic 
intervention via hcBa upregulation appears to show some promise for inflammatory 
disorders. A drug currently in development is being designed to inhibit the degradation 
of IkB (Delhase et al, 2000). Another agent, PSI (Calbiochem) is known to block NF- 
kB but also exerts other inhibitory effects and is toxic to cells at higher concentrations 
so would be unlikely to be of therapeutic benefit.
Real time PCR results presented in section 6.2.7 and results illustrated in 6 viii show 
only a slight induction of IFN-y hence making it difficult to report a conclusive finding 
from the results. However it would appear from 6 viii line A comparing Adv plus PHA 
with Adv-lKB plus PHA showed a significant reduction in the levels of IFN-y produced.
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As before, the variability between the two cell lines and the effects of Adv-IicB would 
necessitate these experiments to be repeated.
A recent report suggests that if NF-kB inhibitors were to be used to treat inflammation, 
the timing of the drug efficacy would be crucial. In that study, using carrageenin- 
induced pleurisy in rats as a model for acute inflammation, it was found that there were 
two phases in which NF-kB was upregulated. Early NF-kB activity was detected after 
6  hrs and was associated with the expression of iNOS and the inflammatory gene TNF- 
a, along with the anti-apoptotic molecule Bcl2 in infiltrating leukocytes. Late phase 
NF-kB, upregulated 24 - 48 hrs following induction of inflammation, coincides with 
increased COX2 expression as well as TGF-pl, and the pro-apoptotic molecule Bax 
was expressed at 48 hrs (Bell, 2002). Therefore, NF-kB activation during the onset of 
inflammation is associated with pro-inflammatory gene expression, whereas its 
activation during the resolution of inflammation is associated with the expression of 
anti-inflammatory genes and the induction of apoptosis (Lawrence et al, 2001). 
Inhibition of NF-kB during the resolution of inflammation protracts the inflammatory 
response and prevents apoptosis. This suggests that NF-kB has an anti-inflammatory 
role in vivo involving the regulation of inflammatory resolution The NF-KB-dependent 
triggering of apoptosis in leukocytes in the early phase appears to be an important 
pathway in inflammatory responses and could be targeted therapeutically (Bell, 2002).
In view of NF-kB having a central role in inflammation, selective inhibitors of the 
molecule chould prove to be efficacious anti-inflammatory agents. It has bean reported 
that anti-inflammatory drugs such as glucocorticoids, and high-dose aspirin and 
sulfasalazine act to decrease NF-kB activation through various mechanisms (Handel 
and Girgis, 2001). The identification of specific inhibitors of NF-kB activation may 
result in the development of more efficacious anti-inflammatory agents with fewer side- 
effects than steroids (Roshak et al, 2002) and CsA.
One major concern with this approach is that inhibition of NF-kB may result in 
generalised immune suppression and impairment of host defences. Knockout mice 
lacking NF-kB proteins tend to develop septicaemia (Barnes, 2001). However, several 
pathways of NF-kB exist and, since certain ones appear be more relevant in 
inflammatory conditions, these would be more attractive targets for therapeutic
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intervention (Nasuhara et al, 1999). It is also worthy to consider that the effective 
downregulation of antigen-specific T cell responses following the blockade of NF-kB in 
DCs could prove to be an efficient immunomodulatory approach in conditions involving 
inflammatory T cell responses (Calder et al, 2003). Another (upstream) potential target 
for immuno mod ulation, involved in the NF-kB signalling cascade, could be IL receptor 
associated kinase 4 (IRAK4) involved in the adaptive and innate immune responses and 
in the generation of IL-18 which consequently induces responses such as NK cell 
activity, Thl IFN-y production, and Thl cell proliferation, all of which are severely 
impaired in IRAK-4-deficient mice. ERAK-4(-/-) Thl cells also do not exhibit NF-kB 
activation or IkB degradation (Suzuki, 2003).
As discussed in the previous chapter the production of IL-10 is thought to be important 
for the generation and/or action of regulatory T cells. During the Third International 
Workshop on IL-10 (2001), A. O’Garra described the generation of regulatory T cells as 
a result of treating T cells (both with and without APCs) with vitamin D3 and 
dexamethasone. It was proposed that the inhibition of activation of NFkB in the APCs 
causes the increased generation of IL-10 producing regulatory T cells in coculture along 
with a block in their expression of pro-inflammatory genes (Volk et al, 2001). We 
looked to see if there was an effect on IL-10 gene expression from the T cells infected 
to over-express IkB, but only minimal IL-10 was detected. The cDNA used in PCR and 
real time PCR experiments would also benefit repetition at an earlier time point such as 
4 hrs post stimulation as the peak cytokine signal is occurring much earlier than die 24 
hrs time point used in this study. Therefore the extraction of mRNA in future 
experiments should be repeated at earlier timepoints post stimulation for the detection 
of higher levels of cytokine expressioa This may produce a greater insight into the 
effects of cytokine production/expression in relation to NF-kB blockade.
It must be mentioned that the hope that surrounded the clinical efficacy of gene therapy 
has not matched with the expected results and a variety of gene therapy trials worldwide 
have produced few successes. Concerns were raised about die toxicity of viral vectors 
and about die ethics of such trials after one patient with an ornithine trans cab amylase 
(OTC) deficiency died after hepatic arterial injection of an AdV carrying a wild-type 
version of the defective enzyme. Also the hope that surrounded the successful 
reconstitution of immune responses in children with X-linked severe combined 
immunodeficiency (X-SCID) using retro viral-mediated deliver} of wild-t}pe gene to
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bone marrow has been hindered by the development of leukaemia in some of the 
patients as a consequence of retroviral insertion In respect of these findings it may be 
too ambitious to attempt long-term genetic reconstitution with such approaches whereas 
in contrast transient gene delivery of contemporary diseases, such as allergy, may offer 
significant clinical benefits (Young et al, 2006).
Ad5-based vectors had been successfully administered in several clinical trials. 
However the Gelsinger case showed that a high dose of the adenovirus may give rise to 
an overwhelming immune response. The AdVs have a broad tissue tropism and 
therefore widespread delivery, and can result in the transduction of non-target tissue 
making the prospect of systemic delivery particularly challenging. In light of this 
problem alternative serotypes and different attachment specificities, besides CAR, are 
currently under investigation as well as the potential use of animal adenoviruses 
(AAVs) for human gene therapy (Young et al, 2006).
Potential problems with AAVs are that many individuals have neutralizing antibodies to 
AAV due to prior infection Additionally the administration of AAV elicits a strong 
humoral response, which can interfere with subsequent doses. A recent phase I trial for 
haemophilia B (Factor IX) using intra-hepatic artery delivery had to be curtailed due to 
concerns of possible liver damage and immune responses to the vector (Kaiser, 2004).
Disadvantages of AdVs include: the non integration of the viral DNA into the host 
hence expression being transient, viral proteins are expressed in the vector following 
administration into the host and AdVs are common human pathogens therefore the in 
vivo delivery may be hampered by prior host immune response to a virus type. The 
field of AdV gene delivery system is an attractive option to rectify defective genes or to 
suppress certain genes such as NFkB however there is need for further studies and 
optimisation of such a delivery system before it can be brought to the clinic (Alba et al, 
2005).
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General Discussion
The focus in this thesis has been to apply cytokine immunomodulating techniques to 
human T cell lines, derived from patients with immune-mediated disease, displaying 
skewed Thl and Th2 cytokine profiles. In vitro manipulation and modulation of such 
cells lines was applied to further understand cytokine-directed immunomodulatory 
strategies for potential future therapeutic use. The term “immunomodulation” usually 
refers to stimulating the immune system along a clinically beneficial pathway (Foster, 
2004). In both immune-mediated ocular conditions CAED and TAO, the 
immunopathology is thought to involve abnormal cytokine production by infiltrating 
cells. It is well-documented that defects or dysregulation of cytokine function may be 
the direct cause of disease, and in many pathological conditions they participate in the 
advancement of the disease in various conditions such as allergic responses, 
autoimmune disorders, graft rejection and cytotoxic responses against tumour cells.
The potential uses of cytokine immunotherapy highlighted include the application of 
cytokines for switching cytokine profiles or functional anti-cytokine blocking 
antibodies. Alternatively, targeting cytokine signalling molecules or their pathways 
may also provide a route for regulating cytokine function, production or the overall 
cytokine balance. In chapters 1, 5 and 6 the results using these methods have been 
presented and discussed. In this chapter, I will briefly highlight other 
immunomodulatory approaches that may be considered as having potential and being 
of relevance to explore and adopt for future research in the quest for improved 
immunomodulatory strategies for CAED and TAO. In light of the recent resurgence 
in the immunomodulatory capacity of T reg cells, a significant proportion of the 
discussion section is dedicated to T reg cells and their potential uses in 
immunotherapy. Most of the work described relates to other Thl and Th2 associated 
pathological conditions however findings could be considered as novel approaches for 
CAED and TAO. It should be noted that clinical trials using several cytokines in 
therapy have been used in various diseases.
IFN-y was one of the first immunomodulatory molecules studied in the 1980’s. 
However it was found to be quite toxic in humans resulting in side effects such as 
severe nausea, vomiting, fever and headache (Jaffe et al, 1991). Gene therapy with 
IFN-y has been investigated and has been successful in murine studies at inhibiting
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airway hyperresponsiveness, airway eosinophilia and IgE levels in sensitised mice 
when compared with controls (Li et al, 1996). Despite these findings this approach 
has not been tried in humans as it is regarded as unethical to use such a form of 
therapy for die treatment of non-life threatening disease. Mouse studies using 
recombinant murine IL-12 administered at the time of immunisation and through an 
aerosol showed this therapy could modulate eosinophilia, IL-12 production and 
suppress die production of IgE. Intravenous and inhalation trials with IL-12 in 
humans have not proved to be as successful and resulted in significant toxicity (Bryan 
et al, 2000). It has been postulated that the administration of both IFN-y and IL-12 
should be tried with polyethylene glycol moieties (pegylation) in view of the fact that 
die liposomal forms of therapeutic agents such as amphotericin B and IFN-a2a have 
been shown to be effective in reducing systemic toxicity (Bloebaum etal, 2004).
In both allergic and autoimmune diseases, there is an aberrant expression of a range of 
cytokines many of which have overlapping functions. It would therefore appear 
increasingly unlikely that therapies targeted at single cytokines will have broad 
enough efficacy to be therapeutically useful (Macaubas et al, 2002). Increasing 
evidence of the pathological roles of multiple cytokines in orchestrating and 
perpetuating inflammation in asthma has prompted the evaluation of novel anti­
cytokine therapies. Anti-IL-5 antibody markedly reduces peripheral blood and airway 
eosinophils, but does not appear to be effective in symptomatic asthma Inhibition of 
IL-4, despite promising early results in asthma has been discontinued and blocking 
IL-13 might be more effective. Agents that target IL-13 are still early in die 
development process. Inhibitory cytokines, such as IL-10, interferons and IL-12 are 
less promising, as systemic delivery produces side effects. Inhibition of TNF-a may 
be more useful in severe asthma Many chemokines are involved in the inflammatory 
response of asthma and several small molecule inhibitors of chemokine receptors are 
in development. CCR3 antagonists, which block eosinophil chemotaxis, are in clinical 
development for asthma therapy. Because so many cytokines are involved in asthma, 
drugs that inhibit the synthesis of multiple cytokines may prove to be more useful; 
several such classes of drug are now in clinical development and any risk of side 
effects with these non-specific inhibitors may be reduced by the inhaled route 
(Ichinose and Bames, 2004). However it may be too simplistic to define all tissue
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responses as either Thl or Th2. It has been shown that increases of IFN-y have 
effects in exacerbating allergic diseases (Sterner al, 2005). The production of IFN-y 
may be an integral component of allergic conjunctivitis as well as with some other, 
previously Ih2 classified diseases (Magnan, et al, 2000).
The increased prevalence of both autoimmune and allergic disorders has been 
proposed to be the result of decreased exposure to common pathogens. The so-called 
hygiene hypothesis’ proposes hat an increase in allergic diseases such as asthma has 
arisen due to a reduction in childhood exposure to bacterial and viral pathogens that 
are hypothesized to be protective against asthma and other atopic disorders (Willis- 
Karp et al, 2001). It has been proposed that the genetic background as well as the 
effect of the viral infection is likely to contribute to the subsequent allergic 
sensitisation and disease (Dahl et al, 2004). The hygiene hypothesis’ provides an 
explanation for ‘allergy epidemics’ although its immunological basis remains 
controversial (Romagnani, 2004).
The importance of reduced immune suppression rather than missing immune 
deviation has been focussed upon more recently. This theory postulates that reduced 
microbial burden does not result in the induction of lower production of Thl- 
polarising cytokines, but decreases activity of T regulatory cells, and subsequent 
immune suppression (Yazdanbakhah et al, 2002). It has been reported that treatment 
of mice with SRP299, a killed Mycobacterium vocozi-suspension, gives rise to 
allergen-specific CD4CD45RBio Treg cells, which suppress airway inflammation via 
EL-10 and TGF-p. Antibodies against IL-10 and TGF-p completely reversed the 
inhibitory effect of CD4+CD45RB1<} T cells. In light of these findings, Treg cells 
induced by mycobacterial treatment may play a role in restoring the cytokine balance 
to prevent and treat allergic diseases (Zuany-Amorim et al, 2002). It has been 
reported that Treg cells control immune reactions to commensal and pathogenic 
bacteria (Asseman et al 2000).
The oral administration of antigen also induces tolerance by suppressing T cell 
mediated immune responses by die secretion of TGF-p from regulatory T cells. Oral 
tolerance has been shown to be effective in suppressing several experimental
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autoimmune diseases such as EAE (Higgins and Weiner, 1988), collagen-induced 
arthritis (Thompson and Staines, 1986) and adjuvant-induced arthritis (Zhang et al, 
1990), EAU (Nussenblatt et al, 1990), and spontaneous diabetes in NOD mice (Zhang 
et al, 1991). Low doses of oral antigen induce active suppression whereas high doses 
induce clonal anergy and deletion (Weiner, 2001). In MS patients the prolonged oral 
administration of myelin has been shown to increase MBP-specific TGF-p 1 secreting 
“Th3” cells (Fukaura et al, 1998), although there was only a poor clinical benefit of 
oral S-antigen in patients with autoimmune uveitis (Nussenblat et al, 1990), 
suggesting that there is a differential response which depends on the target organ.
During the last few years, the concept of T reg cells has received much attention by 
the scientific community, and excitement about the possibility of these ceils in 
therapeutic applications for the treatment of diseases associated with dysfunctional T 
cell regulation. The understanding of immune mechanisms that prevent disease 
occurrence in healthy individuals and evidence for healing linked with altered 
regulatory mechanisms in various autoimmune and allergic diseases offers promise 
for new immune interventions.
There are several modes of suppression by T reg cells, ranging from the anti­
inflammatory cytokines IL-10 and TGF-p to cell-to-cell contact via inhibitory 
molecule CTLA-4. However it is important to distinguish in vitro versus in vivo data 
as they seem to diverge. It must also be recognised that in vivo suppression requires 
careful consideration of the location of T reg and effector cell interactioa The current 
enormity of interest into the potential of T regs is due to potential beneficial effects in 
the outcome of infection, autoimmunity, transplantation, cancer and allergy. It is well 
recognized that interference strategies exist within the immune system, including the 
secretion of cytokines such as IL-10 and TGF-p, to play an important role in the 
down-regulation of inflammatory immune responses and curtail the expansion and 
functional properties of other cells (Moore et al, 2001). Both cytokines are important 
mediators of CD4+ CD25+T reg cells in vivo (Maloy and Powrie, 2001).
Strategies directed at manipulating natural T reg cell function have a number of 
potential therapeutic benefits. In a variety of infections in both mice and humans, the
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removal of natural T reg cells (assessed by expression of CD25) has resulted in 
enhanced effector immune responses (Cabera et al, 2004; Suvas, et al, 2003; Kinter et 
al, 2004 and Mendez et al, 2004). Targeting molecules involved in regulatory cell 
activity in vivo such as CTLA-4, TGF-p or IL-10 alone or in combination has shown 
to be effective in controlling many chronic infections (Gangappa et al, 1998; Belkaid, 
2001; Murphy, 1998). Additonally it has been observed that T reg cells express high 
levels of growth inhibitor genes, including suppressor of cytokine signalling (SOCS) 
1 and 2, (the role of SOCS molecules will be discussed in detail later in this section), 
PD-1 and TGIF. In order to overcome the cell-cycling block a combined strong 
TCR/CD28 signal plus high doses of IL-2 would be required (Bluestone and Tang,
2004).
In order to accomplish a better understanding of the mechanisms of action of the 
naturally occurring T reg cells it would be of great benefit to identify a cell surface 
marker that could uniquely identify this population. A recent study by Powrie and 
colleagues (poster presentation at BSI, Harrogate, December, 2005) profiled the gene 
expression of naturally occurring CD4+CD45RBio CD25+T reg cells in comparison to 
their antigen-experienced CD45RBloCD25+ counterparts. Results revealed a profound 
difference between the populations, in particular following in vitro activation. 
Findings from die study showed die identification of Gpr83 as a cell surface marker 
expressed on T reg cells. The orphan G-protein coupled receptor was shown to be 
highly enriched within the CD45RB1oCD25+ both ex vivo and following in vitro 
activation and occurs constitutively rather than as a consequence of activation.
It has been observed that the reteroviral transduction of Foxp3 into naive CD4+ T cells 
results in the induction of Gpr83. A similar pattern of enrichment was also observed 
in human peripheral and thymic CD4+CD25+ T reg cells. These facts taken together 
indicate a potential role for Gpr83 in the functioning of Foxp3+ regulatoiy T cells 
(Toms, et al, 2005). A recent study has highlighted the potential of generating, 
extraihymically, de novo CD4+ CD25+ T reg cells within secondary lymphoid tissue. 
This finding may represent an important step forward in the induction of antigen 
specific tolerance in both allergy and autoimmunity, and may be beneficial in the 
prevention of tumour-specific immune responses (Kretschmer, et al, 2005). Further
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studies exploring the presence of Foxp3 and Gpr83 on T regs would be of immense 
value. In the case of this particular study it would be intriguing to screen for the 
presence of the cell surface marker Grp83 on die Foxp3+ cells that have been 
identified on AKC conjunctival cells following treatment with CsA. Since the 
compilation of this thesis, within laboratories at the Institute of Ophthalmology, under 
the supervision of Dr V. Calder, research work is being conducted to investigate the 
expression of Foxp3, comparing pre-treated and post CsA treated conjunctival T cells 
from CAED patients. Preliminary results indicate there is a considerable upregulation 
of Foxp3 in post CsA treated cells, suggesting a role of T reg cells. Also in a situation 
where extra ocular muscle biopsies from TAO patients were available it would be of 
benefit to screen tissues for Foxp3 and Grp83 comparing treated versus untreated 
patients or pre and post treatment with steroids.
The recognition of self-agonist ligands in the thymus can give rise to at least two 
different sublineages of self-reactive T cells. It was proposed that this probably 
occurred at a double-positive stage of differentiation in the thymus where the Foxp3 
deficiency probably leads to autoimmune pathology in a variety of organs, as occurs 
in IPEX patients. The development of a method to detect Foxp3 expression at a 
single-cell level would help to monitor the dynamics of T reg cells in clinical settings. 
Additionally a better understanding of the signals that induce Foxp3, identification of 
Foxp3 downstream targets and further elaboration of T reg effector mechanisms are 
vital (Kronenberg and Rudensky, 2005).
In addition to die recognition and identification of T reg cells, it would be of immense 
benefit within many clinical domains to be able to manipulate these cells with a view 
to expand T reg cells for immunotherapy. A recent study by Li et al, 2005, using 
CD4+CD25+ T reg cells and CD4+CD25' control T cell lines generated from cord 
blood sought to examine the signalling properties of human T regs. The T reg lines 
were extremely hyporesponsive to stimulation with dendritic cells also in response to 
anti-CD3/CD28 coated beads. This unresponsiveness was reversed by the addition of 
exogenous IL-2. The TCR (CD3/CD28) mediated activation of Rap 1 and Akt was 
retained in T regs however the activation of Ras, mitogen activated protein kinase 1/2 
(MEK1/2) and extracellular signal regulated kinase 1/2 (Erk 1/2) were found to be 
impaired. The T regs had a high susceptibility to apoptosis that was reversed by IL-2
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and correlated with the activation of Erk 1/2 and the up-regulation of Bcl-x(L) and 
phosphorylation of Bad (Bcl2 antagonist of cell death). The results of this study 
suggest that TCR-CD3/CD28-mediated and IL-2 receptor-mediated signals converge 
at the level of MEK-Erk axis which may exist as a novel strategy for T reg cell 
expansion and therefore as a potential to exploit as a form of immunotherapy, (Li, et 
al, 2005).
Many studies have highlighted the de novo generation of suppressor cells however the 
recent study by Kretschmer et al, (2005) stressed the importance of discriminating 
between these and preexisting suppressor cells by antigen-induced proliferatioa 
Although the conversion is inhibited by proliferation, the proliferation of already 
converted cells is no longer detrimental to their suppressor function. Both conversion 
and subsequent proliferation may represent important strategies in the induction of 
antigen-specific tolerance (Kretschmer, et al, 2005). Understanding the factors that 
are involved in deriving and expanding Foxp3-expressing cells along with their tissue 
trafficking will be important if the cell type is to be exploited for therapy (Fontenot, 
etal, 2005).
The utilization of the histamine pathway may serve as a potential target for the 
treatment of chronic allergic individuals though this remains to be elucidated (Akdis,
2005). Histamine actively participates in the function and activity of DC precursors, 
as well as their immature and mature forms. The histamine receptor 2 (HR2) is 
known to be a key factor associated with peripheral tolerance. HR2 acts as a 
suppressive molecule for antigen-presenlation capacity, suppressing IL-12 production, 
enhancing IL-10 production and inducing IL-lO-producing T cells (Mazzoni et al, 
2001, van der Pouw etal, 1998). Differential patterns of HR expression exist on Thl 
and Th2 cells and appear to determine reciprocal T-cell responses after histamine 
stimulation. Thl cells predominantly, but not exclusively, express HR1, whereas Th2 
cells display increased expression of HR2. Histamine enhances Thl-type responses by 
triggering HR1, whereas both Thl - and Th2-type responses are negatively regulated 
by HR2 (Jutel, i.,et al, 2001). Consequently histamine release and HR2 promote die 
development of peripheral tolerance during SIT. Histamine induces the production of 
IL-10 by DCs (Mazzoni etal, 2001) and Th2 cells and suppresses both Thl and Th2
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cytokines (Osna, etal, 2001; Jutel, etal, 2001). Additionally, histamine enhances the 
suppressive activity of TGF-p on T cells (Kunzmann et al, 2003).
The reconstitution of athymic nude mice with CD4+ CD25+ T cells prevented 
autoimmunity (Sakaguchi et al, 1995). CD4+ CD25+ T reg cells have also been 
implicated in the suppression of other cells involved in inflammatory processes such 
as monocytes/macrophages as well as T effector cells (van Amelsfort, 2004). It 
would be of great interest to elucidate whether an impairment of this response is 
evident in autoimmune and allergic diseases. In RA strategies to control the chronic 
inflammation have included TNF-a blockade which can lead to the temporary 
breakdown of the inflammatory process possible to re-establish the natural 
immunoregulatory mechanisms (Feldman, and Maini, 2001), skewing from Thl to 
Th2 type CD4+ T cells (van Roon et al, 2001) or towards EL-10 producing T reg cells 
(Yudoh, et al, 2000) which have the ablility to induce a shift from proinflammatoiy to 
anti-inflammatory responses.
In humans increasing evidence suggests that immunity to HIV infection may be 
controlled by natural T reg cells. AIDS is associated with the depletion of CD4+ T 
cells. Increases of anti-HIV-specific CD4 and CD8 T cells have been reported in 
response to the removal of T reg cells from peripheral blood (Aandahl, et al, 2004). It 
has been reported that in vitro HTV-specific CD4 and CD8 T cell responses, from 
most HTV-infected individuals, are substantially abrogated by T reg cells (Kinter et al, 
2004). The suppression is cell contact dependent and cytokine independent which 
supports the involvement of natural T reg cells.
A recent study reported that, in addition to the CD25+ CD4+ T reg cells, several other 
important self-reactive T cell sublineages have been identified. The main cells in this 
category of T cells include cells expressing a semi-invariant TCR specific for 
conserved self ligands. These ligands, usually present at a low level might be induced 
to serve as a molecular signal for stress or infection The best characterised of these T 
cell sublineages is the CD ld-dependent NK T cell. Another example of this type of T 
cell are the mucosal invariant T cells that are reactive with the MHC class I molecule 
MR-1. In contrast to CD25+ CD4+ T regs cells that have a dedicated suppressor
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function, the NK T cells in some situations allow autoimmune pathology whereas in 
others they are part of a protective mechanism (Kronenberg and Rudensky, 2005). 
Therefore it is essential to recognise that there may be a detrimental effect of T reg 
cells as they dampen the immune system and hence hinder the effective control of 
viruses and bacteria A consequence of modulation of excessive immune responses 
by natural T reg cells is enhanced pathogen survival and long term persistence in 
some cases (Belkaid and Rouse, 2005). For example natural immunity to malaria has 
been observed in endemic areas and the T reg cells include one possibility. In mouse 
models of malaria the depletion of natural T reg cells protects mice from death from 
the lethal strain of Plasmodium yoeliii and the removal of natural T reg cells during 
malaria allows the restoration of an effective immune response resulting in the control 
of die infection (Hisaeda, et al 2004). This phenomenon has also been observed with 
viral infections such as with mice depleted of natural T reg cells and infected with 
HSV show a considerable enhancement of CD4+ and CD8+ responses. Mice 
immunized, lacking natural T reg cells show greater resistance to viral challenge 
(Suvas, et al, 2003). Also in mice chronically infected with Friends leukaemia virus, 
the increased number of natural T reg cells compromises the efficacy of protective 
CD8+T cell responses (Iwashiro etal, 2001).
It has been highlighted by Sakaguchi (2005), that there exists a delicate balance 
between effectiveness and dysfunctional consequences of T reg cells. He postulates 
that similar to their effect on immunity against pathogens T reg cells can also hinder 
effective immunosurveillance of tumours. Using this theory T reg depletion may 
result in tumour rejection, but may concurrently lead to autoimmunity. Targeting the 
T reg cells holds much promise for autoimmune diseases however, a far greater 
understanding of T reg cells is essential due to the profound effect on myriad 
conditions which intensifies the complexity of the immune system and the need for a 
heightened comprehension of its multiple facets. Ultimately it would be desirable to 
achieve a balance and harmony required for the well-being of the body, either 
naturally or through artificial intervention.
Another consideration regarding the immunoregulatory role CD4+ CD25+ T cells is 
that they may function differently at different stages of disease processes. Their role 
during homeostatic control, via the prevention of autoimmunity may be to determine
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whether or not autoimmune disease will occur. In chronic inflammation the presence 
of CD4T CD25+ T cells may be harmful by inhibiting an effective immune response in 
its natural course and allowing the inflammatory process to change into a chronic 
autoimmune condition. This is illustrated in a study in which the depletion of CD4+ 
CD25  ^ T cells, in mice, resulted in the acceleration of onset and worsening of 
collagen-induced arthritis (Morgan et al, 2003).
The current knowledge suggests the T reg cells are central to the equilibrium of good 
health and thus the way forward in the therapeutic intervention of autoimmune 
diseases and possibly allergic disease states. The current challenge for immunologists 
is to utilize the pro’s and con’s of natural T reg cells and understand how to tailor 
their function to achieve the proper balance between protection and pathology. Future 
studies should aim to identify drugs, cytokines, or costimulatory molecules that 
induce in vivo growth while preserving the suppressor function of T reg cells.
It would appear that T reg cells provide an important and controllable branch of the 
immune system, in which, under certain antigenic challenges or cytokine milieus, 
there is promotion of T reg cell differentiation and expansion. It has been reported 
that small numbers of antigen-specific T reg cells can reverse autoimmunity after 
disease onset, which would suggest an approach to cellular immunotherapy for 
autoimmunity. Efforts to develop therapeutic vaccines for organ-specific 
autoimmunity using this type of cellular therapy will depaid on identifying and 
selectively expanding autoantigen-specific T reg cells in humans. It is hoped that 
techniques will be developed to enable the isolation and expansion of T reg cells 
either using antigen presented on DCs (Tarbell et al,2004) or by using specific MHC- 
peptide agonists in the presence of adequate costimulation and growth factors. When 
these highly active T reg cells have been expanded they may be transferred into 
diseased individuals to reverse disease and to promote long-term tolerance to 
causative antigens (Bluestone and Tang, 2004).
It is of interest that an IL-10 upregulaiory effect with several traditional 
immunosuppressive drugs, such as glucocorticoids, has been demonstrated that 
traditionally were considered as immunosuppressive drugs as opposed to immune 
modulating agents (Zhou et al,2005). Glucorticoid treatment significantly increased
221
levels of transient Foxp3 mRNA expression, tightly correlating with IL-10 mRNA 
expression but only a moderate correlation with the expression of TGF-{3 mRNA, in 
asthmatic patients receiving inhaled glucocorticoid treatment In light of these 
findings it would be beneficial to develop strategies to convert transient 
glucocorticoid-induced T reg activity into a stable phenotype for the treatment of 
inflammatory diseases (Karagiannidis, 2004) such as autoimmune disease and asthma. 
Ultimately, the monitoring of effects of immunomodulatoiy drugs on regulatory T cell 
subsets will help to define their pathogenic role in human autoimmune diseases 
(Viglietta et al, 2004) and allergic diseases. Foxp3 upregulation has been observed in 
short term cultures following the addition of glucocorticoids. However a more 
prominent upregulation of Foxp3 has been observed in differentiation cultures in the 
presence of anti-IL-4/anti-IL-12 neutralizing mAbs. Which is accompanied by 
increased IL-10 expression (Barrat, et al, 2002) and generates a suppressive T cell 
phenotype (Karagiannidis et al, 2004). In research of this nature, when investigating 
the possibilities of manipulating T cells it is vital to remember that T cells do not 
develop in isolation but receive a complex array of signals whose balance determines 
their differentiation into effector cells (Kemeny and Macary, 2005).
The clinical use of inducible T reg cells appears to be promising however there 
remain several unanswered questions for the cure of T cell-mediated diseases. 
Inducible T reg cells, exert their suppressive function primarily via the release of IL- 
10 (Beissert et al, 2006) to maintain peripheral tolerance, control autoimmunity, and 
prevent allograft rejection and graft versus host disease (GvHD). Although little is 
known about their migratory capacity in vivo, their life span, their toxicity and their 
ability to promote tumour development. Results from ongoing proof of concept trials 
and proposed phase I/n clinical trials will prove essential for the future success of T 
reg cells in the clinic (Battagalia et al,2006). Ex-vivo generated inducible T reg cells 
have been proven to be effective in several pre-clinical models of T cell-mediated 
pathologies (Battaglia et al, 2006). A more detailed knowledge about this phenotype 
and their mode of action will significantly increase our understanding of the 
pathogenesis of such diseases and will assist in identifying new therapeutic strategies 
(Beissert et al, 2006) with a promising approach.
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Transcription factors, involved in the development of Thl and Th2 cytokines makes 
them also an attractive target for immunomodulation. Thus NF-kB blockade as a 
cytokine-directed therapy was explored in this thesis. There are several other specific 
transcription factors involved in driving CD4" T cells which could act as potential 
immunomodulatory targets. Thl and Th2 act through STAT4 and STAT6, towards 
subset development in response to IL-12 and IL-4 respectively. STAT6 is expressed 
in both Thl and Th2 cells although its phosphorylation and activation occurs 
exclusively in Th2 cells (Huang and Paul, 1998).
Th2 ceils express transcription factors c-Maf and GATA-3. c-Maf is specific for IL-4 
and is critical for high levels of IL-4 production (Rengarajan et al, 2000). It activates 
the expression of the IL-4 gene whereas GATA-3, in developing and committed Thl 
cells, induces the expression of Th2 specific cytokines and inhibits the production of 
IFN-y (O’Garra, 2000). Retrovirally overexpressed GATA-3 has been reported to 
induce the Th2 cytokine profile in developing Thl cells (Kurata et al, 2002). 
Recently, a yeast two-hybrid screening identified friend of GATA (FOG) as GATA-1 
Nf-interacting molecule in the MEL cell library (Tsang et al, 1997). Subsequently its 
human homologue FOG-2 was identified in embryonic tissues (Svensson et al, 1999). 
FOG is expressed in naive Th cells and functions as a repressor of GATA-3 mediated 
Th2 development hence the downregulation of FOG is an essential step for Th2 cell 
development (Kurata et al, 2002). Studies in mice have supported the concept that 
inhibiting STAT6 with a decoy can disrupt the proliferation of murine Th2 cells and 
human CD4+ T lymphocytes (Wang et al, 2000). It remains to be seen whether there 
is any beneficial effect on lung inflammation in asthmatics. In animal models, 
targeting GATA-3 has been shown to be beneficial in experimental asthma (Finotto et 
al, 2001).
It was recently shown that lymphocytes derived from lung biopsies of asthmatic 
patients were deficient in the transcription factor T-bet (Finotto et al, 2002). It has 
been proposed that the correction of T-bet deficiency might be an effective means of 
immunomodulation and restoring the normal Thl-Th2 balance (Bloebaum et al, 
2004). T-bet was identified by Szabo et al (2000) as being Thl specific, it is induced 
by IL-12 and causes induction of IFN-y at the same time as repressing the expression
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of IL-4 and IL-5 gene expression in both developing and committed Th2 cells. The 
transduction of T-bet into fully polarized Th2 cells converts them into IFN-y- 
producing Thl cells that repress the Th2 cytokines, IL-4 and IL-5 (Romagnani, 2004). 
The suppression of T-bet inhibits Thl-mediated chronic intestinal inflammation. T- 
bet acts in the generation of Thl development and is induced in response to signals 
from the TCR, probably in conjunction with signals from IFN-y, IFN-a/p and/or IL- 
12 receptors. T-bet activates the expression of IFN-y, the p chain of the IL-12 
receptor along with its own expression, thereby enforcing the Thl program even in 
cells cultured under Ih2 conditions (Wilson et al, 2002).
The knowledge of transcriptional polarisation of T cells provides a rationale for 
selective targeting of transcription factors and signalling cascades in T cells in 
autoimmune and chronic inflammatory diseases, the obvious advantage being that 
they target multiple pro-inflammatory cytokines simultaneously rather than a single 
cytokine. For example, targeting GATA-3 expression in the lung would hopefully 
suppress IL-4, IL-5 and IL-13 production concurrently. A downside to this would be 
that given the pleiotropic role of these transcription factors in the normal immune 
system, systemic targeting of these factors may result in various side effects and so 
localised targeting, (for example inhalation for the lung or intraluminal application for 
the gut or eye drops for the eye), may therefore be preferable (Neurath et al, 2002).
SOCS molecules, include a family of eight SOCS molecules, comprising of proteins 
induced in response to cytokine stimulation which block further signalling in a classic 
feedback loop. This is considered to be achieved by targeting signalling intermediates 
for degradation Any imbalance of die SOCS proteins can result in a broad spectrum 
of pathologies as well as being involved in determining cell fate and regulation of the 
inflammatory process. The reason for this is that each of the SOCS targets distinct 
signalling pathways and their altered expression can cause diseases as diverse as IBD, 
allergy, autoimmune diseases and type I diabetes, characterized by selective loss of 
insulin producing beta cells in the pancreatic islets (Elliott and Johnston, 2004). 
Hence determining the function of SOCS proteins might aid the development of novel 
therapeutic strategies and as a possible means of manipulating T reg cells.
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For the purpose of this thesis I shall discuss literature relating to SOCS associated 
with allergic and autoimmune disorders. SOCSl as a crucial inhibitor of IFN- 
y (Marine et a l , 1999). SOCS and IFN-y depleted mice succumb to a range of 
inflammatory diseases resulting in the aberrant signalling of other inflammatory 
cytokines such as IL-2, IL-4. EL-6 IL-12 and IL-15 (Metcalf et al, 2002). SOCSl 
deficiency is therefore associated with a wide range of acute and chronic 
inflammatory disorders, suggesting an important role for SOCSl in autoimmune 
disease (Elliot and Johnston, 2004). SOCSl has been implicated in maintaining DC 
homeostasis and suppressing autoimmunity (Hanada et al, 2003). SOCSl has also 
been reported as having a role in T cell differentiation and is able to inhibit signalling 
of both IL-12 and IL-4.
SOCS5 has been identified for its capacity to block IL-4 (and probably IL-13) 
signalling, and is preferentially expressed in Thl cells (Seki et al, 2002). Recent 
reports suggest the involvement of SOCSl, 3 and 5 in T cell differentiation and, along 
with their function in blocking cytokine production, SOCS3 and SOCS5 appear to be 
attractive therapeutic targets for the treatment of autoimmune disorders and leading to 
the development of effective anti-allergic drugs (Elliott and Johnston, 2004). A 
further understanding of the role of SOCS proteins in T cell development has to be 
gained to potentially combat atopic diseases. A recent study investigating levels of 
SOCS observed in PB T cells from asthmatics compared to non-asthmatics, reported 
that levels of SOCS were significantly higher in asthmatics with the level of SOCS3 
expression correlating with disease severity (Boyton et al, 2004). It is foreseen that 
gene therapy or small interfering RNA (siRNA) technology could be used to blockade 
of specific SOCS expression, thereby suppressing Th-mediated responses associated 
with common autoimmune disorders (Seki et al, 2002).
Another strategy to divot or dampen the immune response from Th2 type responses 
and diverted towards Thl type responses includes the use of specific bacterial DNA 
sequences (unmethylated cytosine-guanine dinucleotides), known as CpG motifs 
(Bloebaum et al, 2004). This strategy employs the use of killed bacteria (or 
components derived from them), which are recognised by the mammalian immune 
system as danger signals. The CpG motifs may be utilized as adjuvant to
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immunotherapy to promote a Thl type response. Promising results have been 
obtained in animal models with the induction of systemic or local allergen-dependent 
or independent Thl immune responses and it is thought these CpG motifs would be 
beneficial in humans (Bloebaum et al, 2004). The molecular mechanisms responsible 
for the immunostimulatory effects of CpG ODN include the activation of B cells, NK 
cells and APCs including monocytes, macrophages, and DCs. Clinical trials using 
CpG ODN as an immune adjuvant appear to be promising. Preclinical studies 
suggested CpG ODN enhances innate immunity against a variety of infections, 
synergize with monoclonal antibody to enhance ADCC, and alter the Thl/Th2 
balance as a possible treatment for allergic diseases and asthma (Weiner, 2000). 
Clinical trials are currently underway to determine whether promising preclinical 
results with CpG ODN can be translated into effective and tolerable clinical treatment 
in asthmatics (Bloebaum et al, 2004).
Immunomodulation is an important candidate in the future of immunotherapy in 
immune polarised diseases such as allergic and autoimmune diseases. Both allergic 
and autoimmune diseases are united by the fact that they both represent poorly 
regulated and exaggerated immune responses (Smit etal, 2004). There is an enormous 
effort focused on immunomodulatory strategies and scope for intervention targeting 
different components within die immune system. However, it is crucial to investigate 
the long-term consequences of the suppression of Thl or Th2 responses to determine 
the exact consequences of modifying the immune system balance (Bloebaum et al, 
2004).
Within this general discussion section I have attempted to collate a range of 
immunomodulatory techniques that have potential scope for use in Thl and Th2 
skewed pathological conditions, including ocular inflammatory conditions such as 
TAO and CAED. As with all the immunomodulatory techniques discussed it is of 
utmost importance that a harmonious balance is created to achieve overall a normal 
physiological state. This is achievable if immunotherapies are directed locally at the 
site of inflammation. In systemic conditions it would be feasible to consider 
therapeutic applications intermittently in order to rectify imbalances and redirect the 
immune system to a balanced state. The normal physiological mechanism, of 
maintaining a stable non-polarised immune system, is regulated by T reg cells and so
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it is considered to be an highly attractive avenue to modulate whether via increase of 
natural T reg cell or more achievable via the administration of immunotherapeutic 
drugs such as dexamethasone combined with vitamin D3 to increase levels of 
inducible T reg cells resulting in increased levels of immunosuppressive cytokine IL- 
10. The amount of advancement within the field of immunotherapy is exciting and 
promising. Experimentation, looking for improved treatments that can stop the 
progression of disease as well as reducing the morbidity and mortality (Bloebaum et 
aL 2004) is a reachable target in the near future.
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